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Abstract 
 
Innate signals are fundamental to determine the class of adaptive response against 
infection. The translation of microbial signatures into adaptive immunity is mediated by 
pattern recognition receptors (PRRs), which are expressed in specialized leukocytes 
called dendritic cells (DCs) and results in responses matched to the nature of the 
offending microbe. Here, I provide evidence that two Syk-coupled C-type lectin 
receptors (CLRs), Dectin-1 and Dectin-2, act in the coordination of adaptive immune 
responses to fungal stimuli and fungal pathogens. 
DC activated via Dectin-1 are strong elicitors of IL-17 production by CD4+ T cells. 
Results presented in this thesis demonstrate that Dectin-1 signalling in DCs results in 
the generation and Foxp3+-IL-17+ T cells, a cell type that defies either regulatory or 
Th17 classification. This process is dependent on IL-23, which is produced by DCs 
upon Dectin-1 ligation. 
In addition, this work identified an additional CLR responsible for the induction of 
Th17 responses during the course of fungal infections. This thesis demonstrates that 
Dectin-2 is a second Syk-coupled PRR involved in DC activation by fungi. In a model 
of Candida albicans systemic infection, Dectin-2 is essential for the induction of Th17 
responses to the organism. 
Finally, I have generated tools to study responses of T cells specific for a fungal-
associated antigen. Furthermore, I provide preliminary evidence regarding the 
activation, proliferation and trafficking of antigen-specific CD4+ and CD8+ T cells 
during systemic fungal infections.  
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Chapter 1. Introduction 
Our immune system has evolved specialized mechanisms to coordinate an appropriate 
anti-pathogen response while maintaining host homeostasis. The immune signalling 
pathways involved in pathogen recognition and clearance are controlled by microbial 
sensors that detect features present in different organisms. The best-characterized 
pathogen sensors of the immune system are the so-called pattern recognition receptors 
(PRRs), first defined by Charles Janeway Jr. in his seminal essay in 1989 (Janeway, 
1989). He defined PRRs as germ-line encoded receptors that are non-clonally 
distributed and are involved in the recognition of invariant pathogen-associated 
molecular patterns (PAMPs) not found in the host (Janeway, 1989). Janeway’s theory 
postulated that innate recognition by PRRs preceded the generation of adaptive 
immunity by regulating the induction of costimulatory signals required for lymphocyte 
activation (Janeway, 1989). 
Five years after the publication of Janeway’s theory, an essay written by Polly 
Matzinger provided new perspectives to the immunological field (Matzinger, 1994). 
She challenged Janeway’s opinion by stating that the immune system is not designed to 
discriminate between “self” and “not self” but it has evolved to detect any form of 
danger signals, even in absence of pathogen presence (Matzinger, 1994). Danger signals 
are intrinsically immunogenic and correspond to endogenous molecules that become 
exposed in cells upon stress, injury and death. In later years, these molecules have been 
referred to as damaged-associated molecular patterns (DAMPs) and there are numerous 
examples including uric acid, calreticulin, ribonucleoproteins and ATP among others. 
Notably, the detection of DAMP presence is also mediated by PRRs, which orchestrate 
the initiation of the immune response in response to the appropriate insult (Rock and 
Kono, 2008). 
In recent years, it has become apparent that both Janeway and Matzinger were correct. 
PAMPs and DAMPs are elicitors of the immune system in conditions of infection 
and/or sterile injury. Whether the immune system distinguishes these two types of 
signals to generate qualitatively different types of immune responses is at present 
unclear. 
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1.1 The discovery of pattern recognition receptors 
According to Janeway’s theory, a PRR should fulfil the three following criteria: first, it 
must localize to the cell surface; second, it must be expressed by APCs such as 
macrophages and DCs; and third, it must be capable of triggering signalling pathways 
that result in the upregulation of costimulatory molecules (Medzhitov, 2009). 
At that time, it was known that stimulation of cells with various innate agents led to the 
activation of the transcription factor NF-κB (Kopp and Ghosh, 1995). NF-κB activation 
was also noted in response to IL-1 receptor triggering (Kopp and Ghosh, 1995). 
Furthermore, the identification of a particular cytosolic signalling domain present in the 
human IL-1R that shared similarity to the Drosophila Toll Protein and to the Tobacco 
Resistance protein N, known as Toll, IL-1R and Resistance domain or TIR (Gay and 
Keith, 1991, Whitham et al., 1994), received much attention. Indeed, the first receptor 
capable of triggering an anti-microbial response directly was the Toll protein from 
Drosophila melanogaster (Lemaitre et al., 1996). In this report, Jules Hoffmann’s group 
identified the Spätzle/Toll/Cactus signalling pathway as an essential axis of antifungal 
resistance in Drosophila (Lemaitre et al., 1996). It was discovered that activation of 
Spätzle by proteolytic cleavage allow it to bind to Toll receptor, and transmit signals to 
Cactus (an IκB-related protein) to control the expression of the antifungal peptide 
drosomycin (Lemaitre et al., 1996).  
The groundbreaking discovery of an innate signalling pathway associated with host 
defense in Drosophila reinforced the idea that signalling PRRs must exist in higher 
eukaryotes. In 1997, Medzhitov and Janeway first reported the identification of a human 
toll homolog that signalled for cell activation (Medzhitov et al., 1997). The human Toll 
protein shared many similarities with Drosophila Toll such as the presence of leucine 
rich repeats (LRRs) and a TIR domain, and the ability to signal through the NF-κB 
pathway (Medzhitov et al., 1997). Furthermore, activation of human Toll resulted in 
cytokine production and upregulation of costimulatory molecules suggesting a role for 
this protein in the coordination of adaptive immunity ((Medzhitov et al., 1997) and 
reviewed in (Medzhitov and Janeway, 1997)). 
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The identification of the first toll-like receptor provided experimental evidence for 
Charles Janeway’s theory and opened an immense field of research dedicated to the 
identification of additional mammalian PRRs and their contribution in immunity. 
At present, four major classes of PRRs have been identified and include members of 
Toll-like receptor, RIG-I-like receptor, NOD-like receptor and C-type lectin receptor 
families. 
1.2 Pattern recognition receptors 
1.2.1 Toll-like receptors (TLRs) 
Following the identification of the first TLR, the discovery of the TLR family made 
rapid progress. Twelve members were identified in mammals. TLRs together with IL-1 
receptors constitute a superfamily based on the homology of the cytoplasmic region. 
Within the TIR domain, the similarities map at the level of three conserved boxes that 
are essential for signalling (Akira and Takeda, 2004). 
In addition to the intracellular signalling domain, TLRs possess an extracellular region 
containing 19-25 tandem copies of LRRs. This region is not present in IL-1R and forms 
a surface suited for PAMP recognition (Akira and Takeda, 2004). 
TLRs reside either in the plasma membrane or in intracellular compartments (Figure 
1.1). TLRs expressed at the cell surface (TLR 1, 2, 4, 5 and 6) recognize a broad range 
of microbial signatures. TLR1, TLR2 and TLR6 recognize lipids including 
peptidoglycan, lipoarabinomannan and phospholipomannan (TLR2), lipoteichoic acids, 
Gram-positive bacteria and bacterial proteins (TLR1/TLR2) (TLR2/TLR6) (Akira et al., 
2006, Iwasaki and Medzhitov, 2010). TLR4 recognizes LPS from Gram-negative 
bacteria whereas TLR5 recognizes flagellin (Iwasaki and Medzhitov, 2010). TLRs that 
are found in endosomal/lysosomal compartments recognize microbial nucleic acids 
including double-stranded RNA (TLR3), single-stranded RNA (TLR7) and double-
stranded DNA (TLR9) (Iwasaki and Medzhitov, 2010). 
Upon ligand binding, TLRs initiate downstream signalling responses by recruiting a 
TIR domain-containing adaptor such as Myeloid Differentiation primary-response 
Chapter 1. Introduction 
 18 
protein 88 (MyD88), TIR-domain-containing adaptor protein (TIRAP) and TIR-
domain-containing adaptor protein inducing IFN-β (TRIF) (Akira and Takeda, 2004). 
TLR-adaptor interaction favours the formation of a complex involving IL-1R-associated 
kinase (IRAK) and TNF receptor-associated factor 6 (TRAF6). This ultimately results 
in activation of NF-κB and MAPKs for induction of proinflammatory cytokines 
(reviewed in (Akira and Takeda, 2004) and (Akira et al., 2006)). 
Although most TLRs signal in a MyD88-dependent manner, TLR3 utilizes the adaptor 
TRIF for NF-κB activation and production of type I IFNs (Akira et al., 2006). Thus, 
MyD88 and TRIF are responsible for the activation of signalling pathways downstream 
of TLRs leading to the induction of proinflammatory cytokines and type I IFNs (Akira 
et al., 2006). 
1.2.2 Cytosolic PRRs 
1.2.2.1 RIG-I-like receptors (RLRs) 
The RIG-I-like receptor family of cytosolic RNA helicases is involved in the detection 
of nucleic acids following viral infection (Figure 1.1). This family comprises three 
members: retinoic acid inducible gene I (RIG-I), melanoma differentiation associated 
gene 5 (MDA5) and Laboratory of genetics and physiology 2 (LGP2). Detection of viral 
RNA by RIG-I and MDA5 results in activation of the adaptor MAVS (mitochondrial 
antiviral signalling), which initiates a signalling cascade involving interferon response 
factor 3 (IRF3), IRF7 and NF-κB. This results in the production of type I IFNs and 
other proinflammatory cytokines (Pichlmair and Reis e Sousa, 2007). RIG-I and MDA5 
recognize different ligands, are activated upon infection with different set of viruses and 
play a non-redundant role in the coordination of antiviral defense (Rehwinkel and Reis 
e Sousa, 2010). 
1.2.2.2 NOD-like receptors (NLRs) 
NLRs constitute a large family of cytosolic sensors involved in the recognition of 
pathogens and danger signals (Figure 1.1). NLR members have three characteristic 
domains: an LRR region, a nucleotide oligomerization domain (NOD or also called 
NACHT) and an effector motif such as CARD, PYRIN or BIR domain (Martinon et al., 
2009). 
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Some members of the NLR family are involved in the recognition of bacterial 
signatures. Two different components present in the bacterial peptidoglycan: γ-D-
glutamyl-meso-diaminopimelic acid (iE-DAP) and muramyldipeptide (MDP) are the 
ligands for NOD1 and NOD2, respectively (Akira et al., 2006). Upon ligand binding, 
NOD 1-2 signal to NF-κB via activation of the kinase RIP2/RICK (Akira et al., 2006). 
Additional members of the NLR family are involved in the activation of a protein 
complex responsible for processing of the cytokines IL-1β/IL-18/IL-33 named 
inflammasome. Is important to note that in the original sense of the terms described 
above, these NLR members do not fulfill the criterion of PRRs; as activation of the 
inflammasome does not culminate in gene regulation. On the other hand, inflammasome 
assembly leads to the activation of caspase-1, which is responsible for the processing 
and secretion of proinflammatory cytokines. 
The NLRs NALP1, NALP3 and IPAF are prototype activators of the inflammasome in 
response to factors derived from bacteria and viruses or to endogenous danger signals 
such as uric acid, potassium efflux, ROS and membrane disruption (reviewed in 
(Martinon et al., 2009)). Inflammasome activation has emerged as a crucial sensor of 
harmful microbial presence and metabolic stress. 
1.2.3 C-type lectin receptors (CLRs) 
The term “C-type lectin” was first used to differentiate a group of Ca+2 dependent 
carbohydrate-binding (lectin) proteins from the rest of animal lectins (Zelensky and 
Gready, 2005). At that time, the analysis of Ca+2 dependent lectins identified a 
particular carbohydrate recognition domain (CRD) that was called “C-type CRD” or 
“C-type lectin domain” (Zelensky and Gready, 2005). The identification of many more 
proteins containing a C-type CRD revealed that not all members of this group bind to 
carbohydrates or even calcium. This contradiction was later solved by introducing a 
more general term; “C-type lectin-like domain” (CTLD) to name proteins containing a 
homologous C-type CRD (Zelensky and Gready, 2005). 
The definition of “C-type lectin” corresponds to any protein possessing one or more 
CTLDs (Kerrigan and Brown, 2010). According to that definition, CLRs encompass a 
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large family of proteins with diverse functions including cell adhesion, pathogen 
recognition, regulation of natural killer function, complement activation, tissue 
remodelling, platelet activation, endocytosis and phagocytosis among others (Zelensky 
and Gready, 2005, Kerrigan and Brown, 2010, Robinson et al., 2006). Notably, there is 
a subset of CLRs that function as transmembrane innate PRRs that are mainly expressed 
on myeloid cells (Figure 1.1).  
CLRs that act as PRRs recognize microbial signatures including mannose, fucose and 
glucan moieties. Glucans are main constituents of the cell wall of fungi, plants and 
mycobacteria species; mannose and high mannose structures are highly expressed by 
some viruses, fungi and mycobacteria. Fucose structures are found on the surface of 
helminths and some bacterial species (Geijtenbeek and Gringhuis, 2009). 
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Figure 1-1: Major classes of cell-associated PRRs in mammals 
Upon PAMP recognition, transmembrane or intracellular PRRs trigger signalling pathways involved in 
the activation of innate and adaptive immunity. (Drawn with reference to (Medzhitov, 2009)).  
1.3 Myeloid CLRs in innate immunity 
According to the nature of their CTLD, myeloid CLRs can be divided into two groups: 
group I contains CLRs belonging to the mannose receptor family and group II contain 
CLRs that belong to the asialoglycoprotein receptor family, which can be further 
divided into Dectin-1 or DCIR subfamilies (Geijtenbeek and Gringhuis, 2009). 
An additional criterion to classify myeloid CLRs is based on their ability to trigger an 
intracellular signalling event. A group of CLRs has been shown to induce signalling 
pathways by associating with signalling adaptors containing an immunoreceptor 
tyrosine-based activation motif or ITAM (YXXL/I X6,8 YXXL/I (Ivashkiv, 2009)). 
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Other CLRs possess an ITAM-like motif (named “hemITAM”; for detailed description 
see section 1.3.2.1) within their intracellular tail, which allows them to activate protein 
cascades directly. A third group of CLRs possesses an immunoreceptor tyrosine-based 
inhibitory motif or ITIM (S/I/V/LxYxxI/V/L (Barrow and Trowsdale, 2006)) that is 
thought to inhibit myeloid cell activation. These types of CLRs are illustrated in figure 
1.2. 
 
 
Figure 1-2: Upon ligand binding, myeloid CLRs induce protein cascades by using distinct proximal 
signalling mechanisms. 
ITAM, hemITAM and ITIM signalling starts with the phosphorylation of the tyrosines located within the 
tyrosine based signalling motif. In the case of ITAM and hemITAM-coupled CLRs, tyrosine 
phosphorylation leads to activation of the kinase Syk and initiation of signalling cascades. In contrast, 
ITIM-containing CLRs can couple to SHP-1 or SHP-2 phosphatases, which may inhibit cell activation. 
Tyrosines contained within the signalling motifs are depicted in red and ‘x’ corresponds to any amino 
acid. Drawn with reference to (Robinson et al., 2006). 
 
For simplicity purposes, CLRs have been associated based on the presence of tyrosine-
based motifs. Myeloid CLRs falling into these four categories are shown in table 1. 
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Table 1: Myeloid CLRs associated by their signalling motifs.  
With reference to (Robinson et al., 2006) and (Geijtenbeek and Gringhuis, 2009). 
CLR Tyrosine-based motif Ligand 
Mannose Receptor None High mannose, fucose 
DEC-205 None ND 
DC-SIGN  None High mannose and fucose 
MGL None Terminal GalNAc 
CLEC5a ITAM-based (adaptor 
DAP10/DAP12) 
ND (Dengue virus) 
Dectin-2 (CLEC4n) ITAM-based (adaptor FcRγ 
chain) 
High mannose, α-mannans 
Mincle (CLE4E) ITAM-based (adaptor FcRγ 
chain) 
α-mannose, glycolipids 
BDCA-2 ITAM-based (adaptor FcRγ 
chain) 
ND 
Dectin-1 (CLEC7a) hemITAM-based  β-1,3 glucans 
CLEC-2 hemITAM-based ND 
DNGR-1 (CLEC9a) hemITAM-based ND 
DCIR (CLEC4a) ITIM-based ND 
CLEC12B ITIM-based ND 
MICL (CLEC12a) ITIM-based ND 
 
1.3.1 Endocytic CLRs lacking classical signalling motifs 
DC-SIGN, DEC-205 and mannose receptor (MR) are CLRs that have endocytic activity 
and mediate internalization of their ligands into intracellular compartments 
(Geijtenbeek and Gringhuis, 2009). Furthermore, these CLRs can direct the cargo into 
the appropriate route for antigen processing and presentation. Despite their involvement 
in antigen trafficking, these CLRs do not contain classical signalling motifs within their 
cytoplasmic tails. Thus, there is limited evidence indicating that they behave as 
signalling PRRs for gene transcription and cytokine production in myeloid cells. It is 
also unclear whether the endocytic properties of these CLRs require signalling via 
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protein cascades. On the other hand, CLRs with endocytic activity expressed in myeloid 
DCs such as DEC-205 have become interesting candidates for vaccine studies. In fact, 
targeting of antigens to DEC-205 enhances antigen presentation and leads to T cell 
immunity (reviewed in (Steinman et al., 2003)). 
1.3.2 CLRs that signal via the spleen tyrosine kinase Syk 
1.3.2.1 Dectin-1, a ‘hemITAM’ containing CLR 
Although not all CLRs are competent to trigger an intracellular signalling event, some 
CLRs have shown to directly couple PAMP recognition to gene induction. The classical 
example of a CLR that induces intracellular signalling cascades is Dectin-1 (“DC-
associated C-type lectin 1”). Despite its name, Dectin-1 is not restricted to DC and it is 
expressed in many other cell types including monocytes, macrophages, neutrophils, a 
subset of T cells, and CCR6-expressing γδ T cells (Taylor et al., 2002, Martin et al., 
2009). 
Dectin-1 is a receptor with specificity for β-linked glucans that are present in the cell 
wall of fungi, but also some bacteria and plants (Brown, 2006). Studies using 
oligosaccharide microarray technology have shown that Dectin-1 specifically 
recognizes β-(1,3)-linked glucans (Palma et al., 2006). Although it was first described 
as a receptor for the crude yeast cell wall preparation zymosan (Brown and Gordon, 
2001), Dectin-1 also binds to fungal pathogens including Candida spp., Aspergillus 
spp., Coccidiodes spp., Pneumocystis spp. and bacterial pathogens such as mycobacteria 
(Brown, 2006, Geijtenbeek and Gringhuis, 2009, Rothfuchs et al., 2007). In addition to 
the ligands derived from pathogens, this receptor possesses an unidentified endogenous 
ligand expressed in T cells (Ariizumi et al., 2000b).  
Dectin-1 is a type II transmembrane protein that contains a single extracellular CTLD 
and an ITAM-like motif on its intracellular tail (Ariizumi et al., 2000b). Classical ITAM 
signalling starts with the phosphorylation of two tyrosines located within the ITAM 
motif by members of Src family kinases. This process provides appropriate docking 
sites for dual interaction with the tandem SH2 domains of Syk family kinases (Syk and 
ZAP-70), leading to the initiation of downstream signal transduction events (Ivashkiv, 
2009). 
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In contrast to the conventional ITAM sequence, the amino terminal tyrosine (Tyr3) of 
Dectin-1 is not located within an appropriate YXXL context and has a highly charged 
triacidic motif (DED) located proximal to distal tyrosine 15 (Ariizumi et al., 2000b, 
Underhill et al., 2005). Despite this unusual sequence, the ITAM-like motif of Dectin-1 
is able to directly recruit and activate Syk upon zymosan binding (Rogers et al., 2005, 
Underhill et al., 2005). Work from the Immunobiology Laboratory has first 
demonstrated that a single phosphorylation on the membrane-tyrosine 15 in the tail of 
Dectin-1 is necessary and sufficient to mediate signalling via Syk (Rogers et al., 2005). 
The single YXXL motif responsible for this unusual mode of Syk activation has been 
termed “hemITAM” ((Rogers et al., 2005) and reviewed in (Robinson et al., 2006)). 
The relevance of Syk signalling in fungal recognition is underscored by the inability of 
Syk deficient DCs to produce IL-2 and IL-10 upon zymosan stimulation, reinforcing the 
notion that Syk is non redundant for innate responses to fungal stimuli (Rogers et al., 
2005). Surprisingly, unlike Syk deficient DCs, DCs lacking Dectin-1 are not impaired 
in their ability to produce IL-2 and IL-10 upon zymosan stimulation indicating that 
additional Syk-coupled PRRs are likely to be involved in fungal recognition 
(LeibundGut-Landmann et al., 2007, Robinson et al., 2009). 
On average, glucans account for 54.7% of yeast zymosan (Di Carlo and Fiore, 1958). 
The remaining fraction contains a large proportion of mannans (18.8%), proteins 
(14.5%), fat (6.6%), inorganic materials (3.2%) and chitin (0.8%) (Di Carlo and Fiore, 
1958). Not surprisingly, this crude preparation has been shown to contain ligands for 
various PRRs including Dectin-1, TLR2/6, mannose receptor and complement receptor 
among others (Brown and Gordon, 2001, Ezekowitz et al., 1984, Sung et al., 1983, 
Gantner et al., 2003). Upon zymosan stimulation, PRRs such as Dectin-1 and TLR2 are 
engaged simultaneously and have shown to collaborate to enhance the production of 
proinflammatory cytokines (Gantner et al., 2003).  
Despite its ability to interact with TLRs for modulating of inflammatory responses to 
complex stimuli, Dectin-1 can also function as a signalling PRR in isolation. Dectin-1 
signalling directs NF-κB activation by recruiting the adaptor protein CARD9 (Gross et 
al., 2006, Goodridge et al., 2009). This adaptor signals via Bcl10 and Malt-1 for NF-κB 
Chapter 1. Introduction 
 26 
activation and is essential for antifungal immunity to Candida albicans in vivo (Gross et 
al., 2006). In addition to the activation of the canonical NF-κB pathway in response to 
Syk/CARD9 signalling, Dectin-1 ligation also results in activation of the non-canonical 
NF-κB pathway. Activation of both NF-κB pathways downstream of Dectin-1 involves 
signalling via Syk and also via the serine/threonine kinase RAF-1 (Gringhuis et al., 
2009). 
Notably, CARD9 signalling in response to Dectin-1 activation seems to be cell-type 
dependent. Whereas GM-CSF-derived BMDC, GM-CSF/IFN-γ primed macrophages 
and peritoneal cells activate NF-κB and produce robust amounts of TNF in response to 
Dectin-1 ligation, FLT3-L-derived BMDCs and M-CSF-derived macrophages are 
unresponsive to a Dectin-1 agonist (Goodridge et al., 2009). The heterogeneity in 
Dectin-1 signalling in different subsets of APC may be of relevance in the study of 
antifungal immunity. 
The intracellular consequences of Dectin-1/Syk activation extend beyond the activation 
of NF-κB. Activation of Dectin-1/Syk by fungal stimuli results in production of reactive 
oxygen species (ROS) and activation of ERK MAP kinase (Underhill et al., 2005, Slack 
et al., 2007). Moreover, ligation of Dectin-1 but not TLR2 results in NFAT activation 
(Goodridge et al., 2007). In DCs stimulated with fungal particles, NFAT controls the 
production of IL-2, IL-10 and IL-12p70 (Goodridge et al., 2007). 
These studies elegantly dissected the role of Dectin-1 in DC responses to complex 
fungal stimuli such as zymosan or C. albicans. Nonetheless, the contribution of Dectin-
1 to the initiation of adaptive immunity was unknown due to the lack of a purified 
agonist. In 2005, Yoshitomi et al. showed that a purified preparation of β-glucan known 
as curdlan was able to induce DC activation. Curdlan is a β-(1,3)-glucan polymer 
produced by culture fermentation from a non-pathogenic and non-toxico strain of the 
bacterium Alcaligenes faecalis (Spicer et al., 1999). BMDCs stimulated with curdlan 
produced TNF in a MyD88-independent manner (Yoshitomi et al., 2005). Remarkably, 
the addition of a blocking antibody to Dectin-1 prevented the induction of TNF by 
curdlan-activated BMDCs suggesting that Dectin-1 was a PRR for this β-glucan 
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preparation (Yoshitomi et al., 2005). At that time, it was unclear whether curdlan could 
act as a specific agonist for Dectin-1. 
Dr Salomé LeibundGut-Landmann (former member of the Immunobiology Laboratory, 
Cancer Research UK) validated curdlan as a specific Dectin-1 agonist and established 
the outcome of the Dectin-1 signalling pathway in DCs. Specific triggering of Dectin-1 
induced upregulation of the costimulatory molecules CD86, CD80 and CD40 and 
activation of the MAP kinases p38, Erk and Jnk together with NF-κB in a Syk 
dependent manner (LeibundGut-Landmann et al., 2007). In addition, curdlan-activated 
DCs produced a distinct pattern of cytokines with robust levels of IL-2, IL-10, TNF, IL-
6 and IL-23. Importantly, that response was dependent on Dectin-1, Syk and CARD9 
and independent of MyD88 (LeibundGut-Landmann et al., 2007). Altogether, this work 
demonstrated for the first time that selective activation of Dectin-1/Syk/CARD9 
signalling pathway in isolation was sufficient to induce full DC activation (LeibundGut-
Landmann et al., 2007). The contribution of Dectin-1 to the initiation of adaptive 
immunity is the main research topic of chapter 3 presented in this thesis. 
Like Dectin-1, there are additional members of this family containing a hemITAM 
motif including CLEC-2 and DNGR-1 (also known as CLEC9A). CLEC-2 recognizes a 
ligand present in the snake venom toxin rhodocytin and in HIV-1. In addition, CLEC-2 
possesses an endogenous ligand called podoplanin, which is involved in platelet 
aggregation, lymphatic vessel formation and tumor metastasis (Kerrigan and Brown, 
2010). Importantly, CLEC-2 behaves as a Syk-coupled PRR in various cell types 
including DCs and platelets (Diego Mourão-Sá, unpublished observations and (Suzuki-
Inoue et al., 2006). DNGR-1 recognizes an unidentified ligand exposed during cell 
necrosis and mediates crosspresentation of dead-cell material by DCs through a 
hemITAM-Syk interaction (Sancho et al., 2009). 
1.3.2.2 CLRs signalling via ITAM-containing adaptors 
In addition to the CLRs that recruit Syk directly via their hemITAM motif, there is a 
second group of receptors that do not contain intracellular signalling regions but trigger 
protein cascades through association with ITAM-containing adaptor molecules. 
Members of this category include Mincle (macrophage inducible C-type lectin, also 
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known as CLEC4E), Dectin-2 (also known as CLEC4n), BDCA2 (blood DC antigen 2 
protein, also known as CLEC4C) and CLEC5A (also known as myeloid DAP12-
associating lectin-1, MDL-1 (Bakker et al., 1999)) (Geijtenbeek and Gringhuis, 2009). 
Mincle is expressed in macrophages and recognizes mannose residues present in fungi 
including C. albicans and Malasezzia sp, and glycolipids present in M. tuberculosis 
(Bugarcic et al., 2008, Wells et al., 2008, Yamasaki et al., 2009, Ishikawa et al., 2009). 
This receptor also recognizes the endogenous ribonucleoprotein SAP130, which is 
released upon cell death (Yamasaki et al., 2008). Upon ligand binding, Mincle 
associates with the ITAM-bearing molecule Fc receptor γ chain (FcRγ) and transduces 
an FcRγ chain-dependent signal that involves Syk and CARD9 (Yamasaki et al., 2008). 
Signalling via Mincle results in the production of TNF by macrophages (Yamasaki et 
al., 2008, Wells et al., 2008). In response to pathogen recognition, Mincle largely 
accounts for the MyD88 independent aspects of mycobacteria recognition and it is 
involved in host defense to C. albicans (Ishikawa et al., 2009) (Wells et al., 2008). 
Dectin-2, like Dectin-1, was identified by subtractive cDNA cloning in DC lines and 
despite its name, is only 19.6% homologous to Dectin-1 (Ariizumi et al., 2000a). 
Dectin-2 is a type II transmembrane CLR involved in the recognition of zymosan and 
various pathogens including C. albicans, Saccharomyces cereviseae, Mycobacterium 
tuberculosis, Paracoccoides brasiliensis, Histoplasma capsulatum, Microsporum 
audouinii, Trichophyton rubrum, Criptococcus neoformans with specificity for the 
hyphae over the yeast form (McGreal et al., 2006, Sato et al., 2006). Dectin-2 is also 
involved in the recognition of house dust mite allergens (Barrett et al., 2009) and glycan 
microarray data revealed that Dectin-2 has specificity for high-mannose structures 
(McGreal et al., 2006). Recently, it was reported that Dectin-2 recognizes α-mannans 
present in C. albicans cell wall (Saijo et al., 2010). As previously noticed for other 
CLRs, Dectin-2 also possesses an unknown endogenous ligand, which is expressed in 
CD4+CD25+ T cells upon UV radiation (Aragane et al., 2003). Although it was 
originally described as a DC-restricted receptor, particularly expressed in Langerhans 
cells (Ariizumi et al., 2000a, Bonkobara et al., 2001), further studies have demonstrated 
that Dectin-2 is expressed in various cell types including tissue macrophages and 
peripheral blood monocytes (Taylor et al., 2005). Dectin-2 associates with FcRγ chain 
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(Sato et al., 2006, Barrett et al., 2009), and hyphal stimulation of Dectin-2-transfected 
macrophages results in protein phosphorylation, NF-κB activation and production of 
TNF and IL-1Ra (Sato et al., 2006). Whether this reflected direct signalling by Dectin-2 
or was a consequence of enhanced fungal binding is unclear. Results presented in 
chapter 5 revealed that Dectin-2 is indeed a Syk-coupled CLR for fungal stimuli in 
DCs. Furthermore; data presented in chapter 5 indicates that Dectin-2 mediates the 
induction of Th17 responses to C. albicans infection (Robinson et al., 2009). 
BDCA-2 (blood dendritic cell antigen 2) is mainly expressed in plasmacytoid DCs 
(Dzionek et al., 2000, Dzionek et al., 2001). BDCA2 forms a complex with the ITAM-
containing transmembrane adaptor FcεRIγ, and leads to a signalling cascade similar to 
that activated downstream of the B cell receptor (BCR)(Cao et al., 2007). The BCR-like 
‘signalosome’ recruited by BDCA-2 involves Syk, BLNK and PLCγ2 and interferes 
with the production of type-I IFN induced by TLR agonists (Cao et al., 2007, Rock et 
al., 2007). It is unclear whether BDCA-2 acts only to prevent TLR signalling or can 
trigger cytokine responses in isolation. 
Finally, CLEC5A is a CLR expressed in monocytes, macrophages and osteoclasts 
(Bakker et al., 1999, Chen et al., 2008, Inui et al., 2009) and associates with the ITAM-
bearing molecules DAP10 and DAP12 (Bakker et al., 1999, Inui et al., 2009). Recently, 
it has been shown that CLEC5A is a PRR for Dengue virus and regulates the production 
of TNF in response to viral challenge (Chen et al., 2008). Whether CLEC5A is a Syk-
coupled receptor has yet to be determined. 
It is important to note that members of this group possess CTLD of different nature and 
fall into different subfamilies of the group II CLRs (Geijtenbeek and Gringhuis, 2009) 
but have been associated here for functional purposes. 
1.3.2.3 Consequences of Syk activation downstream of CLRs. 
Syk activation has pleiotropic effects in cellular biology including differentiation, 
cytoskeletal rearrangements, proliferation, survival and cytokine production (Mocsai et 
al., 2010). The relevance of Syk signalling in innate immunity is starting to be 
elucidated. Although Dectin-1 has been broadly used as the model PRR to study Syk 
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activation, it is now clear that many other CLRs might activate Syk and it will be 
important to reveal the role of this kinase in different types of innate challenge.  
As mentioned above, Syk activation downstream of Dectin-1 ligation results in the 
activation of MAPK including ERK and activation of NFAT (Slack et al., 2007, 
LeibundGut-Landmann et al., 2007, Goodridge et al., 2007). In addition, Syk 
phosphorylation results in the activation of NF-κB through CARD9, which is essential 
for antifungal immunity (Gross et al., 2006). As a consequence, Syk deficient DCs and 
macrophages are greatly impaired at producing of IL-2, IL-10 and ROS in response to 
fungal stimulation (Rogers et al., 2005, Underhill et al., 2005, Gross et al., 2009). Syk 
also has been involved in phagocytosis of fungal particles. Nonetheless, this effect 
seems to be cell-type dependent as phagocytosis of zymosan is a Syk-independent 
process in macrophages but it depends on Syk in DCs (Underhill et al., 2005, Rogers et 
al., 2005, Gross et al., 2006). 
Another aspect of Syk activation involves the regulation IL-1β production during fungal 
infection (Gross et al., 2009). IL-1β is a cytokine with a crucial role in antifungal 
immunity (Vonk et al., 2006) that is transcriptionally regulated by NF-κB and is post-
translationally regulated by the NALP3-inflammasome (described above) (Martinon et 
al., 2009). Whereas the Syk/CARD9 pathway activates the synthesis of pro-IL-1β, Syk 
also activates the NALP3-inflammasome in a ROS-dependent manner, resulting in 
proteolytic processing of IL-1β (Gross et al., 2009). Accordingly, NALP3 deficient 
mice are highly susceptible to fungal infection ((Gross et al., 2009), reviewed in 
(Mocsai et al., 2010)). 
Interestingly, the role of the Syk axis in immunity to pathogens extends beyond fungal 
recognition. The mechanism of adjuvanticity of the mycobacterial cord factor 
Trehalose-6-6-dimycolate (TDM) requires Syk and CARD9 signalling (Werninghaus et 
al., 2009). Mincle has been recently reported the Syk-coupled PRR for TDM (Ishikawa 
et al., 2009) (Schoenen et al., 2010). 
In the context of sterile injury, ligation of Mincle and DNGR-1 by dead cells triggers 
Syk-dependent responses. Whereas Mincle drives the infiltration of neutrophils to the 
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damaged tissue, DNGR-1 promotes cross-presentation of dead-cell derived antigens for 
priming of cytotoxic T cells (Yamasaki et al., 2008, Sancho et al., 2009). 
Notably, Syk functions downstream of CLRs might also encompass non-immune 
responses. Those aspects include osteoclastogenesis; platelet function and vascular 
development (reviewed in (Mocsai et al., 2010)) and CLRs including CLEC5A and 
CLEC2 are likely to be involved. 
Is important to note that these findings might be just a small fraction of the Syk 
“signature” which will have to be addressed using genome-wide screens in various 
immune scenarios. 
1.3.3 CLRs signalling via the serine/ threonine protein kinase RAF1  
In addition to the signalling pathway controlled by Syk, some CLRs have been shown 
to induce a second protein cascade mediated by the serine/threonine protein RAF1. 
Those CLRs are DC-SIGN and Dectin-1 (Gringhuis et al., 2007, Gringhuis et al., 2009). 
DC-SIGN is a human PRR that recognizes mannose signatures present in M. 
tuberculosis, M. leprae, C. albicans, measles virus and HIV-1 (Geijtenbeek and 
Gringhuis, 2009). The initiation of the RAF1 signalling pathway starts with the 
activation of the small GTPase RAS, which binds to RAF1 for subsequent 
phosphorylation in defined tyrosine and serine residues ((Gringhuis et al., 2007) and 
reviewed in (Geijtenbeek and Gringhuis, 2009)). RAF1 activation downstream of DC-
SIGN does not trigger responses in isolation but modulates TLR-mediated NF-κB 
activation. This modulation results in an increase in IL-10 production by unknown 
mechanisms (Gringhuis et al., 2007). Interestingly, the YXXL motif present in the 
intracellular tail of DC-SIGN is not required for activation of this signalling pathway 
(Gringhuis et al., 2007).  
Dectin-1 also activates signalling cascades via RAF1. This pathway operates 
independently of Syk signalling but converges with the latter at the level of NF-κB 
(Gringhuis et al., 2009). Whereas Syk signalling results in activation of the canonical 
and non-canonical NF-κB pathways, RAF1 activation results in phosphorylation of the 
NF-κB subunit p65 (Gringhuis et al., 2009). Phosphorylated p65 can become acetylated 
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or it can generate RelB-p65 inactive dimers that do not bind to DNA (Gringhuis et al., 
2009). Overall, RAF-1 activation enhances the expression of some Syk-dependent 
cytokines including IL-10, IL-12p35, IL-12p40, IL-6 and IL-1β and negatively 
regulates the production of IL-23 (Gringhuis et al., 2009). RAF-1 also regulates IL-
12p70 production by human DCs and has been associated with the induction of Th1 
responses downstream of Dectin-1 (Gringhuis et al., 2009). 
The mechanisms underlying the activation of this innate signalling pathway upon DC-
SIGN or Dectin-1 triggering are currently unknown. 
1.3.4 CLRs signalling via ITIM motifs 
In contrast to CLRs that trigger activatory signalling events, other members of this 
group including MICL (Myeloid inhibitory C-type lectin receptor) and DCIR (DC-
inhibitory receptor) inhibit cell activation via an inhibitory ITIM motif (Robinson et al., 
2006). ITIM phosphorylation in response to receptor ligation leads to the recruitment of 
tyrosine phosphatases such as SHP-1, SHP-2 or SHIP (Barrow and Trowsdale, 2006). 
Phosphatase recruitment results in reduced phosphorylation of the activatory protein 
cascade involving Syk, VAV, PLCγ, BLNK/SLP-76 and others (Barrow and Trowsdale, 
2006). 
In the context of innate recognition, ITIM signalling inhibits ITAM-initiated protein 
cascades and has been proposed to modulate Syk-coupled CLRs and TLR signalling 
(Robinson et al., 2006, Geijtenbeek and Gringhuis, 2009). In the case of DCIR, the 
receptor is expressed in monocytes, monocyte-derived DC, macrophages, B cells and 
DCs and inhibits TLR8-mediated induction of IL-12 and TNF by myeloid DCs and 
TLR9-induced IFN-α production in plasmacytoid DCs (Meyer-Wentrup et al., 2009, 
Meyer-Wentrup et al., 2008). On the other hand, MICL is expressed in human 
granulocytes, monocytes, macrophages and DCs and has shown to inhibit IL-12p40 and 
IL-12p70 to LPS and zymosan (Marshall et al., 2004, Chen et al., 2006). None of these 
receptors have proven to induce responses in absence of TLR signalling (reviewed in 
(Geijtenbeek and Gringhuis, 2009)). ITIM-signalling by CLRs illustrate a mechanism of 
regulating responses to other PRRs and probably modulating the initiation of adaptive 
immunity. 
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1.4 Linking innate into adaptive immunity 
PAMP recognition by PRRs results in the mobilisation of anti-microbial mechanisms 
designed to contain infection. These aspects include the production of a broad variety of 
inflammatory mediators, which trigger cell recruitment to the infected sites for 
subsequent pathogen killing and tissue repair mechanisms. Furthermore, activation of a 
select group of PRRs may also result in the initiation of adaptive defense mechanisms. 
The translation of PAMP presence into priming of effector T cell responses is 
performed by DCs. Distinct properties confer to these leukocytes the ability to convey 
innate information to lymphocytes. First, DCs are able to sample antigens in the 
periphery and migrate into lymphoid organs to favour the contact of naïve T cells with 
foreign antigens (Banchereau and Steinman, 1998). Second, DCs sense the 
environmental milieu and generate an effector T cell response that is matched to the 
nature of the offending insult (Reis e Sousa, 2006). By expressing a broad range of 
PRRs, DCs can orchestrate the initiation of adaptive immunity. 
When DCs encounter a pathogen in the periphery, they uptake the microbial cargo, 
become activated and migrate into draining lymphoid tissues for the presentation of 
antigenic peptides into MHC-I/II molecules. The transition from an “immature” DC to a 
“mature” DC that is competent to stimulate naïve T cells is the result of PRR ligation. 
The best-studied PRRs in the initiation of adaptive responses are the TLRs. Indeed, 
most TLR agonists induce upregulation of the costimulatory molecules CD80, CD86 
and/or CD40 in DCs (Iwasaki and Medzhitov, 2004).  
In addition to promoting DC “maturation”, PRRs also activate DCs to decode pathogen 
information and instruct the differentiation of effector T cell fates. Effector CD4+ T 
cells can be subdivided into Th1, Th2 and Th17 cells. The differentiation of effector T 
cell lineages is required for protection against infections but it must be strictly regulated 
in order to prevent autoimmunity. Aberrant Th17 and Th1 responses have been 
associated with the development of organ specific autoimmunity whereas uncontrolled 
Th2 responses contribute to the pathogenesis of allergic asthma (Korn et al., 2009, Zhou 
et al., 2009a). These types of excessive T cell responses can be kept under control by a 
specific subtype of T cells known as regulatory T cells (Tregs), which play an essential 
role in the maintenance of immune homeostasis. 
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1.4.1 Differentiation of effector T cell lineages 
1.4.1.1 Th1 cells 
Th1 cells produce the cytokine IFN-γ and are involved in activation of macrophages and 
other cell types for clearance of intracellular pathogens. Th1 cells also provide help to B 
cells to produce IgG2 type of antibodies (Mosmann and Coffman, 1989, Medzhitov, 
2007).  
The cytokines IFN-γ and IL-12 and the member of the T-box family of transcription 
factors T-bet, are crucial regulators of Th1 cell differentiation (Murphy and Reiner, 
2002). Upon antigen recognition, the differentiation of Th1 cells starts with the 
induction of T-bet in response to IFN-γ signalling. In turn, T-bet triggers the production 
of IFN-γ and induces the expression of the β2 subunit of IL-12 receptor, conferring IL-
12 responsiveness (Murphy and Reiner, 2002). This latter cytokine acts through signal 
transducer and activator of transcription 4 (STAT4) to amplify the production of IFN-γ 
and to fully establish the Th1 lineage. IL-12 also increases the expression of the 
receptor for IL-18, another STAT4 dependent inducer of IFN-γ (Murphy and Reiner, 
2002). Terminally differentiated Th1 cells produce vast amounts of IFN-γ in response to 
TCR triggering. 
During microbial infections, the initiation of Th1 responses is subjected to the 
activation of the innate immune system. It is proposed that in the context of antigen 
presentation, pathogen-activated cells such as NK cells might initially secrete IFN-γ to 
uncommitted Th1 cells to promote T-bet expression (Martin-Fontecha et al., 2004). The 
process of Th1 development continues with the supply of IL-12 and IL-18 by pathogen-
activated macrophages and DCs, which results in the generation of mature IFN-γ-
producing CD4+ T cells (Murphy and Reiner, 2002) (Figure 1.3). Notably, various types 
of TLR ligands trigger the production of IL-12 by DCs and are involved in priming of 
Th1 cells (Medzhitov, 2007). Th1 cells emerge in response to IL-12 production induced 
by pathogens such as Listeria monocytogenes (Hsieh et al., 1993). 
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1.4.1.2 Th2 cells 
Th2 cells play a role in immunity against extracellular parasites and produce cytokines 
IL-4, IL-5 and IL-13, which are involved in the activation of basophils/eosinophils and 
provide help for IgE production by B cells (Mosmann and Coffman, 1989, Medzhitov, 
2007). 
Th2 cells are instructed by the cytokine IL-4 and are characterized by the expression of 
the transcription factor GATA-3 (Murphy and Reiner, 2002). IL-4 signals via STAT6 to 
promote the expression of GATA-3, which leads to the remodelling of the IL-4 locus 
and subsequent transcription of the IL-4 gene by the transcription factors c-MAF, 
NFAT and AP1 (Murphy and Reiner, 2002). The mechanisms underlying the initiation 
of Th2 responses to pathogens or allergens are not fully understood. This is because the 
cellular sources of IL-4 in vivo have yet to be clearly defined. In particular, the 
initiation of Th2 responses to the helminth Trichuris muris, the allergen papain and 
immunoglobulin E complexes can be mediated by basophils (Sokol et al., 2007, Sokol 
et al., 2009, Perrigoue et al., 2009, Yoshimoto et al., 2009). Basophils are activated by 
the stimuli described above to produce the cytokines IL-4 and TSLP. It has been 
claimed that basophils can also act as antigen presenting cells for Th2 priming (Sokol et 
al., 2009, Perrigoue et al., 2009, Yoshimoto et al., 2009) (Figure 1.3). Nevertheless, this 
notion has been challenged by recent publications demonstrating that CD11c-expressing 
DCs are necessary and sufficient to prime Th2 responses to the parasite Schistosoma 
mansoni, to house dust mite allergens and to papain (Phythian-Adams et al., 2010, 
Hammad et al., 2010, Tang et al., 2010). 
Additional subsets of innate leukocyte cells have been described as important sources of 
Th2 cytokines during helminth infections (Saenz et al., 2010, Neill et al., 2010, Moro et 
al., 2010). These subsets include ‘Nuocytes’, a multipotent progenitor known as MPP, 
and ‘natural helper’ cells (Saenz et al., 2010, Neill et al., 2010, Moro et al., 2010). 
Those cell types promote Th2 responses by producing large amounts of cytokines in 
response to helminth infection or by giving rise to cells involved in the initiation of Th2 
responses such as basophils (Saenz et al., 2010, Neill et al., 2010, Moro et al., 2010). 
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The innate signalling pathways involved in controlling Th2 responses are not clearly 
defined. One reason accounting for these adversities might be that during innate 
recognition of allergens and parasites, the determinant is associated with the outcome of 
enzymatic activity rather than with the presence of a defined molecular signature. 
Therefore, is not surprising that the production of IgE in response to papain 
immunisation is a MyD88 independent process (Sokol et al., 2007). 
As previously shown for other T cell lineages, the differentiation of Th2 cells is not a 
fixed process. It has been recently shown that TGF-β induces reprogramming of the 
Th2 cell lineage into an IL-9 producing T cell subset (named ‘Th9’ cells) (Dardalhon et 
al., 2008, Veldhoen et al., 2008b). Th9 cells are distinct from Th2 or any T cell effector 
lineage and their function is not fully elucidated as IL-9 can also be produced by other T 
cell subsets including Th17 cells (Nowak et al., 2009). 
1.4.1.3 Th17 cells 
Th17 is a recently described subset of CD4+ cells that produces the cytokines IL-17A, 
IL-17F, IL-21 and IL-22 (Harrington et al., 2005, Langrish et al., 2005, Park et al., 
2005, Nurieva et al., 2007, Korn et al., 2007, Liang et al., 2006). IL-17A and IL-17F 
belong to the same family of cytokines (Kolls and Linden, 2004) and IL-17 commonly 
denotes IL-17A. IL-17 acts on non-hematopoietic cells to upregulate chemokines for 
neutrophil recruitment to the site of infection and tissue repair (Weaver et al., 2007). 
Th17 cells play a role in host defense against extracellular bacteria and fungi (Korn et 
al., 2009).  
Th17 cells were first described as a CD4+ effector subset distinct from Th1 and Th2 in 
2005 (Harrington et al., 2005, Park et al., 2005). However, the ability of CD4+ T cells to 
produce IL-17 under some conditions of immune challenge was noted before (Happel et 
al., 2003, Langrish et al., 2005, Infante-Duarte et al., 2000). Over the last years, studies 
on Th17 function and differentiation have made substantial progress. This subset is 
currently characterized by the expression of the lineage-specific factors RORγt, RORα 
and the AP-1 protein BATF (Ivanov et al., 2006, Yang et al., 2008c, Schraml et al., 
2009). Additional factors including IRF4 are also required for the generation of Th17 
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cells in vitro and in vivo (Brustle et al., 2007). IRF4 is not Th17-restricted and is also 
required for the development of Th2 cells (Brustle et al., 2007). 
Upon antigen encounter, the Th17 differentiation process is initiated by the 
synchronized effect of IL-6 and TGF-β on naïve T cells (Mangan et al., 2006, Bettelli et 
al., 2006, Veldhoen et al., 2006a). In presence of TGF-β, IL-6 acts via STAT3 to direct 
lineage commitment and regulate the expression of RORγt, RORα and probably BATF 
(Yang et al., 2007, Mathur et al., 2007, Laurence et al., 2007, Yang et al., 2008c). The 
Th17 differentiation process results in the production of IL-17 and subsequent 
upregulation of the IL-23 receptor, which confers IL-23 responsiveness (Zhou et al., 
2007, Nurieva et al., 2007). Although dispensable for the initial differentiation of Th17 
cells, IL-23 is essential to sustain and expand committed Th17 cells. This cytokine 
promotes high levels of IL-17 production by activated CD4+ T cells and is critical for 
the development of Th17 cells in vivo (Aggarwal et al., 2003, Langrish et al., 2005). 
Moreover, the acquisition of Th17 pathogenic function associated with autoimmunity in 
the central nervous system is dependent on IL-23 (Langrish et al., 2005, McGeachy et 
al., 2007). Along these lines, IL-23 deficient mice have reduced numbers of Th17 cells, 
which result in susceptibility to infection with the pathogen Citrobacter rodentium but 
also results in resistance to experimental autoimmune encephalomyelitis (EAE)(Cua et 
al., 2003, Mangan et al., 2006). 
In addition to the differentiation programme induced by IL-6 and TGF-β, there is an 
alternative pathway of Th17 differentiation that involves the cytokine IL-21. IL-6 
activated T cells produce large amounts of IL-21 in a RORγt-independent manner (Zhou 
et al., 2007). In turn, the combination of autocrine IL-21 with TGF-β can direct the 
Th17 differentiation program in absence of IL-6 (Nurieva et al., 2007, Korn et al., 2007, 
Zhou et al., 2007). Notably, the expression of IL-23R in response to IL-6 plus TGF-β 
requires IL-21 signalling (Nurieva et al., 2007, Korn et al., 2007, Zhou et al., 2007). 
Thus, the sequential engagement of IL-6, IL-21 and IL-23 pathways constitute a 
positive amplification loop that results in full Th17 differentiation. It is important to 
note that whereas IL-6, IL-21 and IL-23 act via STAT3 and induce mRNA transcripts 
encoding RORγt, none these factors are sufficient to drive Th17 differentiation on their 
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own. This indicates that additional signals provided by TGF-β are required for the 
production of IL-17 by T cells (Zhou et al., 2007). 
The role of TGF-β in Th17 differentiation is well documented. Nonetheless, the 
mechanisms underlying TGF-β signalling are not fully understood. There is evidence 
indicating that the role of TGF-β in Th17 differentiation is dependent on the 
concentration of the cytokine. Low doses of TGF-β promote Th17 priming by 
synergizing with IL-6 and IL-21 whereas high doses of TGF-β represses RORγt 
expression and favours the generation of regulatory T cells (Zhou et al., 2008a). In 
addition, it has been argued that the role of TGF-β in Th17 priming is indirect, by 
inhibiting Th1 and Th2 differentiation. In favour of this notion, mice deficient in Th1 
and Th2 cells (Stat6-/- T-bet-/- mice) generate Th17 responses in absence of TGF-β (Das 
et al., 2009). Similar results have been observed in CD4+ cells isolated from Stat6-/- T-
bet-/- mice bred with a mice transgenic for a dominant negative form of the TGF-β 
receptor (Stat6-/- T-bet-/- /TGF-βRIIDN mice) indicating that in absence of Th1 and Th2 
signals, IL-6 is sufficient to drive Th17 differentiation (Das et al., 2009). 
There are additional factors that have accessory roles in the initiation of Th17 
responses. Notably, IL-1β and TNF increase the frequency of IL-17 producing cells in 
vitro (Veldhoen et al., 2006a). IL-1β synergizes with IL-6 and IL-23 for Th17 
differentiation in vitro and is required for the generation of these responses in vivo 
(Sutton et al., 2006, Chung et al., 2009). Another modulator of Th17 cell function is the 
aryl hydrocarbon receptor (AhR)(Veldhoen et al., 2008a, Quintana et al., 2008). AhR is 
a cytosolic transcription factor that recognizes environmental toxins and becomes 
activated upon ligand binding. AhR ligands include some classes of aromatic 
hydrocarbons such as the toxin dioxin and the endogenous ligand FICZ (a tryptophan 
derived photoproduct) (Veldhoen et al., 2008a). AhR is selectively expressed by Th17 
cells and controls IL-22 synthesis (Veldhoen et al., 2008a). 
Like Th1 cells, the generation of Th17 cells is also controlled by activation of innate 
signalling pathways. Although DCs activated with TLR ligands are effective inducers of 
Th1 responses, addition of exogenous TGF-β to those same cultures deviates the 
differentiation to Th17 cells (Veldhoen et al., 2006a). TLR ligation results in the 
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production of IL-6, TNF and probably IL-1β by DCs, which synergize with TGF-β for 
the initiation of the Th17 differentiation program. In vitro, Treg-derived TGF-β is 
sufficient to support the differentiation of IL-17 producing cells in response to TLR 
triggering although is not clear whether Tregs perform similar functions in vivo 
(Veldhoen et al., 2006a). 
Notably, Dectin-1 activation in DCs results in enhanced production of IL-6, TNF and 
IL-23 but little IL-12, suggesting that this type of innate activation is also suited for the 
generation of IL-17 producing cells (LeibundGut-Landmann et al., 2007). Working 
together with Salomé LeibundGut-Landmann, I found that activation of the Dectin-
1/Syk/CARD9 axis leads to the initiation of Th17 responses (LeibundGut-Landmann et 
al., 2007). These results are presented in this thesis and effectively showed that Dectin-1 
signalling in DCs leads to the initiation of adaptive immunity. Furthermore, results 
presented in this thesis together demonstrate that Dectin-1 activated DCs are competent 
to induce IL-17 production by T cells in an IL-23 dependent manner. 
The cellular sources of Th17 polarizing cytokines in vivo have not been clearly 
elucidated. For Th17 cells generated during microbial infections, pathogen-activated 
innate immune cells like DCs might provide IL-6 and IL-23 necessary to sustain the 
Th17 response. In contrast, the cellular source of TGF-β has not been clearly defined 
but it might not correspond to member of the innate immune system. Although every 
cell in the body produces TGF-β, it has been reported that T-cell production of TGF-β 
is necessary for Th17 cell differentiation in vivo (Li et al., 2007). It is still unclear 
whether Treg-derived TGF-β accounts for this phenotype. Nonetheless, these results 
suggest that there must be a tight coordination between cells of the innate and adaptive 
immune system to enable the generation of a type 17 responses to immune challenge 
(Figure 1.3). 
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Figure 1-3: Effector T cell differentiation to microbes.  
Models for (a) Th1, (b) Th2 and (c) Th17 differentiation in response to microbial challenge. Adapted 
from (Weaver et al., 2007, Korn et al., 2009).  
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1.4.1.4 Regulatory T cells (Tregs) 
The specification lineage in Tregs is carried out by the transcription factor Foxp3 (Hori 
et al., 2003, Fontenot et al., 2003, Khattri et al., 2003). Foxp3 expressing cells can be 
subdivided in two groups: natural Tregs (nTregs) that are thymically derived and 
inducible (or adaptive) Tregs (iTregs), which differentiate in the periphery from naïve 
precursors under the influence of TGF-β (Weaver et al., 2006). The mechanisms of 
thymic differentiation of nTregs are not entirely defined but current models propose that 
nTreg development requires higher TCR affinity interactions than Foxp3 negative 
counterparts (Weaver et al., 2006). For peripherally induced iTregs it has been showed 
that activation of naïve T cells in presence of TGF-β results in upregulation of Foxp3 
and acquisition of suppressive functions (Chen et al., 2003, Bettelli et al., 2006). This 
effect is dependent on the cytokine dose as Foxp3 expression is optimally induced by 
high concentrations of TGF-β (Zhou et al., 2008a). In vivo, TGF-β is required for the 
maintenance of Treg subsets outside the thymus and for the peripheral induction of 
iTregs (Weaver et al., 2006). 
The relevance of Tregs in vivo is illustrated in studies in Scurfy mice (which have a 
frameshift mutation in the Foxp3 gene), in Foxp3 deficient mice and in patients with 
Foxp3 mutations. Mice and humans develop a severe autoinflammatory 
lymphoproliferative disorder attributable to the absence of Tregs (Fontenot et al., 2003, 
Khattri et al., 2003). 
The molecules that mediate Treg suppressive function are still being investigated. Treg-
derived TGF-β and IL-10 contribute to maintain gut homeostasis (Maloy et al., 2003). 
In addition, Tregs have been recently shown to produce the cytokine IL-35, which is 
involved in the acquisition of suppressive function (Collison et al., 2007). 
Some conditions of immune challenge overcome the dominant effect of Tregs in the 
control of T cell responses. Pasare and Medzhitov first described that T cell suppression 
by Tregs was reversed in cultures containing DCs stimulated with TLR agonists (Pasare 
and Medzhitov, 2003). TLR-activated DCs produce IL-6, which interferes with the 
suppressive abilities of Tregs by unknown mechanisms (Pasare and Medzhitov, 2003). 
Three years later, Veldhoen et al further demonstrated that in those cultures, the 
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combination of TLR-derived IL-6 plus Treg-derived TGF-β gave origin to Th17 cells, 
highlighting the role of Tregs in promoting appropriate T helper responses under some 
conditions of innate stimulation (Veldhoen et al., 2006a). 
1.4.2 Relationship between Th17 and Tregs 
As mentioned above, TGF-β is required for inducing both Th17 and iTreg cells. This 
highlights the close relationship between proinflammatory and regulatory T cell 
programs. Naïve T cells exposed to TGF-β upregulate both Foxp3 and RORγt (Zhou et 
al., 2008a, Ichiyama et al., 2008). This metastable population has the potential to 
become either Th17 or Treg cells depending on the cytokine milieu. Notably, the 
Foxp3-RORγt double positive T cell population has been found in vivo, particularly in 
the small lamina propria of mice and has shown to produce little or no IL-17 (Zhou et 
al., 2008a, Lochner et al., 2008). Moreover, it is proposed that CD4+Foxp3+RORγt+ T 
cells behave as regulatory T cells and produce IL-10 (Lochner et al., 2008). The 
Foxp3+-RORγt+ T cell population has been recently identified in humans (Voo et al., 
2009).  
The observations showing that Foxp3+-RORγt+ T cells do not produce IL-17 in steady 
state suggests that Treg and Th17 cell programs are antagonistic. This notion is 
supported by the fact that Foxp3 can directly interact with RORγt to inhibit its effect. 
The interaction region of Foxp3 is located within the exon 2, which contains the 
forkhead (FKH) domain (Zhou et al., 2008a, Ichiyama et al., 2008). Similarly, Foxp3 
can also inhibit RORα activity (Du et al., 2008, Yang et al., 2008b). 
The Th17/Treg lineage commitment is strictly regulated by TGF-β. Low doses of TGF-
β in combination with inflammatory cytokines favour Th17 differentiation by activating 
RORγt and inhibiting Foxp3 function. In contrast, high doses of TGF-β in absence of 
proinflammatory cytokines results in enhanced Foxp3 function and Treg development 
(Zhou et al., 2009a). Notably, TGF-β stimulation triggers binding of Foxp3 to active 
chromatin sites whereas TGF-β and IL-6 treatment results in decreased binding of 
Foxp3 to those same regions (Samanta et al., 2008). These observations provide a 
possible molecular explanation of the mechanisms controlling Treg or Th17 cell 
development. 
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The balance between Treg and Th17 cells is also influenced by additional factors 
particularly at mucosal sites. One example is retinoic acid (RA), which in combination 
with TGF-β favours Treg differentiation and inhibits Th17 development in the intestine 
(Mucida et al., 2007, Benson et al., 2007). A second example is IL-2, which is required 
for the generation of iTreg and survival of nTreg and the inhibition of Th17 
differentiation via STAT5 (Laurence et al., 2007). 
Notably, although Foxp3 inhibits IL-17 production, Foxp3+ T cells from mice and 
humans are able to produce IL-17 upon stimulation with proinflammatory cytokines 
(Xu et al., 2007, Yang et al., 2008b, Zheng et al., 2008a, Koenen et al., 2008). This 
process is characterized by extinction of Foxp3 and subsequent upregulation of RORγt 
and IL-17 (Yang et al., 2008b). Genetic fate mapping studies have shown that at least 
one quarter of IL-17 producing T cells have expressed Foxp3 at some stage of their 
development (Zhou et al., 2009b). Results presented in this thesis demonstrate that DCs 
activated via Dectin-1 are competent to convert Foxp3+ T cells into Foxp3+IL-17+ T 
cells, indicating that these cells may emerge under certain conditions of immune 
challenge (Osorio et al., 2008). The role of Foxp3+IL-17+ T cells in health and disease is 
yet to be elucidated. 
1.4.3 Th17 effector cytokines in host defense 
Intracellular bacteria and viruses are known elicitors of Th1 responses whereas parasite 
infection induces a Th2 cell response. Infection with pathogenic extracellular bacteria 
and fungi leads to the initiation of a type 17 response. Is important to note that Th17 
cells are not the only source of IL-17 following immune stimulation. Various cell types 
including γδ T cells, lymphoid tissue inducer cells, NK cells, NKT cells, monocytes and 
neutrophils are non-CD4+ T cell sources of IL-17 in response to microbial challenge 
(Martin et al., 2009, Duan et al., 2010, Takatori et al., 2009, Ferretti et al., 2003, Michel 
et al., 2007, Starnes et al., 2001). This indicates that the Th17 effector cytokines are 
produced sequentially by the innate and adaptive immune system for effective microbial 
clearance 
The Th17-associated factors IL-17A, IL-17F and IL-22 regulate multiple aspects of an 
immune response. IL-17A modulates granulopoiesis by inducing the expression of G-
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CSF in stromal cells (Fossiez et al., 1996). Activation of the IL-17A/G-CSF axis is 
controlled by the cytokine IL-23, which is produced by APCs upon pathogen 
recognition or during impaired clearance of apoptotic neutrophils (Stark et al., 2005). In 
addition, IL-17A and IL-17F mediate neutrophil recruitment to the infected site by 
inducing the expression of the chemokines CXCL1, CXCL2 and CXCL5 on epithelial 
and fibroblast cells (Ouyang et al., 2008, Kolls and Linden, 2004). IL-17 signalling also 
triggers an inflammatory response by inducing IL-6 and IL-8 production by 
keratinocytes (Ouyang et al., 2008). 
IL-17F also has important functions in immune homeostasis. In addition to Th17 cells, 
innate cells and epithelial cells produce IL-17F (Ishigame et al., 2009). IL-17A and IL-
17F are 55% homologous and they bind to the receptor IL-17RA/IL-17RC (Dubin and 
Kolls, 2009). Although these cytokines are functionally related and bind to the same 
receptor complexes, they have different immune functions. Unlike IL-17A, IL-17F is 
dispensable for the induction of autoimmune disease models including EAE (Yang et 
al., 2008a, Ishigame et al., 2009). IL-17F overexpression in lung epithelial cells in vivo 
leads to enhanced lung inflammation and mucus overproduction (Yang et al., 2008a). 
Together with IL-17A, IL-17F coordinates host defense to mucosal infection with 
extracellular pathogens. It is proposed that IL-17A has higher bioactivity than IL-17F, 
which provides an explanation for their different immune functions. In addition, it has 
been shown that IL-17A and IL-17F can form a heterodimer that possesses intermediate 
bioactivity (Dubin and Kolls, 2009). 
IL-22 is usually coexpressed with IL-17 by Th17 cells and it has been associated with 
the maintenance of epithelial cell function. Nonetheless, various cell types including 
DCs and RORγt-expressing cells such as NK subsets and LTi cells are innate sources of 
IL-22 (Cella et al., 2009, Satoh-Takayama et al., 2008, Sanos et al., 2009, Takatori et 
al., 2009). Furthermore, IL-22 produced by innate cells is important in the protection to 
C. rodentium infection (Zheng et al., 2008b). Cells from innate and adaptive immune 
system can provide IL-22 to promote host defense, inflammatory responses, 
chemokines and antimicrobial peptides in epithelial cells (Ouyang et al., 2008). 
Notably, IL-17 and IL-22 cooperate to induce the expression of antimicrobial peptides 
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in the same target cells, highlighting the role of these cytokines in host defense (Liang 
et al., 2006). 
 
1.4.3.1 Th17 effector cytokines during bacterial infections 
Th17 effector cytokines mediate protection against various infections with extracellular 
bacteria. Blockade of IL-22 or IL-23, or deficiency in IL-17R and IL-17A results in 
enhanced susceptibility to Klebsiella pneumoniae infection (Ye et al., 2001, Happel et 
al., 2005, Aujla et al., 2008). In addition, IL-23, IL-22, IL-17A and IL-17F orchestrate 
host defense mechanisms against C .rodentium infection (Mangan et al., 2006, Zheng et 
al., 2008b, Ishigame et al., 2009). IL-17 derived from CD4+ T cells mediates the 
formation of abscesses during Bacteroides fragilis infection in vivo (Chung et al., 
2003). IL-17A and IL-17F are required for host protection to mucosal infection with 
Staphylococcus aureus and IL-23 is also involved in microbial clearance in a model of 
respiratory Mycoplasma pneumoniae infection (Ishigame et al., 2009, Wu et al., 2007). 
Even though Th17 effector cytokines seem to be dispensable for controlling 
intracellular bacterial infections, they may have an indirect role in the initiation of Th1 
responses. For example, although IFN-γ is critical in controlling M. tuberculosis 
infection; IL-17-producing T cells are required to attract protective Th1 cells to the site 
of infection (Khader et al., 2007). In addition, IL-17 has been shown to promote IFN-γ 
T cell responses and bacterial clearance during infection with the intracellular pathogen 
Francisella tularensis (Lin et al., 2009). 
1.4.3.2 Th17 effector cytokines during fungal infections 
Cytokines associated with the Th17 lineage confer protection in some models of fungal 
infection. IL-17 receptor knock out mice succumb to systemic candidiasis (Huang et al., 
2004). Furthermore, the same cytokines are also important to confer protection to C. 
albicans in the oral cavity. IL-23, IL-17 and IL-22 deficient mice to a lesser extent, are 
susceptible to murine oropharyngeal candidiasis (OPC), a model that closely resembles 
features of human OPC (Conti et al., 2009). Notably, this model is dependent on 
adaptive immunity to the organism as illustrated by the enhanced susceptibility to OPC 
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in TCRβ deficient mice (Conti et al., 2009). Altogether, these results suggest that T cell-
derived IL-17 might be crucial for the generation of an appropriate antifungal response 
in the oral cavity. Indeed, human T cells specific for C. albicans have a Th17 
phenotype. In addition, patients with mutations in STAT3 fail to generate Th17 cells and 
suffer from recurrent chronic mucocutaneous candidiasis (CMC) and S. aureus 
infections (Acosta-Rodriguez et al., 2007) (Ma et al., 2008, Milner et al., 2008, de 
Beaucoudrey et al., 2008). Notably, patients with deficiency in the autoimmune 
regulator (AIRE) gene suffer from recurrent CMC and generate autoantibodies against 
IL-17A, IL-17F and IL-22 (Puel et al., 2010, Kisand et al., 2010). These results indicate 
that IL-17 and Th17 cells mediate host protection to fungal infection. However, in a 
mouse model of gastric C. albicans infection, IL-23 and IL-17 exacerbate gut pathology 
(Zelante et al., 2007) indicating that the site of infection may influence the outcome of 
the Th17 response. The Th17 effector cytokines have been studied in other fungal 
infection models. In response to P. carinii infections, IL-23 deficient mice show higher 
fungal burden although they are competent to clear infection (Rudner et al., 2007). In 
addition, during C. neoformans infection, IL-23 deficiency is associated with reduced 
survival and delayed fungal clearance (Kleinschek et al., 2006), suggesting that the IL-
17 axis of cytokines may contribute to antifungal defense. 
1.4.4  Innate control of Th17 differentiation 
Pathogens or PAMPs derived from Propionibacterium acnes, B. burgdorferi, K. 
pneumoniae, B. fragilis, C. rodentium, C. albicans and zymosan trigger the production 
of IL-17 by CD4+ T cells (Perona-Wright et al., 2009, Infante-Duarte et al., 2000, 
Happel et al., 2005, Chung et al., 2003, Mangan et al., 2006, Acosta-Rodriguez et al., 
2007, Veldhoen et al., 2006b). It is important to note that Th17 cells not only emerge 
during the course of infections but also are constantly induced by signals derived from 
the microbiota. Th17 accumulate preferentially in the intestine of mice and their 
frequency is drastically reduced under germ free conditions (Atarashi et al., 2008, 
Ivanov et al., 2008). Interestingly, monocolonization of germ free mice with a single 
commensal bacterium known as segmented filamentous bacterium (SFB) leads to the 
development of Th17 cells in the gut by unknown mechanisms (Ivanov et al., 2009). 
Microbiota-derived signals can also act as adjuvants for the initiation of Th17 
Chapter 1. Introduction 
 47 
responses. ATP derived from commensal bacteria activates a CD70high CD11clow subset 
of intestinal DCs to promote Th17 differentiation (Atarashi et al., 2008). 
The role of innate signalling pathways in the initiation of Th17 responses to microbial 
challenge is yet to be elucidated. For K. pneumoniae, innate recognition by TLR4 
controls the production of IL-23 and IL-17 (Happel et al., 2003). In response to the 
microbial flora, Th17 responses are preserved in MyD88-TRIF doubly deficient and 
RIP-2 deficient mice indicating that signals derived from TLRs and NLRs are either 
dispensable or redundant (Atarashi et al., 2008, Ivanov et al., 2008, Ivanov et al., 2009). 
The contribution of the CLR/Syk and CARD9 innate signalling pathway in the 
induction of intestinal Th17 cells has not been addressed. 
Th17 cells also emerge in response to fungi and fungal PAMPs. In this context, fungal 
CLRs are likely to be crucial sensors of these responses. Zymosan contains ligands for 
various CLRs and is a strong elicitor of Th17 responses (Veldhoen et al., 2006b). Data 
presented in this thesis together with those from Salomé LeibundGut Landmann 
indicate that Dectin-1 ligation results in the generation of IL-17-producing CD4+ T cells 
(LeibundGut-Landmann et al., 2007, Osorio et al., 2008). In addition to conventional 
CD4+ T cells, γδ T cells are an important innate source of IL-17 to fungal challenge 
(Martin et al., 2009). Notably, γδ T cells express TLR2 and Dectin-1 on their surface 
and respond to curdlan, Pam3CSK4 and C. albicans by producing IL-17 (Martin et al., 
2009). These data strongly suggests that innate production of IL-17 may be of vital 
importance for an appropriate coordination of antifungal immunity. 
Signalling by CLRs directly contribute to the establishment of host defense to fungi. In 
addition to the enhanced susceptibility to C. albicans infection observed in CARD9 
deficient animals, this strain of mice is unable to generate Th17 cells to the organism 
(LeibundGut-Landmann et al., 2007). It is important to note that Th17 but not Th1 cells 
are absent in CARD9 deficient mice infected with C. albicans, suggesting that TLR 
signalling can induce Th1 responses but cannot compensate for CLR signals in the 
establishment of a type 17 response to fungi (LeibundGut-Landmann et al., 2007). 
Notably, the Th17 deficiency observed in CARD9 deficient mice infected with C. 
albicans is not seen in mice lacking Dectin-1, indicating that additional Syk/CARD9 
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coupled receptors mediate Th17 responses to fungi (LeibundGut-Landmann et al., 
2007). Results presented in Chapter 5 of this thesis demonstrate that Dectin-2 is the 
Syk/CARD9-coupled compensatory CLR responsible for the initiation of a type 17 
response to Candida (Robinson et al., 2009).  
1.5 Immunology of fungal infections 
Whilst fungal infections are unusual in healthy individuals, fungal diseases occur in 
individuals with defects in the innate and/or adaptive arms of the immune system 
(Crameri and Blaser, 2002). Fungal organisms including Histoplasma capsulatum, 
Paracoccidioides spp, C. neoformans, A. fumigatus, Pneumocystis jirovecii are present 
in high frequencies in the environment (Romani, 2008). In addition, C. albicans is a 
long-lasting commensal that colonizes human skin, the gastrointestinal tract and the 
genitourinary tract (Kumamoto, 2008). C. albicans infection is the fourth most 
important cause of hospital acquired bloodstream infections and A. fumigatus and A. 
terreus infections are an important cause of death in patients undergoing transplantation 
(Romani, 2008). On the other hand, cutaneous fungal infections are characterized by 
colonization with the microorganisms Microscporum spp, Trichophyton spp and 
Malassezia spp (Romani, 2008). 
The risks of fungal infections are clearly associated with various types of 
immunodeficiencies. Patients with primary (Hyper IgE syndrome; HIES, autoimmune 
polyendocrinopathy with candidiasis and ectodermal dystrophy; APECED, severe 
combined immunodeficiencies; SCID, and chronic granulomatosus disease; CMG 
among others) or secondary immunodeficiencies such as HIV infection are highly 
susceptible to fungal infections with C. albicans (Buckley, 2002, Kisand et al., 2010). 
Candida infections vary from local colonization and superficial skin infections to lethal 
systemic invasion. The risk factors for systemic fungal infections are increased in 
patients that received organ transplantation, and in patients with leukemia leading to 
neutropenia and granulocytopenia (Crameri and Blaser, 2002). Indeed, neutropenia is a 
determinant risk factor for invasive C. albicans and A. fumigatus infections (Crameri 
and Blaser, 2002). Along these lines, patients with CMG have defective production of 
ROS by phagocytic cells and are highly susceptible to fungal infections (Crameri and 
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Blaser, 2002). The enhanced susceptibility to systemic fungal infections in patients 
receiving the immunosuppressant cyclosporine A has been recently linked to a defect in 
neutrophil-associated NFAT signalling in a murine model (Greenblatt et al., 2010). 
Altogether, these results indicate that fungal killing by phagocytic cells is an essential 
arm of the systemic antifungal response. 
Antigen-specific T cells also play a role in controlling Candida infections. Notably, T-
cell immunodeficiencies are not strongly linked to systemic mycoses but to infection at 
mucosal sites. Protection from CMC in nails, skin or mucosal surfaces is thought to be 
T cell mediated (Grubb et al., 2008, Crameri and Blaser, 2002). In mice models, T-cell 
deficiency does not render animals more susceptible to systemic Candida infection, but 
it contributes to resistance to mucosal candidiasis in the mouth and gastrointestinal tract 
(Jones-Carson et al., 2000, Giger et al., 1978, Cantorna and Balish, 1991, Conti et al., 
2009). In humans, extensive OPC constitutes a clinical marker of disease in HIV-
infected individuals (Greenblatt et al., 2010). Interestingly, these patients are not more 
susceptible to vaginal candididiasis suggesting that CD4+ T cell protection may not be a 
determinant for all mucosal sites (Conti et al., 2009). Patients with gene mutations in 
Stat3 and AIRE are highly susceptible to CMC due to the lack of antifungal Th17 cells 
or the presence of autoantibodies against IL-17 and IL-22 (Ma et al., 2008, Milner et al., 
2008, de Beaucoudrey et al., 2008, Puel et al., 2010, Kisand et al., 2010). 
The contribution of antibodies to the resolution of fungal infections is not entirely 
understood. Even though any fungal organism can trigger an antibody response, it is 
unknown whether those responses contribute to antifungal immunity (Cutler et al., 
2007). Furthermore, there is no clear association between antibody deficiency and 
susceptibility to fungal infections (Romani, 2004). Nonetheless, it has been shown that 
anti-β-glucan IgG antibodies elicited in response to β-glucan vaccination protect against 
systemic and vaginal infections with C. albicans (Torosantucci et al., 2005). In addition, 
glycopeptide vaccines made by conjugation of fungal β-mannan with specific Candida-
derived antigens elicit antibody responses and induce host protection to systemic 
infections (Xin et al., 2008). These results indicate that antibody responses induced after 
vaccination may help resolve disseminated mycoses. 
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1.6 C. albicans recognition by the innate immune system 
1.6.1 C. albicans cell wall composition 
The fungal cell wall is a highly complex structure that preserves the integrity and 
viability of fungal organisms. The main structural components of C. albicans cell wall 
are β-(1,3)-glucans, β-(1,6)-glucans and chitin (a β-(1,4)-polymer of N-
acetylglucosamine (GlcNAc)) (Netea et al., 2008). These molecules are covalently 
linked to form a dense net of fibrils located in the inner layer of the cell wall (Netea et 
al., 2008). The outer layer contains a large fraction of glycosylated proteins, including 
glycosylphosphatidylinositol (GPI)-anchor-dependent cell wall proteins, which are 
attached to the skeleton core. These glycosylated proteins are highly mannosylated with 
O-linked and N-linked mannans (Netea et al., 2008). O-linked mannans are short 
structures of α-(1,2)-mannans linked to Ser/Thr polypeptides. On the other hand, N-
linked mannans are highly branched structures consisting of a long backbone of up to 
150 α-(1,6) mannans with side chains of α-(1,2) and α-(1,3) mannans and 
phosphomannan attached to a core of Man8GlcNAc2 (Netea et al., 2008). According to 
this molecular organization, mannans are highly exposed PAMPs in Candida cell wall 
whereas β-glucans become accessible in bud scars regions (Netea et al., 2008, Gantner 
et al., 2005). 
1.6.2 PRR recognition of C. albicans 
Various PRR detect signatures present in C. albicans. N-linked mannans are 
preferentially recognized by mannose receptor, DC-SIGN and SIGNR1 in DCs and 
macrophages (Cambi et al., 2008, Taylor et al., 2004). It was recently shown that 
Dectin-2 recognizes α-mannans present in C. albicans cell wall and that TLR2 can 
detect phospholipomannan-containing molecules (Saijo et al., 2010, Jouault et al., 
2003). Although Mincle has also been reported to be a PRR for Candida (Wells et al., 
2008) another study has shown that this receptor recognizes the fungus Malassezia 
exclusively (Yamasaki et al., 2009). Additionally, sensing of O-linked mannans has 
been attributed to TLR4 (Netea et al., 2006). 
C. albicans-derived β-glucans are ligands for Dectin-1, complement receptor 3 (CR3) 
and the scavenger receptors CD36 and SCARF1 (Gantner et al., 2005, Forsyth et al., 
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1998, Means et al., 2009). Chitin is a potent inducer of Th2 responses (Reese et al., 
2007) and is highly enriched in C. albicans cell wall. However no innate chitin 
receptors have been identified so far. 
Although many PRRs are involved in innate recognition of C. albicans, they seem to 
coordinate different aspects of the antifungal response. Phagocytosis of Candida is 
likely to be mediated by opsonic and non-opsonic receptors, DC-SIGN, MR, and 
signalling CLRs. On the other hand, activation of the respiratory burst and cytokine 
production to fungi might be mediated by signalling CLRs and TLRs. PRRs involved in 
C. albicans recognition expressed at the cell membrane level of DCs and macrophages 
are depicted in figure 1.4. 
The contribution of individual PRRs in the establishment of antifungal defense has been 
elucidated using in vivo models of fungal infection. These studies have shown that CR3 
and FcγR receptors might have immunosuppressive effects during systemic candidiasis 
as enhanced resistance and lower fungal burden has been noted in CR3 and FcγR knock 
out mice infected with the organism (Romani et al., 2004). Along these lines, the 
contribution of individual TLRs has also been addressed in vivo. Two studies have 
shown that TLR2 deficient mice are more resistant to C. albicans infection suggesting 
an inhibitory role for this receptor during fungal recognition (Netea et al., 2004, 
Bellocchio et al., 2004). It is proposed that in response to C. albicans, TLR2 mediates 
the induction of IL-10-producing Tregs, which might be detrimental for antifungal 
defense (Netea et al., 2004). On the other hand, TLR4 or TLR9 deficiency does not 
impair survival to systemic candidiasis, suggesting that these receptors are redundant 
(Bellocchio et al., 2004). In contrast to single TLR deficiency, lack of the adaptor 
MyD88 renders mice highly susceptible to disseminated candidiasis (Bellocchio et al., 
2004, Villamon et al., 2004). This effect might also encompass signalling via IL-1R, as 
IL-1R knock out mice are equally susceptible to systemic infection (Bellocchio et al., 
2004). Interestingly, the negative regulator of TLR/IL-1R signalling TIR8 (Toll IL-1R8) 
is non-redundant in anti-Candida defense as TIR8 knock out mice succumbs to 
disseminated candidiasis (Bozza et al., 2008). These results indicate that a fine 
regulation of TLR/IL-1R signalling is necessary for effective clearance of fungal 
pathogens. 
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The contribution of CLR signalling to C. albicans infection is beginning to be 
elucidated. Mannose receptor is not involved in resistance to intraperitoneal C. albicans 
infection. Nonetheless, this model of infection is not an established model and does not 
resemble disseminated candidiasis (Lee et al., 2003). In addition, the role of Dectin-1 in 
systemic antifungal defense is controversial. Whereas one group reported high 
susceptibility of Dectin-1 deficient mice to C. albicans infection, another group 
reported no differences in infection with the same organism (Taylor et al., 2007, Saijo et 
al., 2007). The reason accounting for these differences are still unclear. Notably, 
patients with Dectin-1 deficiency suffer from vulvovaginal candidiasis and 
onychomycosis (fungal infection in the nail beds) but not from systemic fungal 
infections (Ferwerda et al., 2009). In murine settings, Dectin-1 and TLR2 control fungal 
dissemination and inflammasome activation in the model of OPC (Hise et al., 2009). 
These data indicate that those receptors mediate antifungal responses at least at mucosal 
sites. On the other hand, although Mincle was previously reported not to signal in 
response to C. albicans stimulation (Yamasaki et al., 2009), higher fungal burden is 
observed in Mincle deficient mice systemically infected with the organism (Wells et al., 
2008). 
Work presented in Chapter 5 helped to elucidate the role of Dectin-2 during systemic 
Candida infection. Although we did not observe a role for this receptor in innate 
resistance within the first week of infection, another group has recently reported the 
generation of the Dectin-2 deficient mice and has found enhanced susceptibility starting 
on day 10-post infection (Saijo et al., 2010). This data indicates that Dectin-2 is an 
additional CLR involved in antifungal defense.  
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Figure 1-4: Recognition of C. albicans by PRRs expressed in DCs and macrophages. 
Adapted from (Netea et al., 2008, Gross et al., 2006, LeibundGut-Landmann et al., 2007, Wells et al., 
2008). 
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1.7 Questions addressed in this Thesis 
When this project was started, it had been recently demonstrated that Dectin-
1/Syk/CARD9 constituted an innate signalling pathway that promoted DC activation in 
absence of TLR signals. Dectin-1 was the first member of the CLR family able to 
trigger intracellular signalling events resulting in the expression of innate response 
genes in DCs. Furthermore, Salomé LeibundGut Landmann had recently observed that 
DCs activated via Dectin-1 induced accumulation of IL-17 producing CD4+ T cells, 
validating Dectin-1 as a bona fide PRR, according to Janeway’s definition. These 
results opened many interesting avenues in the CLR field. An important question to 
address was how signalling via Dectin-1/Syk/CARD9 coupled to adaptive immunity. In 
addition, it was not known whether Dectin-1 was the only CLR competent to induce 
immunity via Syk and CARD9 or there were additional Syk-coupled CLRs that could 
account for the CARD9-dependent but Dectin-1-independent aspects of fungal 
recognition. 
The aims of this project are to elucidate the contribution of fungal C-type lectin 
receptors to the initiation of effector T cell responses to fungal infection. Experiments in 
this thesis address the role of Dectin-1 and Dectin-2 in DC activation and Th17 cell 
induction. Questions addressed in each chapter can be summarised as: 
1. What are the mechanisms underlying the generation of IL-17-producing CD4+ T 
cells in response Dectin-1 signalling in DCs? 
 
2. Is Dectin-2 a Syk-coupled PRR involved in Th17 responses to infection? 
 
3. What is the phenotype of antigen-specific T cells generated in response to C. 
albicans-derived antigens during the course of infection? How the CLR 
signalling pathway contributes to this response? 
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Chapter 2. Materials and Methods 
2.1 Reagents 
2.1.1 Common Buffers, Solutions and Media 
PBS-Dulbeccos: (GIBCO-BRL) 
MACS-Buffer: PBS-Dulbecco containing 1% FCS (Autogen Bioclear, UK) and 2 mM 
EDTA (Sigma) 
RPMI 1640 medium: (GIBCO-BRL) 
R10: RPMI 1640 medium supplemented with 10% FCS (Autogen Bioclear), Penicillin 
100U/ml, Streptomycin 100U/ml, L-Glutamine 0.3µg/ml (GIBCO-BRL), 50µm β-
mercaptoethanol (GIBCO-BRL) 
R10*: RPMI 1640 medium supplemented with 10% FCS (Autogen Bioclear), Penicillin 
100U/ml, Streptomycin 100U/ml, L-Glutamine 0.3µg/ml (GIBCO-BRL), 50µM β-
mercaptoethanol (GIBCO-BRL), 10mM HEPES (GIBCO-BRL), 1mM Sodium 
pyruvate (GIBCO-BRL), 0.1mM Non-essential Amino acids solution (GIBCO-BRL). 
Red Blood Cell (RBC) lysis buffer: (Sigma) 
ELISA block: PBS containing 2.5% FCS (Autogen Bioclear), 0.02% NaN3 (w/v) 
(Sigma) 
ELISA coating buffer: 0.1M NaHCO3 (Sigma) in dH2O, pH 8.2 
ELISA wash: 0.05% Tween-20 (Sigma) in PBS1X 
LB medium: produced by Cancer Research UK. 
Osmotic Stabilizing Buffer (OSB) mix: 0.2M Lithium Acetate solution (Sigma), pH 7.5, 
40% Polyethylene glycol 8000 (Calbiohem), 0.1M Dithiothreitol (Invitrogen) and 250 
µg/ml DNA MB grade from fish sperm (Roche Diagnostics).  
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Synthetic Defined (SD) media: ddH20 containing 0.67% w/v Yeast Nitrogen base 
without aminoacids (Sigma), 2% glucose. 
Synthetic Complete drop out (SC-URI) media: SD Agar media containing 2g/L drop out 
mix stock. 
Drop out mix stock: amino acid composition is shown below (to prepare SC-URI, 2g 
Uridine must be omitted from the mix) 
Drop out mix stock 
Amino acids (g) Amino acids (g) 
L-Adenine 0.5 g L-Lysine 2 g 
L-Arginine 2 g myo-Inositol 2 g 
L-Asparagine 2 g L-Methionine 2 g 
L-Aspartic acid 2 g para-Aminobenzidine 0.2 g 
L-Cysteine 2 g L-Phenylalanine 2 g 
L-Glutamic acid 2 g L-Proline 2 g 
L-Glutamine  2 g L-Serine 2 g 
L-Glycine 2 g L-Threonine 2 g 
L-Histidine 2 g L-Tryptophan 2 g 
L-Isoleucine 2 g L-Tyrosine 2 g 
L-Leucine 10 g L-Valine 2 g 
(all from Sigma) 
Yeast Peptone Dextrose (YPD) media: 500ml of ddH20 containing 1% w/v Yeast 
Extract, 2% w/v Bactopeptone ± 2% w/v Bactoagar (all DIFCO), 2% glucose, 0.02% 
w/v adenine (Sigma). 
YPD-Uri+ media: YPD media containing 0.08g/L Uridine (Sigma). 
2.1.2 Peptides, cytokines and neutralizing antibodies 
Ovalbumin peptide (residues 323-339) and SIINFEKL peptide (residues 257-264) were 
synthesized and purified by high performance liquid chromatography at Cancer 
Research UK. Ovalbumin protein (OVA) was from Calbiochem.  
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Anti-CD3ε (clone 145-2C11) antibody was from BD pharmingen.  
Recombinant cytokines used for in vitro assays were rmIL-23 (eBioscience), rhTGF-β1 
(Sigma), rmIL-6 and rhIL-2 (RnD systems). 
Neutralizing antibodies and isotype controls used in assays in vitro are described in the 
following table: 
Antibody Clone Company 
Anti-TGF-β  1D11 RnD systems 
Anti-mouse IgG1 11711 RnD systems 
Anti-p19 G23.8 eBioscience 
Anti-rat IgG1 R3-34 BD Pharmingen 
Anti-IFN-γ XMG1.2 BD Pharmingen 
Anti-IL-4 11B11 BD Pharmingen 
 
2.1.3 Microbial Stimuli 
Curdlan, purified from Alcaligenes faecalis was purchased from Wako (Osaka, Japan) 
and suspended in PBS at a concentration of 10mg/ml. CpG 1668 oligonucleotide 
(sequence TCCATGACGTTCCTGATGCT) was synthesized by Sigma. 
Zymosan was purchased from InvivoGen (San Diego, CA). Lipopolysaccharide (LPS) 
from E. coli, Serotype R515 was purchased from Alexis Biochemicals (UK) 
2.2 Cells and Mice 
2.2.1 Mice 
Wild-type C57BL/6 (H-2b) were obtained from Charles River or Cancer Research UK 
animal facility (Clare Hall, UK). Congenic B6.SJL.CD45.1 mice were from the Cancer 
Research UK animal facility (Clare Hall, UK). 
C57BL/6 or congenic B6.SJL.CD45.1 OT-II mice bearing a transgenic TCR specific for 
OVA323-339 presented on I-Ab were from the Cancer Research UK animal facility (Clare 
Hall, UK). 
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Congenic B6.SJL.CD45.1 OT-I mice bearing a transgenic TCR specific for OVA257-264 
(SIINFEKL) presented on H2-Kb were originally obtained from Dr Dimitris Kioussis 
(National Institute for Medical Research, Mill Hill, UK). OT-I transgenic mice on a 
rag1-/- background were originally obtained from Dr Fiona Powrie (Oxford University, 
UK). Both strains are bred at the Cancer Research UK animal facility (Clare Hall, UK). 
MyD88 and TRIF deficient mice were a gift from Dr Shizuo Akira (Osaka, Japan) and 
MyD88-TRIF double knock out mice were generated by intercrossing the two strains. 
Myd88-/-trif-/- mice are bred at Cancer Research UK under specific pathogen free 
conditions. 
DEREG mice (Lahl et al., 2007) are bred at Technische Universität München or at 
Cancer Research UK in specific pathogen-free conditions.  
IL-23 p19-deficient mice (Ghilardi et al., 2004) were provided by A. MacDonald 
(Edinburgh, UK) with kind permission from N. Ghilardi, Genentech, and are bred at 
Cancer Research UK in specific pathogen-free conditions.  
CD11cΔSyk mice used in this study is the intercross between the CD11c cre+ mice 
strain (Kindly provided by Dr Boris Reizis, Columbia University medical center, New 
York and described in (Caton et al., 2007) and the syk fl/fl mice strain (Kindly provided 
by Dr Alexander Tarakhovsky, Rockefeller University, New York). CD11cΔSyk mice 
were genotyped by PCR for the expression of the Cre transgene and floxed alleles.  
Rorc(γt)-GfpTG mice (Lochner et al., 2008) were bred at Institut Pasteur. Radiation 
chimeras in C57BL/6 hosts using bone marrow from DEREG or Rorc(γt)-GfpTG mice 
were generated at Cancer Research UK.  
Bone marrow from Clec7a-/- mice (Taylor et al., 2007) was a kind gift from Dr G.D. 
Brown (University of Cape Town, South Africa) and fetal liver cells from Syk-/- 
embryos were a kind gift from Dr V.L. Tybulewicz (National Institute for Medical 
Research, Mill Hill, UK). Bone marrow from those mice was used to generate radiation 
chimeras in C57BL/6 hosts. 
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All animal experiments were performed in accordance with national and institutional 
guidelines for animal care. 
2.2.2 Bone marrow chimeras 
Host mice were kept on acid water (0.1 ml conc. HCL in 840 ml water, sterile filtered) 
for one week before irradiation and then for at least 4 weeks after bone marrow 
reconstitution. Mice received γ-irradiation using a 137Cs source (IBL 637; CISbio 
International, Gif-sur-Yvette, France) with two doses of 5.5 Gy separated by 3 hrs. 20-
24 hrs later, mice were reconstituted intravenously with >106 bone marrow or foetal 
liver cells in 200µl of sterile PBS. The health status of the mice was checked 
periodically. Six weeks after reconstitution blood samples were taken for FACS 
analysis of congenic marker expression on granulocytes and T cells. Full reconstitution 
was accepted when 95-100% of the granulocyte population were of donor origin. 
2.2.3 Generation of GM-CSF BMDC 
Bones from femurs and tibia from 8-12 weeks old mice were prepared under sterile 
conditions and the bone marrow was flushed with 2 ml of R10 medium into a 5 ml 
polypropylene tube using a 1ml syringe with a 23G needle. Cells were strained through 
a 70µm filter into 22.5 ml R10 containing GM-CSF (GM-CSF was made by Cancer 
Research protein purification service and was titrated for optimal growth conditions of 
BMDCs) and plated into a 6-well plate (Falcon). Cells were cultured at 37°C and 5% 
CO2. On day 2 of culture, 2.5ml of the culture medium was removed and was replaced 
with 3 ml of fresh R10 medium containing GM-CSF. On day 3 of culture, the wells 
were washed off extensively in order to remove all non-adherent and loosely adherent 
cells. The medium was replaced with 4 ml of fresh R10 medium containing GM-CSF. 
On day 5 of culture, cells were harvested using a sterile rubber policeman and collected 
in a 50ml tube (Falcon). CD11c-expressing cells were purified after enrichment with 
CD11c MACS beads (Miltenyi biotec) (30µl per 107 cells) using a LS MACS column 
according to manufacturer’s instructions. CD11c+ cells purified under this protocol are 
usually >95% pure and the yield is 107 cells approximately. 
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2.2.4 Isolation of conventional DC from spleen 
Spleens were aseptically removed and were perfused with serum-free RPMI containing 
Liberase C1 (1.7 U/ml, Roche Diagnostics) and DNase I (0.2 mg/ml, Roche 
Diagnostics). Samples were incubated at 37°C for 30 min. Digested spleens were 
mashed through a 50µm cell strainer and washed with ice-cold MACS buffer. Single 
cell suspensions were suspended in 190µl of MACS buffer and 10µl of CD11c-MACS 
beads was added (clone N418, Mitenyi biotec, UK). Tubes were incubated for 10 min at 
4°C and were washed with ice-cold MACS buffer. CD11c positive cells were positively 
selected using varioMACS and LS columns (Miltenyi Biotec) according to 
manufacturer’s instructions. Alternatively, the CD11c enriched fraction was labelled 
with anti-CD8 FITC, anti-CD4 PerCP and anti-CD11c APC antibodies and 
CD11c+CD4+, CD11c+CD8+ and CD11c+CD8-CD4- populations were sorted by flow 
cytometry using a MoFlo (Dako cytomation) or a FACSAria (BD Biosciences). 
2.2.5 CD4+ T cell purification 
Cell sorting of CD4+ T cells was performed using a MoFlo (Dako cytomation) or a 
FACSAria (BD Biosciences). 
For in vitro T cell assays containing T cells from OT-II mice (on C57BL/6 background), 
CD4+CD25- T cells and CD4+CD25+ T cells were sorted from spleens by cell sorting. 
Alternatively, for studies of antigen presentation of C. albicans-associated antigens, 
CD4+CD25-CD62LhiCD44lo (naïve) cells from OT-II mice were sorted from spleens by 
cell sorting.  
For in vitro T cell assays containing T cells from C57BL/6 mice, CD4+CD25-
CD62LhiCD44lo (naïve) and CD4+CD25+ cells were sorted from spleens by cell sorting.  
For in vitro T cell assays containing T cells from DEREG mice, CD4+GFP+CD25+ and 
CD4+GFP-CD25- cells from DEREG mice or DEREG bone marrow chimeras were 
purified from spleen and lymph nodes by cell sorting. 
Chapter 2. Materials and Methods 
 61 
For in vitro T cell assays containing T cells from Rorc(γt)-GfpTG bone marrow chimeras, 
CD4+GFP+CD25+FR4+CD45.1- and CD4+GFP-CD25+FR4+CD45.1- cells were purified 
from mesenteric lymph node by cell sorting. 
For in vivo experiments involving naïve CD4+ T cells from OT-II mice, naïve 
CD4+CD25-CD62LhiCD44lo were sorted from spleens and lymph nodes by cell sorting. 
2.2.6 CD8+ T cell purification 
CD8+ T cells were isolated from spleen and lymph nodes from OT-I mice. Spleen was 
perfused in 5 ml of R10 and it was centrifuged. Red blood cells were lysed using 1 ml 
RBC buffer per spleen for 4 min and samples were washed with R10. Lymph nodes 
were mashed through a 50µm cell strainer to produce a cell suspension. Cells from 
spleen and lymph nodes were pooled and washed twice in ice-cold MACS-buffer. A 
lineage depletion cocktail of PE-conjugated antibodies was used for negative selection 
of CD8+ T cells. All antibodies were used at 1:100 dilutions and were purchased from 
BD Pharmingen. 
Antibody Antibody 
PE anti-CD4 PE anti CD16/CD32 
PE anti-CD11b PE anti-B220 
PE anti-Ly6G/C PE anti-CD11b 
Antibody clone details are provided in the Flow cytometry section 
Cells were incubated with PE-conjugated antibodies for 15 minutes at 4ºC and washed 
twice in ice-cold MACS buffer. The cell suspension was incubated with anti-PE 
multisort MACS beads (Miltenyi Biotec) for 10 minutes at 4ºC and then washed in ice-
cold MACS buffer. CD8+ T cells were negatively selected using MACS LS columns 
according to manufacturer’s instructions. 
2.2.7 CFSE labelling of cells 
Cell suspensions were washed twice in PBS and suspended in 5 ml of PBS. 2µl of 
CFSE 5mM was added to the cells and tubes were incubated 12 min at 37ºC. Cells were 
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washed twice with PBS if used for in vivo experiments or with R10* if used for in vitro 
assays. 
2.3 In vitro assays for DC activation 
2.3.1 Stimulations of BMDC: 
For analysis of cytokine production, 105 BMDC were cultured for 18-24 hrs in p96 U-
bottom plates in 200µl of R10 supplemented with GM-CSF. Cells were incubated in the 
presence of the following stimuli: curdlan (50µg/ml), CpG (0.5µg/ml), LPS (100ng/ml), 
Zymosan (100µg/ml), heat-killed or live C. albicans yeast or hyphae (105–5x105). For 
cultures containing live C. albicans, 2.5µg/ml of fungizone (Invitrogen) or 50ng/ml 
caspofungin (Merck) was added to the cultures after 2 hrs of stimulation. Cytokines 
were detected in supernatants and quantified by sandwich ELISA. 
2.3.2 Study of Dectin-2 function in BMDC: 
105 BMDC were cultured as described above. Before the addition of stimuli, cells were 
pre-incubated for 2 hrs with 10µg/ml soluble anti-Dectin-2 antibody (clone 11E4, 
kindly provided by Dr Phillip Taylor, Cardiff university) or an isotype-matched control 
(Rat IgG2a). 105–5x105 heat-killed or live C. albicans were added to the cultures for a 
total time of 12-14 hrs. 2.5µg/ml of fungizone (Invitrogen) or 50ng/ml caspofungin 
(Merck) was added to the cultures 2 hrs after live C. albicans stimulation. Cytokine 
levels in the supernatants were evaluated by sandwich ELISA. 
2.3.3 Dectin-1 and Dectin-2 staining by FACS 
Splenic DCs were isolated as in section 2.2.4 and stained with anti-CD8 FITC, anti-
CD4 PerCP and anti-CD11c-APC in ice-cold FACS buffer containing 1% mouse serum. 
Anti-Dectin-1 antibody (clone 2A11) or isotype matched control were used at a 
concentration of 10µg/ml. Alternatively, anti-Dectin-2 antibody (clone 11E4) or isotype 
matched control were used at a concentration of 10µg/ml. Cells were incubated for 30 
min at 4ºC and washed in ice-cold FACS buffer. Anti-rat IgG-PE (1:200, Jackson 
ImmunoResearch laboratories) was used a secondary reagent for both Dectin-1 and 
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Dectin-2 antibodies. Samples were incubated for 30 min at 4ºC and washed in ice-cold 
FACS buffer prior to acquisition. 
2.3.4 Lentiviral knockdown of Dectin-2 in BMDC: 
The shRNA construct for mouse Dectin-2 in PLKO.1 lentiviral vector 
(TRCN0000066785, Open Biosystems) chosen for this study was based on a previous 
publication (Barrett et al., 2009). The hairpin construct consists of a 21-bp sense and 
antisense sequence and a 6-bp loop. The sequence for TRCN0000066785 is as follows: 
CCGGGCGGTGTGTTTCAATAGTTTACTCGAGTAAACTATTGAAACACACCGC
TTTTTG. 
Color codes: sense, loop, antisense. 
A scramble shRNA was used on these studies as a control. Lentiviral particles were 
generated in the laboratory of Dr Luis Ferreira Moita (Instituto de Medicina Molecular, 
Universidade de Lisboa, Portugal) after cotransfection of 293T cells with the PLKO.1 
construct, the packaging vector Δ8.9 and the envelope vector VSV-G.  
105 bone marrow precursors were cultured in R10 medium supplemented with GM-CSF 
in p96 U-bottom plates. At day 2, media was carefully removed and 10µl of the viral 
stocks was added to the cells. 40µl of media containing 8µg/ml hexadimethrine bromide 
was added immediately to the well and cells were centrifuged at 1,130 x g for 90 
minutes, 37ºC. After centrifugation, the media-containing virus particles was carefully 
removed and replaced with 200µl R10 supplemented with GM-CSF. At day 4, 5µg/ml 
puromycin was added to the cultures. On day 6, cells were harvested and used for 
stimulations as described in section 1.3.1. 
2.4 In vitro assays for T cell activation  
CD4+ T cells are isolated as described in section 2.2.5. Cells were cultured in p96 U 
bottom plates (Falcon) in a total volume of 200µl in R10*. 
For assays containing T cells from OT-II mice, 5×104 CD4+CD25- OT-II T cells were 
cultured in the presence or absence of 2.5×104 CD4+CD25+ OT-II T cells (2:1 mixture) 
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plus 1x104 BMDCs and 2nM of OVA323-339 peptide. Innate stimuli used were 50µg/ml 
curdlan and 0.5µg/ml CpG oligonucleotide 1668. Exogenous cytokines used were 
rhTGF-β1 (1, 10ng/ml) and neutralizing antibodies used were anti-TGF-β (10µg/ml) 
and anti-p19 (10µg/ml) or isotype matched antibodies.  
For assays containing T cells from C57BL/6 mice, DEREG mice or Rorc(γt)-GfpTG 
chimeras, 5×104 sorted T cells were cocultured with 2x104 BMDCs and 0.2µg/ml of 
soluble anti-CD3ε in the presence or absence of 50 µg/ml curdlan, 0.5 µg/ml CpG 
oligonucleotide 1668 or IL-23 (10ng/ml). 
Th17 control consisted of CD4+GFP-CD25- T cells from DEREG mice or DEREG bone 
marrow chimeras cocultured with BMDCs in presence of rhTGF-β1 (10ng/ml), IL-6 
(20ng/ml) and neutralizing antibodies against IFN-γ (2µg/ml) and IL-4 (2µg/ml). 
“Treg” control consisted of CD4+GFP+CD25+ cells from DEREG mice or DEREG bone 
marrow chimeras cocultured with BMDCs in presence of 100IU/ml of rhIL-2. On day 5 
or day 7, cells were stimulated with PMA, ionomycin and brefeldin A for 4h. 
Intracellular staining for Foxp3 and IL-17 was analyzed by flow cytometry as described 
on section 2.6.2 and 2.6.3. Alternatively, half of the content of each well were 
stimulated on day 5 on plate bound anti-CD3ε (5µg/ml) for 48 h and cytokines in the 
supernatant were analyzed by sandwich ELISA as described in section 2.5. 
2.5 Sandwich ELISA for detection of mouse cytokines 
For detection of cytokines present in supernatants of stimulated cells, MAXISORP 96-
well immunoplates (Nunc 4-39454) are coated with 50µl of a solution containing 
capture antibodies diluted in ELISA coating buffer. Plates are sealed and incubated for 
6hr at room temperature or overnight at 4°C in a humidified chamber. Then plates are 
washed 3 times with ELISA wash and blocked with 200µl ELISA block for 2 hrs at RT. 
After blocking, plates are washed 3 times with ELISA wash and 50µl of experimental 
supernatants and cytokine standards are added to the wells. Sealed plates are incubated 
overnight at 4°C in a humidified chamber following by 3 washes with ELISA wash. 
50µl of detection antibodies diluted in ELISA block are added to the wells and plates 
are incubated 1hr at RT. Plates are washed 6 times with ELISA wash and incubated 
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with 50µl of Extravidin-Alkaline Phosphatase (Sigma) diluted 1:5000 in ELISA block 
for 1hr at RT. Then plates are washed 6 times with ELISA wash and 100µl of Alkaline 
Phosphatase substrate (Sigma FAST tablet set, pNPP, Sigma) is added to the wells. 
405nM Absorbance is measured after 15min, 1hr and 2hrs using a SpectraMax 190, 
Molecular Devices, UK and data is analyzed using SoftMax Pro software (Molecular 
Devices) and GraphPad Prism software. 
 IL-2 IL12 p40 TNF IL-10 IL-6 
JES6-
1A12 C15.6  AF-410-NA 
JES5-2A5 MP5-20F3 
(4µg/ml) (5µg/ml)  (2µg/ml) (4µg/ml) (4µg/ml) 
Capture      
antibody 
BD 
Pharminge
n 
BD 
Pharmingen 
R&D 
BD 
Pharmingen 
BD 
Pharmingen 
5 ng/ml 10ng/ml 15 ng/ml 15 ng/ml 10ng/ml 
          
Top 
standard 
          
JES6-5H4- C17.8  BAF410- SXC-1- MP5-32C11- 
Biotin Biotin Biotin Biotin Biotin 
(1µg/ml)  (1µg/ml) (250ng/ml) (1 µg/ml)  (1 µg/ml) 
Detection 
antibody 
BD 
Pharminge
n 
BD 
Pharmingen 
R&D  
BD 
Pharmingen 
BD 
Pharmingen 
 
 IFN-γ  IL-17 
R4-6A2  TC11-18H10 
(5µg/ml)  (2µg/ml) 
Capture      
antibody 
BD 
Pharmingen 
BD 
Pharmingen 
20ng/ml 10ng/ml 
    
Top 
standard 
    
XMG1.2 TC11-8H4.1 Detection 
antibody Biotin Biotin 
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 (0.5µg/ml) (1µg/ml)  
BD 
Pharmingen 
BD 
Pharmingen 
 
2.6 Flow cytometry 
2.6.1 Surface staining of cells 
Cell suspensions were washed once in ice-cold FACS buffer and labelled with surface 
staining antibodies for 20 min at 4ºC on the dark. Data were acquired on a 
FACSCalibur (BD Biosciences) or LSRII (BD Biosciences) and analyzed using FlowJo 
software (Treestar). 
All antibodies were purchased from BD pharmingen unless otherwise indicated and 
used at a concentration of 1:100. 
Antibody Clone Antibody Clone 
Anti-CD4 RM4-5 Anti-CD45.1 A20 
Anti-CD8α  53-6.7 Anti-CD62L MEL-14 
Anti-CD11b M1/70 Anti-TCRβ H57-597 
Anti-CD11c HL3 Anti-FR4 (eBioscience) 12A5 
Anti CD16/CD32 2.4 G2 Anti-Ly6G/C RB6-8C5 
Anti-CD25  PC61 Anti-B220 RA3-6B2 
Anti-CD44 IM7   
 
2.6.2 Intracellular staining for T cell cytokines/transcription factors 
Intracellular antibodies used in this study  
Antibody Clone Company Antibody Clone Company 
Anti-IL-17 TC11-
18H10.1 
eBioscience Anti-IL-17 TC11-
18H10.1 
BD 
Pharmingen 
Anti-Foxp3 FJK-16s eBioscience Anti-IFN-γ XMG1.2 BD 
Pharmingen 
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Cells suspensions were restimulated for 4h with phorbol 12-myristate 13-acetate 
(PMA)(10ng/ml; Sigma), ionomycin (1µg/ml; Calbiochem) and brefeldin A (5µg/ml; 
Sigma) or Golgiplug (1:1000; BD pharmingen). Cells are washed once with ice-cold 
FACS buffer and stained with surface antibodies. After 20 min incubation at 4ºC, cells 
were washed in ice-cold FACS buffer and fixed with “Fix and Perm” Reagent A (Caltag 
laboratories) for 30 min at room temperature. Cells were washed once in ice-cold FACS 
buffer and resuspended in “Fix and Perm” Reagent B (Caltag laboratories) containing 
fluorochrome-conjugated intracellular antibodies. After incubation for 20 min at 4ºC, 
cells were washed and resuspended in ice-cold FACS buffer containing a defined 
number of Calibrite beads (BD pharmingen). 
All antibodies were used at a concentration of 1:100. 
2.6.3 Intracellular staining of Foxp3 
Cells suspensions were restimulated, stained and washed as described above. Cells were 
fixed using a Fixation/Permeabilization solution from mouse/rat Foxp3 staining set 
(eBioscience) for 30-45 min at 4ºC. After incubation, cells were washed in 
permeabilization buffer 1X from mouse/rat Foxp3 staining set (eBioscience) and 
resuspended in permeabilization buffer 1X containing fluorochrome-conjugated 
intracellular Foxp3 and IL-17 antibodies. After incubation for 30 min at 4ºC, cells were 
washed with permeabilization buffer 1X and resuspended in ice-cold FACS buffer 
containing a defined number of Calibrite beads (BD pharmingen). 
2.7 Western Blot for Syk kinase (appendix section) 
Splenic DCs from CD11cΔSyk mice and WT littermates were purified with CD11c 
beads (described in section 2.2.4) and sorted into CD11c+CD4+, CD11c+CD8+ and 
CD11c+CD8-CD4- population by flow cytometry. As a positive control, B220 
expressing cells were sorted by flow cytometry. Cells were washed in PBS and 
suspended in 60µl of RIPA buffer (1% Nonidet-P40, 0.5% deoxycholic acid, 0.1% 
SDS, 150mM NaCl, 10nM NaF, 1mM Na3VO4, 2nM Na4P2O7 and a cocktail of 
protease inhibitors (Roche). Samples are incubated in ice for 30 min followed by 
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centrifugation at 13000rpm for 10 min. Supernatants containing the protein fraction are 
carefully transferred into new tubes containing SDS loading buffer. Protein extracts 
were separated on 4-20% acrylamide gradient, Tris-glycine (Novex, Invitrogen), in 
Tris-Glycine-SDS running buffer (Invitrogen) and subsequently transferred into a 
polyvinyldifluoride membrane (Millipore) using methanol transfer buffer (48mM Tris-
base, 39nM Glycine, 1.3 mm SDS, 20% MeOH). Membrane was blocked in PBS-
1%Tween-20 containing 5% w/v milk for 1 hour at RT. Syk protein was detected using 
a anti-Syk rabbit serum (serum “2131” raised against the peptide 318-330 of murine 
Syk and described in (Turner et al., 1995), kindly provided by Dr V. Tybulewicz). 
Serum 2131 was diluted 1:1000 in PBS-1%Tween-20 containing BSA and membranes 
were incubated overnight at 4ºC with shaking. The membrane was then washed 3 times 
for 15 min in 15ml PBS-1%Tween-20 at RT with shaking. HRP-goat-anti-rabbit HRP 
was diluted 1:5000 in PBS-1%Tween-20 containing BSA and membrane was incubated 
for 1hr at RT with shaking. After the incubation, the membrane was washed 3 times for 
15 min in 15ml PBS-1%Tween-20 at RT with shaking and incubated for 5 min with 
Supersignal WestPico Chemiluminescent substrate (Pierce). The membrane was 
exposed to X-ray film for developing. 
2.8 Molecular Biology and cloning 
2.8.1 Transformation of competent E. Coli 
1µl of plasmid DNA was added to 60µl of One Shot TOP10® chemically competent 
bacteria E. Coli (Invitrogen) and samples were incubated 30 min on ice. Tubes were 
transferred to a 42ºC water bath for 1 minute and then were returned to ice for 10 min. 
500µl of SOC medium (Invitrogen) was added to the samples and tubes were incubated 
in a shaker at 1050 rpm, 1 hr and 37ºC. Cells were centrifuged at 2000 rpm for 2 min 
and suspended in 200µl SOC medium. Cells were plated into selective agar plates 
containing 100µg/ml Carbenicillin (Sigma) following by incubation at 37ºC, overnight. 
2.8.2 Plasmid isolation 
Resistant clones were picked using sterile tips into 5ml LB containing 100µg/ml 
carbenicilin and incubated at 37ºC, 220rpm overnight. Plasmid isolations were 
performed by the miniprep service provided by the equipment park (Cancer Research 
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UK). For large-scale plasmid isolation, 1 ml of the cultures was added to 200ml of LB 
containing carbenicilin and incubated at 37ºC, 220 rpm overnight. Cells were 
centrifuged at 3500 rpm for 5 minutes and pellets were processed using HiPure Plasmid 
Filter Maxiprep Kit (Invitrogen) according manufacturer’s instructions. 
2.8.3 Restriction enzymes reaction 
All enzymes, buffers and BSA were purchased from New England Biolabs (UK) and 
used according to manufacturer’s instructions. Briefly, 1µg of plasmid was added to 2µl 
of 10x buffer, ± 0.2µl BSA, 1µl of restriction enzyme and ddH20 to a final volume of 
20µl. Samples were incubated for 1-1.5 hours at 37ºC. 
2.8.4 Gel Electrophoresis 
DNA samples were prepared on ddH20 and mixed with DNA loading buffer (Sigma) in 
ratio 6:1. 1% Agarose gels were prepared in TAE buffer and melted in a microwave 
oven. 1µg/ml of ethidium bromide (Sigma) was added to the gel before pouring it into a 
gel tray. The solidified gel was placed onto a gel chamber filled with TAE buffer and a 
voltage of 80-120 V was applied for 30-45 min. 
2.8.5 Gel purification of DNA fragments 
Bands were excised by using a sterile scalpel and cleaned using QIAGEN gel 
purification kit according to manufacturer’s instructions.  
2.8.6 Purification of DNA fragments from solution 
DNA purification was carried out using QIAquick PCR purification kit (QIAGEN) 
according to manufacturer’s intructions. DNA was routinely eluted in 30µl of ddH20. 
2.8.7 Isolation of RNA from T cells 
CD4+ T Cells were harvested on day 5 or 7, washed on ice-cold PBS and supernantats 
were discarded. Total RNA was prepared by adding 1 ml of TRIzol reagent (Invitrogen) 
and 5 min incubation at room temperature. 200µl of chloroform was added to each 
sample and tubes were shaken vigorously by hand for 20 sec. Samples were incubated 
at room temperature for 3 min and then centrifuged at 12,000 g, 15 min, 4ºC. The upper 
phase (600µl approx) was transferred into a new eppendorf tube and 500µl isopropanol 
plus 5µg glycogen was added to the samples. Tubes were mixed by inversion and 
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incubated for 10 minutes at room temperature. Then samples were centrifuged at 12,000 
g for 15 minutes at 4ºC supernatants were discarded. RNA was washed with 500µl of 
70% ethanol and centrifuged at 7,500 g for 5 min at 4ºC. Supernatants were discarded 
and RNA was air-dried at room temperature. Samples were resuspended in 50µl ddH2O. 
2.8.8 Isolation of RNA from BMDC stimulated with C. albicans 
Total RNA from BMDCs was extracted after 3 hrs of stimulation with yeast or hyphae 
using the RNeasy Mini Kit (QIAGEN) following manufacturer’s instructions. As an 
additional step, contaminating DNA was removed from the samples by using RNase-
Free DNase set (QIAGEN) according to manufacturer’s instructions. 
2.8.9 Reverse transcription reaction 
cDNA was synthesized from total RNA with random hexamers and Superscript II 
following manufacturer’s instructions. Briefly, 11.5µl of RNA solution were incubated 
with 1µl of random hexamers 50µM (Invitrogen) for 10 min at 70ºC. Tubes were placed 
on ice and 7.5µl per reaction of a Superscript II containing mix (see below) was added 
to the samples. 
Superscript II-containing mix (all from Invitrogen):  
5x first strand buffer 4µl 
0.1M DTT 2µl 
10mM dNTP 1µl 
SuperscriptII 0.5µl 
Total volume per 1 sample 7.5µl 
 
Samples were incubated for 60 min at 42ºC. Then samples were incubated 15 min at 
70ºC and left at 4ºC.  
20µl of cDNA generated above was diluted by adding 40µl of ddH2O plus 0.1µg/ml 
glycogen to each tube. 
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2.8.10 Real-time RT-PCR 
5µl/well of the cDNA solution prepared as above was added to a MicroAmpTM Optical 
96-well reaction plate (Applied Biosystems). Quantitative real-time PCR was carried 
out using Platinum SYBR green pPCR Supermix-UDG with ROX (Invitrogen). 
Reaction protocol per well: 
2x SYBRgreen pre-mix 10µl 
ddH20 4.8µl 
Primer mix (stock 10µM) 0.2µl 
Template 5µl 
Total volume per 1 sample 20µl 
 
Measurements were performed in duplicate wells using the ABI PRISM 7700 sequence 
detection system (Applied Biosystems) and analysed using SDS 1.9.1 and Microsoft 
Excel. 
List of real time PCR primers used in this thesis: 
Gene name Primer 
name 
Sequence Reference 
IL-17F fwd 
IL-17F rev 
C135 
C136 
GAGGATAACACTGTGAGAGTTGAC 
GAGTTCATGGTGCTGTCTTCC 
(Ivanov et 
al., 2006) 
RORγt fwd 
RORγt rev 
C137 
C138 
CCGCTGAGAGGGCTTCAC 
TGCAGGAGTAGGCCACATTACA 
(Ivanov et 
al., 2006) 
IL-23R fwd 
IL-23R rev 
C139 
C140 
GCCAAGAAGACCATTCCCGA 
TCAGTGCTACAATCTTCTTCAGA 
GGACA 
(Mangan et 
al., 2006) 
IL-23 fwd 
IL-23 rev 
A583 
A584 
TGCTGGATTGCAGAGCAGTAA 
GCATGCAGAGATTCCGAGAGA 
(Holscher et 
al., 2001) 
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18S fwd 
18S rev 
C66 
C67 
CGGCTACCACATCCAAGGAA 
GCTGGAATTACCGCGGCT 
- 
GADPH primers were bought commercially from Applied Biosystems.  
Normalization was performed using 18S rRNA or GADPH as a reference and results 
are shown as relative mRNA quantities. 
2.9 Treg control of Helicobacter hepaticus-triggered intestinal 
inflammation 
H. hepaticus infections were carried out at the laboratory of Dr Fiona Powrie (Oxford 
University, UK) as previously described (Maloy et al., 2003), and were done in 
conjunction and under supervision of Philip Ahern, senior graduate student in that 
laboratory. Briefly, H. hepaticus was grown in blood agar plates under microaerophilic 
conditions and checked for viability prior to infection. 129SvEvRag2-/- female mice 
were infected by oral gavage four times on alternate days with 5x107–1x108 CFU H. 
hepaticus. In addition, mice were reconstituted on the first day of infection with 1x105 
CD4+CD45RBlowCD25+ T cells intraperitoneally (purified by cell sorting facility at 
Oxford university). 
Alternatively, a group of mice was additionally fed with 5mg curdlan in PBS by oral 
gavage on a weekly basis starting on the first day of infection. Weight loss was 
monitored throughout the course of the experiment and mice were sacrificed 8 weeks 
after the first H. hepaticus inoculation. Spleen, mesenteric lymph node and colonic 
lamina propria were removed for T cell analysis and histological score was performed 
by facilities at Oxford University. 
2.10 Construction of C. albicans strains  
2.10.1 C. albicans preparations 
Strains of C. albicans were routinely grown at 30ºC on YPD media overnight in a water 
bath with agitation with the exception of CAI4 strain, which was grown on YPD-Uri+ 
media. For cell stimulations or infections, cells were washed twice with sterile PBS 
before use. Cells were used either live or heat-killed by boiling for 30-45 minutes. 
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For hyphal induction, cells were suspended in RPMI containing 10% FCS at a 
concentration of 107 cells/ml. 5 ml of the cell suspension was seeded on a petri dish and 
incubated overnight at 37ºC, 5% CO2. After washing in PBS, hyphae was used as live 
or heat-killed for stimulations. Morphology was verified by differential interference 
contrast microscopy using a 40x objective (Plan Fluor; Nikon) and analyzed with 
ImageJ program. 
2.10.2 C. albicans strains generated in this thesis 
The strains of C. albicans used on this study are listed in the following table: 
Strain Parent Genotype Reference 
SC5314 Wild 
type 
dddds  
CAI4 CAF2-1 ura3::λimm434/ura3::λimm434 
 
(Fonzi and 
Irwin, 1993) 
pACT1-GFP CAI4 ura3::λimm434/ura3::λimm434 
RPS10/RPS10 ::CIp10-ACT1p-
GFP  
(Barelle et al., 
2004) 
pACT1- GFP-
OVA323-339 
CAI4 ura3::λimm434/ura3::λimm434 
RPS10/RPS10 ::CIp10-ACT1p-
GFP-OVA323-339 
This study 
pACT1- GFP-
SIINFEKL 
CAI4 ura3::λimm434/ura3::λimm434 
RPS10/RPS10 ::CIp10-ACT1p-
GFP-SIINFEKL 
This study 
 
2.10.3 Plasmids for C. albicans transformation 
pACT1-GFP (Barelle et al., 2004) is a vector derived from the integrative plasmid 
CIp10 (Murad et al., 2000) expressing a codon optimised yeast enhanced version of 
GFP (described in(Cormack et al., 1997)) under the promoter region (-2 to-1019) of the 
CaACT1 gene (Barelle et al., 2004). 
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The fusion GFP-OVA323-339 was generated by PCR from pACT1-GFP vector using the 
oligonucleotides FO 8_5’ and FO 23_3’ and then subcloned at the HindIII and NheI 
sites in pACT1-GFP vector in place of GFP to generate pACT1-GFP-OVA323-339.  
The fusion GFP-SIINFEKL was generated by PCR as described above for GFP-
OVA323-339 but using the oligonucleotides FO 8_5’ and FO 22_3’.  
The sequences encoding OVA323-339 and SIINFEKL peptides were designed for optimal 
codon utilisation in C. albicans according to Brown et al (Brown et al., 1991). 
Oligonucleotide name Sequence (5’-3’)a,b 
FO 23 
(C. albicans optimized 
OVA323-339 –NheI) antisense 
TAGCGCTAGCTTAAACAACTTCTCTACC 
AGCTTCATTAATTTCAGCATGAGCAGCA 
TGAACAGCTTGTGAAATTTTAAGGTCGA 
CTTTGTACAATTCATCCATACC 
FO 22 
(C. albicans optimized 
SIINFEKL –NheI) 
antisense 
TAGCGCTAGCTTAAGTCAATTTTTCAAAA 
TTAATAATACTCTCAAGGTCGACTTTGTA 
CAATTCATCCATACC 
FO 8 (located upstream of 
GFP ORF) 
CTCCTGGTTTTCTTTCTTTC 
a black underline indicates NheI restriction site 
b blue underline indicates SalI restriction site 
 
Fusion sequences were checked by digestion with the restriction endonucleases 
HindIII/NheI and HindIII/SalI and analyzed by sequencing. 
2.10.4 Sequencing of PACT1-GFP, PACT1-GFP-OVA323-339 and PACT1-GFP-
SIINFEKL 
DNA sequencing was performed by the equipment park at Cancer Research UK. 
Briefly, 8µl of BigDye Terminator mix (Cancer Research UK) was mixed with 2µl of 
sequencing primer (3.2 pmol) and 10ul of a solution containing 150 ng of plasmid in 
ddH20. The PCR reaction was carried out using the following program: 
Step 1 Denature 96ºC 30s 
Step 2 Anneal 50ºC 15s 
Step 3 Extension 60ºC 4mins 
Step 4 Return to step 1 x 25  
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Step 5 Chill 4ºC Forever 
 
The primers FO 10 and FO 21 were used to confirm plasmid integrity  
FO 10: sense - GTCTTGTTACCAGACAACC it binds within GFP region 
FO 21: antisense – CTTGAGTTGGATCTACGCG it binds downstream of GFP region 
in PACT1-GFP vector 
2.10.5 C. albicans transformation 
Before transformation, all plasmids were linearized with the blunt restriction 
endonuclease StuI (New England Biolabs) following by 30 min at 65ºC to allow 
enzyme inactivation. 
C. albicans was transformed using a modified version of the lithium-acetate procedure 
(Sanglard et al., 1996). A single colony of C. albicans CAI4 (Uridine auxotroph, kindly 
provided by Dr. Alistair Brown, Aberdeen, UK) was grown for 24 hrs on YPD-Uri+ 
media in a water bath with agitation. 200µl of the culture was centrifuged and 
resuspended in 100µl of Osmotic Stabilizing Buffer (OSB mix described above). 1µg of 
the linearized vector was added to the cell suspension and tubes were vortexed to allow 
mixing. Cells were incubated for 30-45 min at 43.5ºC and plated out onto selective SC-
URI media. Few transformants were observed 3-4 days after transformation. Single 
colonies were grown on YPD (Uri-) media overnight and frozen stocks were kept at -
80ºC. 
2.10.6 Isolation of C. albicans genomic DNA 
The procedure for isolation of yeast genomic DNA has been described previously 
(Harju et al., 2004). A single colony of C. albicans was inoculated into YPD and 
incubated overnight at 30ºC in a water bath with agitation. 1.5 ml of liquid culture was 
transferred to a microcentrifuge tube and centrifuged at 13000 x g for 5 min. Cells were 
resuspended in 200µl of lysis buffer (2%Triton X-100, 1%SDS, 100mM NaCl, 10mM 
Tris-HCl, pH 8.0, 1mM EDTA pH 8.0). The tubes were placed in -80ºC freezer for 2 
minutes (until completely frozen) following by 1 min incubation at 95ºC. This process 
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was repeated once and the tubes followed by vortex for 30 seconds. 200µl Chloroform 
was added to the tubes and followed by vortex for 2 minutes and centrifugation at room 
temperature 13000 x g, 3 min. The aqueous phase was transferred to a microcentrifuge 
tube containing 400µl ice-cold 100% ethanol and the samples were incubated 5 minutes 
at room temperature and then centrifuged at 13000 x g for 5 minutes. Supernatants were 
discarded and pellets were washed with 500µl of 70% ethanol. Samples were incubated 
5 minutes at 60ºC and resuspended in 25-50µl ddH20 for PCR analysis. 
2.10.7 Plasmid integration into RPS10 locus in C. albicans 
Integration into the C. albicans RPS10 locus was confirmed by PCR using the 
following primers described in (Barelle et al., 2004) 
Oligonucleotide name Sequence  
FO 24 (located on chromosomal RPS10 
locus, outside of plasmid sequences) 
(Barelle et al., 2004) 
 
CGTATTCACTTAATCCCACAC 
FO 25 (located in the GFP ORF) 
(Barelle et al., 2004) 
 
CCAATTGGTGATGGTCC 
 
PCR reaction was performed in a 50µl reaction containing 50pmol of primers using the 
following program:  
Step 1 Denature 95ºC 7 mins 
Step 2 Denature 95ºC 1 min 
Step 3 Anneal 60ºC 45s 
Step 4 Extension 72ºC 1min 
Step 5 Return to step 2 x 29  
Step 5 Chill 4ºC forever 
GFP expression in C. albicans integrants was confirmed by western blot. 
2.10.8 C. albicans protein extraction protocol 
A single colony of C. albicans was inoculated into YPD and grown overnight at 30ºC in 
a water bath with agitation. 106 cells were washed with ddH2O and cells were suspended 
on 100µl of ddH2O. 100µl of NaOH 0.2M was added to the cell suspension following 
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by vortex and 5 minute incubation at room temperature. After centrifugation at 13000xg 
for 1 min, media was carefully removed and 50µl of 2x loading buffer containing DTT 
was added to the protoplasts. Then the suspension was incubated for 5 min at 95ºC and 
centrifuged at 10000xg for 10 min. Supernatants were collected and 5µl were loaded on 
an acrylamide gel for western blot analysis. 
2.10.9 Western blot for detection of GFP in C. albicans transformants 
Protein extracts were resolved by SDS PAGE (4-20% acrylamide gradient, Tris-glycine; 
Invitrogen). Proteins were transferred to a polyvinyldifluoride membrane (Millipore) as 
in section 2.7. GFP (FL) protein was detected by incubation with an anti-GFP rabbit 
polyclonal IgG antibody (Santa cruz, sc-8334, used 1:1000) and a HRP Goat anti-rabbit 
IgG (H+L) antibody (Invitrogen, used 1:5000). GFP was visualized using a 
chemoluminescence kit (Pierce). 
2.10.10 Microscopy 
C. albicans morphology was verified by differential interference contrast microscopy 
using a 40x objective (Plan Fluor, Nikon). 
For analysis of GFP expression, cells were grown in synthetic defined media to avoid 
autofluorescence and GFP fluorescence was analysed using a LSM 510 confocal 
microscope (Zeiss).  
2.11 In vitro T cell differentiation assays to Candida-associated 
antigens 
2.11.1 Assays containing CD4+ OT-II T cells 
104 BMDC were incubated in a p96 U-bottom plate for 2 hrs with various doses of heat-
killed or live C. albicans-GFP-OVA323-229. When using live organisms, fungizone was 
added at the end of the incubation time. Then 5x104 naïve OT-II T cells labelled with 
CFSE were added to the wells. As a positive control, OVA323-339 peptide was used at the 
indicated concentrations and C. albicans-GFP (9/1 candida/DC) was used as a negative 
control. On day 5, half of each well was analyzed and counted by FACS. The second 
half was restimulated for analysis of cytokine production by plating on immobilised 
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anti-CD3 (5µg/ml) for 48 hours in a p96 flat bottom plate. Cytokines were quantified by 
sandwich ELISA as described in section 2.5. 
2.11.2 Assays containing CD8+ OT-I T cells 
104 BMDC were incubated in a p96 U-bottom plate for 2 hrs with various doses of heat-
killed or live C. albicans-GFP-SIINFEKL. When using live organisms, fungizone was 
added at the end of the incubation time. Then 5x104 OT-I T cells labelled with CFSE 
were added to the wells. As a positive control, SIINFEKL peptide was used at the 
indicated concentrations and C. albicans-GFP (9/1 candida/DC) was used as a negative 
control. On day 5, half of each well was analyzed and counted by FACS. The second 
half was restimulated for analysis of cytokine production by plating on immobilised 
anti-CD3 (5µg/ml) for 48 hours in a p96 flat bottom plate. IFN-γ production was 
quantified by sandwich ELISA as described in section 2.5. 
2.12 Systemic C. albicans infection model 
2.12.1 Study of Dectin-2 function during systemic C. albicans infection 
These experiments were performed in the laboratory of Dr Philip Taylor (Cardiff 
University, UK). Wild-type or Clec7a -/- (129/Sv background) female mice aged 12-16 
weeks were injected with 200µg anti-Dectin-2 (D2.11E4) or isotype matched control 
(OX11), intraperitoneally. After 6h, mice were injected i.v. with 3x104 live C. albicans 
yeast. On day 2 and 4 after infection, mice were further injected i.p. with 200µg of anti-
Dectin-2 or isotype control. Mice were weighed on a daily basis and on day 7, they 
were sacrificed. Total splenocytes were harvested and seeded in a 96-well U bottom 
plate at 2x106 cells/well. Splenocytes were restimulated with medium alone, 105 or 106 
heat-killed C. albicans per well for 2 days. IL-17 and IFN-γ on supernatants were 
measured by sandwich ELISA as described in section 2.5. 
2.12.2 Analysis of antigen-specific CD4+ T cell responses to C. albicans-
associated antigens 
These experiments were performed at Imperial college and Cancer Research UK. Naïve 
OT-II cells are isolated from congenic B6.SJL.CD45.1 OT-II mice as described in 2.2.5 
and labelled with CFSE. 1x106 OT-II cells were transferred i.v. into wild-type 
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(C57BL/6) female mice aged 12-18 weeks. One day later, mice were infected i.v. with 
1x105 or 5x104 C. albicans-GFP-OVA323-339 or C. albicans-GFP. Mice were sacrificed 
on day 5 or alternatively, on day 7. OT-II proliferation was analyzed on day 5 in Spleen, 
mesenteric LN, renal LN, brachial LN and inguinal LN by gating on CD4+CD45.1+ cell 
population. For intracellular cytokine staining, renal LN cells were stimulated with 
PMA and Ionomycin in the presence of BFA as described in 2.6.2. 
2.12.3 Analysis of antigen-specific CD8+ T cell responses to C. albicans-
associated antigens 
These experiments were performed at Imperial college and Cancer Research UK. Naïve 
OT-I cells are isolated from congenic B6.SJL.CD45.1 OT-I mice as described in 2.2.6 
and labelled with CFSE. 1x106 OT-I cells were transferred i.v. into wild-type 
(C57BL/6) female mice aged 12-18 weeks. One day later, the mice were infected i.v. 
with 5x104 C. albicans-GFP-SIINFEKL or C. albicans-GFP. Mice were sacrificed on 
day 4. OT-I cell proliferation and cytokine production were analyzed by FACS in 
kidneys, spleen and renal LN. For intracellular FACS staining in the OT-I cell 
population, 2x106 splenocytes and half of a renal LN were pulsed with 1µM SIINFEKL 
peptide for 1 hour following by the addition of BFA for 3 additional hours.  
2.12.4 Systemic infection in CD11cΔSyk mice (appendix section). 
These experiments were carried out at Cancer Research UK. cd11c cre+ x syk fl/fl 
(CD11cΔSyk) or cd11c cre- x syk fl/fl (wild type littermate) female mice aged 12-18 
weeks were injected i.v. with 5x104 live C. albicans yeast. Mice were weighed on a 
daily basis and were sacrificed at day 6-7 or when the human end point established in 
the national and institutional guidelines for animal care (Animal Scientific Procedures 
Act 1986, UK) was reached. 
2.12.5 Quantification of fungal burden 
Kidneys, lung and liver were aseptically removed, weighed and disrupted in 0.5ml PBS 
using an electrical homogenizer (T 25 digital ULTRA-TURRAX®, IKA®). 20µl of 
serial dilutions (0, 1/10, 1/100, 1/1000 and 1/10000) were plated on agar plates in 20µl 
drops in duplicate. Plates were incubated overnight at 37ºC and the total number of 
colonies was counted and calculated back to colony forming units. 
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2.12.6 Histopathology (appendix) 
Samples were fixed in 10% Neutral Buffered Formalin and analyzed by the 
histopathology laboratory at Cancer Research UK. Samples were dehydrated with 
ethanol and embedded in paraffin. Periodic Acid Schiff (PAS) and hematoxylin and 
eosin (H&E) were used to assess fungal invasion and leukocyte infiltration respectively. 
2.12.7 Statistical analysis 
The statistical significance of the study described in 2.12.1 was determined by one-way 
analysis of variance with Tukey multiple comparison of all pairs for posttest analysis. 
The statistical significance of the experiments described in section 2.9 and 2.12.4 
(appendix section) was determined by Mann-Whitney U test. All other values are 
graphed as mean ± SD unless otherwise stated. 
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Chapter 3. Dectin-1 in the induction of IL-17-
producing CD4+ T cells. 
3.1 Introduction 
3.1.1 Curdlan is an adjuvant for the induction of Th17 responses. 
Before this project was initiated it was established that Dectin-1 was a PRR that 
directed signalling via the Spleen tyrosine kinase Syk ((Rogers et al., 2005, Underhill et 
al., 2005), for details see introduction). Syk deficiency abrogated the production of IL-2 
and IL-10 in zymosan-stimulated DCs and partially decreased uptake of fungal particles 
(Rogers et al., 2005). Furthermore, the adaptor CARD9 was identified as a downstream 
effector of Dectin-1/Syk signalling by activating NF-κB in response to fungal infection 
(Gross et al., 2006). 
Those studies demonstrated that the Dectin-1/Syk/CARD9 axis constituted a novel 
innate signalling pathway that can act independently of TLR/MyD88 stimulation. 
Nonetheless, it remained unclear whether Dectin-1/Syk/CARD9 signalling was capable 
of inducing cytokines other than IL-2 and IL-10 on DCs. Moreover, it was undefined 
whether activation via Dectin-1 rendered DCs competent to prime effector T cell 
responses. 
To determine the impact of Dectin-1/Syk signalling pathway on phenotype and function 
of DCs, it was necessary to identify a selective Dectin-1 agonist. Dr Salomé 
LeibundGut-Landmann (former member of the Immunobiology Lab, currently based at 
ETH zurich, Switzerland) validated the β-(1,3)-glucan preparation known as curdlan 
(for details see introduction) as a purified Dectin-1 agonist. Stimulation of bone marrow 
derived DC (BMDC) with curdlan led to the induction of the costimulatory molecules 
CD86, CD80 and CD40, activation of the MAPKs p38, Erk and Jnk and activation of 
NF-κB (LeibundGut-Landmann et al., 2007). Furthermore, curdlan-activated BMDC 
produced a subset of cytokines including IL-2, IL-10, TNF, IL-6, IL-12p40 and IL-23 
but very little IL-12 p70 (LeibundGut-Landmann et al., 2007). Importantly, all 
cytokines triggered by the Dectin-1 agonist were dependent on Dectin-1, Syk and 
CARD9 and were independent of MyD88 and TRIF (LeibundGut-Landmann et al., 
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2007). Thus, this work demonstrated for first time that selective activation of Dectin-
1/Syk/CARD9 signalling pathway in isolation was sufficient to induce full DC 
activation (LeibundGut-Landmann et al., 2007). 
Notably, curdlan-stimulated BMDCs produced high levels of the cytokines involved in 
Th17 cell induction including IL-6, TNF and IL-23 (Aggarwal et al., 2003, Veldhoen et 
al., 2006a, Bettelli et al., 2006, Mangan et al., 2006, Harrington et al., 2005). This 
distinctive cytokine signature elicited by this Dectin-1 agonist suggested that curdlan 
could be used as an adjuvant for the induction of Th17 responses. Thus, Salomé 
LeibundGut-Landmann first showed that when curdlan-stimulated BMDCs were 
cultured with transgenic OT-II CD4+ T cells in the presence of specific antigen, an 
accumulation of IL-17-producing CD4+ T cells was observed (LeibundGut-Landmann 
et al., 2007). The production of IL-17 was dependent on Syk signalling in BMDCs and 
was independent of MyD88 (LeibundGut-Landmann et al., 2007). These series of 
experiments elegantly demonstrated that the Dectin-1/Syk/CARD9 axis constitute an 
innate signalling pathway leading to the induction of Th17 effector responses 
(LeibundGut-Landmann et al., 2007). Remarkably, depletion of CD4+CD25+ T cells 
from the CD4+ transgenic T cell preparation in curdlan-containing cocultures reverted 
this effect (LeibundGut-Landmann et al., 2007), as previously reported for TLR-
containing cultures (Veldhoen et al., 2006a). Only when CD4+CD25+ T cells were 
present, the production of IL-17 was restored and transcripts encoding RORγt, IL-17A 
and IL-17F were detected (LeibundGut-Landmann et al., 2007). 
In vivo, curdlan could also be used as an adjuvant for inducing Th1 and Th17 responses 
and antibody production against ovalbumin (LeibundGut-Landmann et al., 2007). In 
sum, these results demonstrate that activation of the Dectin-1/Syk/CARD9 innate 
signalling pathway results in the instruction of adaptive immunity. 
The aim of work described in this chapter is to identify the mechanism involved in the 
induction of Th17 responses upon activation of the Dectin-1 signalling pathway in DCs. 
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3.2 Results 
3.2.1 Curdlan-activated BMDCs trigger IL-17 production by CD4+ T cells 
at various doses of antigen or stimulus. 
The remarkable superiority of curdlan over CpG at inducing Th17 responses 
(LeibundGut-Landmann et al., 2007) raises the question as to whether this faculty 
reflects qualitative differences between both innate signalling pathways or is the result 
of a quantitative effect. Factors such as the antigen dose and concentration of microbial 
stimuli can influence the ability of DCs to direct Th1 and Th2 development (Boonstra et 
al., 2003). First, we decided to evaluate whether the efficiency of curdlan-stimulated 
BMDCs to induce Th17 responses was subjected to the concentration of antigen present 
in the cultures. CD4+ T cells were isolated from OT-II transgenic mice, which express a 
TCR specific for the peptide 323-339 from ovalbumin. CD4+CD25- and CD4+CD25+ T 
cells from OT-II mice were cultured in a mixture 2:1 in the presence of BMDCs 
stimulated with curdlan or CpG plus different concentrations of OVA323-339 peptide for 5 
days. The production of IL-17 and IFN-γ was measured by sandwich ELISA after two 
days of restimulation with plate-bound α-CD3 antibody. Results are shown in Figure 
3.1.a. When no stimulus was present, lower peptide concentrations resulted in low 
production of IFN-γ and IL-17 whereas higher doses of peptide led to the production of 
IFN-γ as previously described (Boonstra et al., 2003). The presence of CpG enhanced 
the production of IFN-γ at 2nM of OVA323-339 peptide and elicited little production of 
IL-17 at various doses of antigen. The presence of curdlan did not promote the secretion 
of IFN-γ compared to unstimulated cultures but led to the production of high levels of 
IL-17. These results indicate that variations on antigen concentration do not modify the 
quality of the CD4+ effector response induced by DCs activated with the Dectin-1 
agonist (LeibundGut-Landmann et al., 2007). 
To determine whether the concentration of stimuli modifies the ability of BMDCs to 
induce Th1 or Th17 cells, titration of both stimuli was performed. CD4+CD25- and 
CD4+CD25+ T cells from OT-II mice plus BMDCs were cultured with 2nM of OVA323-
339 peptide in the presence of various doses of stimuli and the production of IL-17 and 
IFN-γ was measured after restimulation. Results are shown in Figure 3.1b. Whereas 
various doses of CpG led to the production of high levels of IFN-γ and very little IL-17 
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from CD4+ T cells, titration of curdlan in the cocultures resulted in the production of 
high levels of IL-17 and little IFN-γ. These results indicate that curdlan is a bona fide 
Th17 inducer and its effect is a consequence of qualitative effects on DC activation, as 
titration of both stimuli does not induce interconversion of their effect (LeibundGut-
Landmann et al., 2007). 
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Figure 3-1: Dendritic cells stimulated with curdlan preferentially induce Th17 cells. 
(a) 5x104 CD4+CD25- OT-II T cells and 2.5x104 CD4+CD25+ OT-II T cells were cocultured with 1x104 
C57BL/6 plus 50µg/ml curdlan or 0.5µg/ml CpG and the indicated amounts of OVA323-339. At day 5, cells 
were restimulated for 2 extra days in the presence of 5µg/ml coated a-CD3e. (b) Cells were cultured as in 
(a) in the presence of 2nM OVA323-339 plus the indicated amounts of curdlan or CpG. Cytokines were 
measured by sandwich ELISA and data shown are mean + s.d. of triplicate wells. 
 
3.2.2 Curdlan-activated BMDCs promote development of IL-17-producing 
CD4+ T cells in a mechanism involving IL-23, TNF, TGF-β and 
CD4+CD25+ T cells.  
As mentioned above, curdlan-stimulated BMDCs produced cytokines involved in the 
development of Th17 cells such as IL-6, TNF and IL-23 (LeibundGut-Landmann et al., 
2007). Thus we sought to identify whether those factors are required for the generation 
of IL-17-producing CD4+ T cells in response to Dectin-1–activated BMDCs. 
Neutralizing antibodies specific for IL-23 and TNF were added to cocultures containing 
the CD4+CD25- and CD4+CD25+ T cells mixture, BMDCs plus OVA323-339 peptide in 
the presence of curdlan or CpG. 
Figure 3.2a shows that in curdlan-containing cocultures, IL-23 plays a non-redundant 
role in promoting the generation of Th17 cells as the addition of a blocking antibody 
against the p19 subunit of IL-23 abrogated the production of IL-17 when compared to 
an isotype-matched control. 
As previously described for TLR containing cocultures (Veldhoen et al., 2006a), the 
addition of an anti-TNF antibody to curdlan-containing cocultures slightly reduced the 
production of IL-17 (Fig 3.2b), reinforcing the notion that this cytokine has an 
accessory role by augmenting the frequency of IL-17 producers. 
We attempted to determine the role of IL-6 in the differentiation of Th17 cells from 
cocultures containing the Dectin-1 agonist. The addition of a neutralizing antibody to 
IL-6 did not modify the production of IL-17 in cocultures containing curdlan as 
stimulus (data not shown). Is important to note that there may be caveats with this 
experiment associated with the efficiency of the blocking antibody to neutralize 
cytokine bioactivity. In agreement with previous reports (Bettelli et al., 2006, Veldhoen 
et al., 2006a), IL-6 signalling might be crucial for Th17 induction in conditions of 
Dectin-1 stimulation and this would be clarified by using IL-6 deficient BMDCs.  
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Considering the relevance of TGF-β signalling in the process of Th17 differentiation 
(reviewed in (Weaver et al., 2007, Korn et al., 2009)), we sought to determine the 
involvement of this factor in Dectin-1-associated Th17 responses. The addition of a 
neutralizing antibody to TGF-β to curdlan-containing cocultures abrogated the 
production of IL-17 after restimulation (Fig 3.2.c), in agreement with previous 
publications (Veldhoen et al., 2006a, Bettelli et al., 2006, Mangan et al., 2006). 
Interestingly, accumulation of IL-17-producing cells in cocultures containing the 
Dectin-1 agonist has shown to be directly proportional to the amount of CD4+CD25+ 
OT-II T cells present initially in the well (LeibundGut-Landmann et al., 2007). In this 
set of experiments, Salomé LeibundGut-Landmann showed that Tregs did not only act 
to prevent Th1 differentiation, as their effect could not be mimicked by the addition of 
an IFN-γ neutralizing antibody (LeibundGut-Landmann et al., 2007). In addition, it is 
known that Tregs produce robust amounts of TGF-β for Th17 differentiation in cultures 
containing TLR agonists (Veldhoen et al., 2006a). In order to test whether TGF-β could 
substitute for the Treg presence in cocultures containing curdlan, CD4+CD25+ T cells 
from OT-II mice were replaced with 1 or 10ng/ml of hTGF-β1 in cocultures containing 
CD4+CD25- OT-II T cells, BMDCs, OVA323-339 peptide in the presence of curdlan or 
CpG. Results are shown in Figure 3.2.d. The addition of exogenous hTGF-β1 to curdlan 
containing cocultures supported the differentiation of Th17 cells albeit at very low 
levels. Broader titration of TGF-β was performed with similar results (data not shown) 
indicating that the presence of Tregs in the culture results in greater Th17 skewing. 
These results are particularly intriguing as they suggest that Tregs may not only act as 
TGF-β producers under this condition of culture. One explanation to these findings is 
that CD4+CD25+ T cells serve in part as a source for TGF-β but they also provide 
additional signals that support the induction of Th17 cells. 
In this context I sought to further investigate the role of CD4+CD25+ T cells in the 
induction of Th17 by curdlan-stimulated BMDCs. 
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Figure 3-2: Dectin-1 activated BMDCs induce IL-17-producing CD4+ T cells through a mechanism 
involving IL-23, TNF and TGF-β . 
(a) 5x104 CD4+CD25- OT-II T cells and 2.5x104 CD4+CD25+ OT-II T cells were cocultured with 1x104 
C57BL/6 plus 50µg/ml curdlan or 0.5µg/ml CpG and 2nM OVA323-339. On days 0 and 3, 10µg/ml anti-IL-
23p19 (α-p19) or Isotype control was added to the cultures. At day 5, cells were restimulated for 2 extra 
days in the presence of 5µg/ml coated a-CD3e. (b) as in (a) with the addition of 10µg/ml anti-TNF (α-
TNF) or Isotype matched control on day 0. (c) as in (a) with the addition of 10µg/ml anti-TGF-b (α-TGF-
b) on day 0. (d) Cells were cultured as in (a) with the addition of increasing doses of recombinant human 
TGF-β1 (1 and 10ng/ml) on day 0. Cytokines were measured by sandwich ELISA and data shown are 
mean + s.d. of triplicate wells. Data are representative of two to three independent experiments. 
 
3.2.3 CD4+CD25+ T cells cultured with curdlan-activated BMDCs become 
IL-17 producers. 
To further investigate the role of CD4+CD25+ T cells in the induction of curdlan-
associated Th17 responses, we dissected our original three-cell system consisting of 
CD4+CD25- T cells, CD4+CD25+ T cells and BMDCs described above. We cocultured, 
separately, naïve T cells (purified as CD4+CD25-CD62LhighCD44low) or CD4+CD25+ T 
cells from C57BL/6 mice with BMDCs plus soluble α-CD3 mAb in the presence of 
curdlan or CpG in order to identify the cell source of IL-17. In Figure 3.3a, cultures 
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were restimulated at day 5 of culture for 2 extra days in the presence of coated α-CD3 
mAb (5µg/ml) and the production of IFN-γ and IL-17 was evaluated by capture ELISA. 
In cultures in which naïve T cells were the starting population, the presence of CpG led 
to the secretion of IFN-γ rather than IL-17. The inverse was observed when curdlan was 
present, as previously shown in Figure 3.1 and in (LeibundGut-Landmann et al., 2007). 
Remarkably, in cultures containing CD4+CD25+ T cells as the starting population, 
neither curdlan nor CpG induced the secretion of IFN-γ but curdlan induced the 
production of high levels of IL-17. 
To determine the production of IL-17 on a per-cell basis I employed intracellular 
staining for cytokines. Cultures containing naïve or CD4+CD25+ T cells (as described 
above) were analyzed after 5 days by restimulation with PMA, Ionomycin and 
Brefeldin A for 4 hrs and stained with a surface antibody to CD4 and antibodies to 
intracellular IL-17 and IFN-γ. Results are shown in Fig 3.3b. In agreement with the 
ELISA data, the presence of CpG in cultures containing naïve T cells led to the 
development of cells producing IFN-γ. On the other hand, the presence of curdlan in the 
same cultures induced a small population of cells producing IL-17. Notably, in 
cocultures containing CD4+CD25+ T cells as the starting population, the presence of 
curdlan promoted the appearance of a large frequency of IL-17 producing cells. The 
total number of IL-17 producers and total CD4+ T cells at the end of the culture were 
calculated by adding a fixed amount of Calibrite beads during acquisition. Figure 3.3c 
illustrates that the effect induced by curdlan in cultures containing CD4+CD25+ T cells 
is accompanied by an increase in the absolute number of IL-17 producing cells. In 
addition, there is a greater expansion of total CD4+CD25+ T cells when compared to 
cultures containing CpG or lacking any innate stimulus suggesting that factors produced 
by BMDCs in response to curdlan favour proliferation /survival of CD4+CD25+ T cells 
and promote the development of an IL-17 producing population. 
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Figure 3-3: Curdlan stimulated BMDCs promote IL-17 production by CD4+CD25+ T cells. 
(a) FACS-sorted naïve T cells (CD4+CD25-CD62highCD44low) or CD4+CD25+ T cells from C57BL/6 mice 
were cocultured for 5 days with C57BL/6 BMDCs and soluble α-CD3e (0.2µg/ml) in medium alone or in 
the presence of curdlan (50µg/ml) or CpG (0.5µg/ml). Half of the content of each well was restimulated 
on day 5 for 48 hr with coated α-CD3 (5µg/ml) and cytokine production was determined by sandwich 
ELISA. (b) As in (a) but cells were restimulated on day 5 with PMA (10ng/ml), ionomycin (1µg/ml) and 
brefeldin A (5µg/ml) for 4 hr and the presence of intracellular cytokines was analyzed by flow cytometry. 
Data show IFN-γ and IL-17 after gating on CD4+ T cells. (c) Total numbers of CD4+ T cells or CD4+IL-
17+ T cells obtained on day 5 in cultures containing naïve or CD4+CD25+ T cells. Graphs on (c) show 
mean + SEM of three independent experiments. Data are representative of two to six independent 
experiments. 
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3.2.4 Curdlan-activated BMDCs induce the generation of Foxp3+IL-17+ T 
cells 
Natural Tregs are characterized by expressing constitutive levels of CD25, CTLA-4, 
GITR, CD152 and CD103. However none of these markers are exclusively expressed 
by Tregs and they can be expressed on conventional T cells upon activation (reviewed 
in (Sakaguchi, 2004)). Foxp3, a transcription factor involved in the development and 
function of Tregs is the only marker restricted to this T cell population (Hori et al., 
2003, Fontenot et al., 2003, Khattri et al., 2003). To work with a highly purified 
population of Tregs, we isolated Foxp3+ T cells from the bacterial artificial 
chromosome-transgenic mice termed “depletion of regulatory T cell” (DEREG) mice 
(kindly donated by Dr. Tim Sparwasser, Hannover), which express GFP fused to the 
primate diphteria toxin receptor under the foxp3 gene regulatory regions (Lahl et al., 
2007). Foxp3 positive T cells were sorted from DEREG mice (or from radiation 
chimeras bearing bone marrow from DEREG mice) based on the expression of CD4, 
GFP and CD25. To analyze whether curdlan has an effect on proliferation of Tregs, 
CD4+CD25+GFP+ T cells were labelled with CFSE and were cocultured with BMDCs 
plus α-CD3 mAb and cells were analyzed on day 5 by flow cytometry. As the 
geometric mean value of the GFP+ population in FL1 is dim (it ranges between 30-50 as 
quantified in a FACS Calibur, data not shown), this allows the use of CFSE to track cell 
proliferation. Results are shown in Figure 3.4a. As for the total CD4+CD25+ T cells 
used previously, CD4+CD25+GFP+ DEREG cells proliferated more extensively when 
curdlan was present. As a positive control for Treg proliferation, we compared curdlan 
to IL-2 (called “Treg” control), which acts a Treg mitogen (reviewed in (Sakaguchi, 
2004)) and independently analyzed the blast and resting T cell population for Foxp3 
expression and production of IL-17. As a positive control for Th17 differentiation, a 
cocktail of cytokines containing IL-6 and TGF-β plus blocking antibodies to IFN-γ and 
IL-4 (“Th17 control”) was added to cocultures of naïve T cells and BMDCs. Blast and 
non blast cells were selected by forward and side-scatter criteria, whereas Foxp3 
expression was assessed by nuclear staining with a specific mAb to directly measure the 
expression of the protein at the time of analysis. Results are shown in Figure 3.4b. As 
expected, Foxp3+ T cells expanded when cultured under “Treg” conditions and IL-17-
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producing cells were readily detected in “Th17 control” cultures. Notably, in curdlan-
containing cocultures of Foxp3+ T cells and BMDCs, an accumulation of Foxp3+-IL-17+ 
double-positive cells emerged, which were especially noticeable in the blast fraction. T 
cells producing IL-17 and coexpressing Foxp3 in curdlan containing cocultures 
continued to accumulate over time and represented one fourth of the cells at day 7 (Fig 
3.4c). At both time points, we detected the presence of transcripts related with Th17 cell 
fate such as RORγt, IL-23R and, to a lesser extent, IL-17F. We conclude that in 
response to BMDC activated by curdlan, Foxp3+ T cells can give rise to T cell 
population capable of coexpressing Foxp3 and IL-17, which constitutes a distinct 
phenotype from classical Th17 or Tregs.  
 
Figure 3-4: Dectin-1 activated BMDCs induce the generation of Foxp3+IL-17+ T cells. 
(a) 5x104 CFSE-labelled CD4+CD25+GFP+ DEREG T cells were cultured for 5 days with 2x104 wild-type 
C57BL/6 BMDCs and soluble α-CD3 (0.2µg/ml) in the absence (NT) or presence of curdlan (50µg/ml) or 
rhIL-2 (100IU/ml) (“Treg”), as indicated. Plots show CFSE profile after gating on CD4+ cells. (b) As in 
(a) but with the addition of a “Th17” control consisting of 5x104 CD4+GFP-CD25- T cells cultured with 
2x104 BMDC, α-CD3 and IL-6 (20ng/ml)+TGF-β (10ng/ml) in the presence of neutralizing antibodies to 
IFN-γ (2µg/ml) and IL-4 (2µg/ml). All cells were restimulated on day 5 with PMA, ionomycin and 
brefeldin A for 4 hrs and the expression of Foxp3 and IL-17 was analyzed by gating separately on CD4+ 
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cell blasts or non-blasts by flow cytometry. (c) Analysis of parallel cultures from (b) on day 7. (d) RT-
PCR analysis of transcripts for RORγt, IL-17F and IL-23R in the indicated cultures at 5 and 7 days. Data 
are representative of two to six independent experiments. 
 
3.2.5 Foxp3+RORγt+ but not Foxp3+RORγt- become Foxp3+IL-17+ T cells in 
response to curdlan-stimulated BMDC 
As previously mentioned in this chapter, Foxp3+ T cells are a heterogeneous population 
and include a fraction that coexpresses RORγt and produces little or no IL-17 (Zhou et 
al., 2008a, Lochner et al., 2008). Given the importance of RORγt in the differentiation 
of conventional Th17 cells (Ivanov et al., 2006), we sought to determine whether 
Foxp3+RORγt+ might represent the source of Foxp3+IL-17+ double positive cells 
observed in curdlan-containing cocultures. We therefore compared RORγt+ and RORγt- 
Tregs isolated from chimeric mice bearing bone marrow from Rorc(γt)GfpTG mice in 
which GFP reports RORγt expression (Lochner et al., 2008). To obtain a highly purified 
population of Tregs, cells were sorted based on the expression of CD4, CD25 and folate 
receptor 4, a membrane receptor that closely mirrors Foxp3 expression (Yamaguchi et 
al., 2007). To confirm that the combination of these 3 antibodies accurately identifies 
Tregs in our system, we sorted CD4+CD25+FR4+ T cells from C57BL/6 mice and then 
stained for intracellular Foxp3 after sorting. As shown in Figure 3.5a and as previously 
described, the CD4+CD25+FR4+ T cell fraction constitutes a population of cells 
expressing high levels of Foxp3. We then prepared donor origin CD4+CD25+FR4+ cells 
from Rorc(γt)GfpTG chimeric mice, which were subdivided into GFP+ or GFP- fractions 
and cultured separately with BMDCs, α-CD3 mAb in the presence of curdlan for 5 
days. Remarkably, only CD25+ FR4+GFP+ T cells but not CD25+ FR4+GFP- T cells 
gave rise to IL-17 producing cells in response to curdlan stimulated BMDC. The 
majority of these cells coexpressed Foxp3 although some IL-17 single positives could 
be observed, probably reflecting expansion of contaminating Foxp3-RORγt+ T cells 
present at the beginning of the culture. We conclude that Foxp3+RORγt+ but not 
Foxp3+RORγt- T cells can be induced to produce IL-17 after culture with curdlan 
activated BMDC. 
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Figure 3-5: Foxp3+RORγt+ but not Foxp3+RORγt- T cells become Foxp3+IL-17+ T cells in response 
to curdlan-activated BMDCs. 
(a) FACS-sorted CD4+CD25+FR4+ and CD4+CD25-FR4- T cells from C57BL/6 mice stained for 
intracellular Foxp3. (b) FACS-sorted CD4+CD25+FR4+GFP+CD45.1- and CD4+CD25+FR4+GFP-CD45.1- 
T cells from Rorc(γt)-GfpTG chimeras were cocultured with wild-type BMDCs and soluble α-CD3 in the 
presence of curdlan (Cdl). Cells were restimulated on day 5 with PMA, ionomycin and brefeldin A for 4 
hrs and the expression of Foxp3 and IL-17 on CD4+ T cell blasts was analyzed by flow cytometry. Data 
are representative of two independent experiments. 
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3.2.6 IL-23 drives the generation of Foxp3+IL-17+ T cells 
As previously shown in this chapter, IL-23 was required to induce IL-17-producing 
cells from cultures containing naïve T cells, CD4+CD25+ T cells and curdlan-activated 
BMDCs. To address the role of IL-23 in the induction of Foxp3+IL-17+ T cells, we 
cultured IL-23 deficient (p19-/-) or wild type BMDC with Foxp3+ T cells from DEREG 
mice in the presence of curdlan. Notably, the frequency of Foxp3+IL-17+ T cells was 
drastically reduced when p19-/- cells were used as a source of APC (Figure 3.6a). This 
observation also correlated with the decrease in absolute numbers of Foxp3+IL-17+ T 
cells while total cell numbers remained unaffected (Figure 3.6b). These results indicated 
that p19-/- BMDC are not impaired at inducing T cell proliferation/survival of Foxp3+ T 
cells but they failed to promote the development of Foxp3+IL-17+ T cells. The 
appearance of RORγt and IL-23R transcripts in curdlan containing cocultures were also 
IL-23 dependent indicating that IL-23 is necessary to switch to the IL-17 associated 
program in Foxp3+ T cells (Figure 3.6c). Given that IL-23 is required for the 
development of Foxp3+IL-17+ T cells, we wondered if that cytokine was sufficient to 
drive the generation of those cells. To address that question, curdlan was replaced with 
IL-23. Although IL-23 was able to induce similar frequencies of Foxp3+IL-17+ T cells 
when compared to curdlan, T cell expansion was reduced resulting in lower number of 
Foxp3+IL-17+ T cells at the end of the culture (Figure 3.6d-e). These data indicate that 
although IL-23 is necessary for the production of IL-17 in Foxp3+ T cells, it is not 
sufficient for the maintenance of Foxp3+IL-17+ T cells and other factors might be 
required to support the phenotype and/or survival of this T cell population. 
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Figure 3-6: IL-23 drives the generation of Foxp3+IL-17+ T cells in response to curdlan-activated 
BMDCs. 
(a) FACS-sorted CD4+CD25+GFP+ DEREG T cells were cultured with wild-type or p19-/- BMDCs plus 
soluble α-CD3 in the presence of curdlan. Cells were restimulated on day 5 and 7 with PMA, ionomycin 
and brefeldin A for 4 hrs and the expression of Foxp3 and IL-17 on CD4+ cell blasts was analyzed by 
flow cytometry. (b) Total numbers of Foxp3+IL-17+ T cells and CD4+ T cells from cultures as in (a) on 
day 5. (c) RT-PCR analysis of transcripts encoding RORγt, and IL-23R in cultures as in (a) analyzed on 
day 5. (d) CD4+CD25+GFP+ DEREG T cells were cultured for 5 days with wild-type BMDCs plus 
soluble α-CD3 in the presence of curdlan or IL-23 (10ng/ml). Cells were restimulated on day 5 with 
PMA, ionomycin and brefeldin A for 4 hrs and the expression of Foxp3 and IL-17 on CD4+ cell blasts 
was analyzed by flow cytometry. (e) Numbers of Foxp3+IL-17+ T cells obtained in cultures as in (d). Data 
in (b) and (e) are mean + SEM of three independent experiments. Data are representative of two to four 
independent experiments. N.D., not done. 
 
3.2.7 Foxp3+IL-17+ T cells emerge in vivo but their frequency is not 
increased upon curdlan administration 
Small numbers of Foxp3+RORγt+ T cells are found in the lamina propria of mice and 
have been shown to produce little or no IL-17 (Lochner et al., 2008, Zhou et al., 2008a). 
In addition, a small percentage of Foxp3 and IL-17F coexpressors can be detected in IL-
17f rfpFoxp3gfp dual reporter mice upon immunisation with OVA plus CFA (Yang et al., 
2008b). To determine whether Foxp3+IL-17+ cells arise in vivo and evaluate the impact 
of the Dectin-1 agonist on these responses, we analyzed the coexpression of IL-17 and 
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Foxp3 during Treg-control of colitis induced by Helicobacter hepaticus. This T-cell 
independent model of colitis is induced in RAG2 deficient mice infected with H. 
hepaticus, which leads to severe intestinal inflammation and is prevented by 
coadministration of CD4+CD45RBlowCD25+ T cells (Maloy et al., 2003). In this 
experimental setting, we sought to determine whether curdlan administration (by oral 
gavage) could promote the appearance of Foxp3+IL-17+ cells from the 
CD4+CD45RBlowCD25+ T cell compartment according to the experimental design 
shown in figure 3.7a. 
This experiment was executed in the Laboratory of Dr Fiona Powrie and it was set up 
and analyzed by myself together with Philip Ahern, senior graduate student from 
Powrie’s Laboratory and must be considered as preliminary data as it was performed 
once with 6 mice per experimental group. 
All mice were sacrificed when infected animals without T cell reconstitution showed 
signs of disease, which was 8 weeks later. All mice that received Treg cells did not 
develop intestinal inflammation as expected (Maloy et al., 2003), and the administration 
of curdlan had no effect on the resolution of the disease (according to histological score 
assessed by pathologists at Oxford University, data not shown).  
On week 8, CD4+ T cells were analyzed in spleen, mesenteric lymph node and colonic 
lamina propria and were analyzed for the expression of IL-17 and Foxp3. Results are 
shown in Figure 3.7b-c. Unexpectedly, a noticeable population of Foxp3+IL-17+ cells 
was clearly found in spleen, mesenteric lymph node and lamina propria from Treg 
reconstituted mice. The Foxp3 and IL-17 coexpressors constituted a considerable 
fraction of the total CD4+IL-17+ pool found under this experimental setting and 
accounted for 16% of the total IL-17 produced by CD4+ T cells approximately. Notably, 
the presence of IL-17-producers was not associated with immunopathology as T-cell 
reconstituted mice did not develop intestinal inflammation (according to histological 
score by pathologists at Oxford University, data not shown). Administration of the 
Dectin-1 agonist did not increase the frequency of Foxp3+IL-17+ cells in any of the 
organs analyzed and it reduced the percentages of Foxp3+IL-17+ T cells found in the 
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lamina propria (Figure 3.7c). In addition, the frequency of Foxp3 or IL-17 single 
positives was not modified by oral administration of curdlan (Figure 3.7c). 
These results indicate that Foxp3+IL-17+ T cells is a cell population that can be 
naturally found in vivo in the context of Treg control of innate colitis. In addition, these 
results indicate that curdlan administration had a negative effect of this response noticed 
in the lamina propria but not in spleen or mesenteric lymph node. Whether H. Hepaticus 
itself contain a Dectin-1 ligand that promotes the generation of Foxp3+IL-17+ T cells is 
unknown. Moreover, it is unclear whether Foxp3+IL-17+ T cells are beneficial or 
detrimental in the context of intestinal inflammation. 
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Figure 3-7:Foxp3+IL-17+ T cells emerge during Treg control of H. hepaticus-mediated colitis, but 
their frequency is not increased upon curdlan administration. 
(a) Schematic representation of the experimental procedure. (b) Spleen, mesenteric lymph node and large 
intestine lamina propria were collected from H. hepaticus-infected mice reconstituted with 
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CD4+CD25+CD45RBlow T cells in presence or absence of curdlan administration. Cells were restimulated 
with PMA, ionomycin and brefeldin A for 4 hrs and the expression of Foxp3 and IL-17 on CD4+ T cells 
was analyzed by flow cytometry. (c) Frequencies of CD4+-IL-17+, CD4+-Foxp3+, CD4+-Foxp3+-IL-17+ 
and CD4+-Foxp3--IL-17+ analyzed at the end of the experiment. Each point represents one mouse. 
Statistically different groups are indicated (*, 0.01< p < 0.05). 
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3.3 Discussion 
Innate recognition of pathogens by the immune system results in the initiation of 
adaptive responses that will be matched to the nature of the offending microbe. 
Identifying qualitative differences between innate signalling pathways in the outcome of 
adaptive immunity is essential to understand the initiation of effector T cell responses 
against infection. 
3.3.1  The induction of IL-17-producing CD4+ T cells by curdlan-activated 
DCs requires IL-23 and Tregs 
Work from Salomé LeibundGut-Landmann demonstrated that activation of the Dectin-
1/Syk/CARD9 signalling pathway leads to activation of BMDCs suited to generate 
Th17 responses (LeibundGut-Landmann et al., 2007). Results shown Fig 3.1a-b 
demonstrate that activation of the Dectin-1 signalling pathway leads to the production 
of IL-17 by T cells response at different doses of antigen or stimuli. 
Although IL-17 producing T cells have been previously noticed to develop in cultures 
containing DC plus TLR agonists (Veldhoen et al., 2006a), results presented in this 
chapter together with the work from Salomé LeibundGut-Landmann (LeibundGut-
Landmann et al., 2007), indicate that activation of the Dectin-1 pathway induces greater 
Th17 skewing (Fig 3.1b) (LeibundGut-Landmann et al., 2007).  
BMDCs stimulated with CpG produce both IL-23 and IL-12p70 whereas BMDCs 
activated by curdlan produce mainly IL-23 (LeibundGut-Landmann et al., 2007). The 
lack of IL-12 p70 and the presence of IL-10 in curdlan-containing cocultures might 
inhibit the development of Th1 cells (Harrington et al., 2005). Notably, data presented 
in this chapter showed that IL-23 is required for the production of IL-17 in cocultures 
containing CD4+CD25-, CD4+CD25+ T cells and curdlan-activated BMDCs (Fig 3.2a 
and (LeibundGut-Landmann et al., 2007)). This is an intriguing observation, as IL-23 
has shown to be dispensable for the differentiation of IL-17 producing cells in cultures 
containing naïve T cells and TLR-activated BMDCs (Veldhoen et al., 2006a). 
Furthermore, the T cell targets of IL-23 in vitro arise mainly from the effector and 
memory T cell compartment (Langrish et al., 2005) (Aggarwal et al., 2003) with no 
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effect in the differentiation of naïve T cells (Bettelli et al., 2006, Mangan et al., 2006, 
Veldhoen et al., 2006b). This result suggests that IL-17 production in response to 
curdlan-activated DCs may arise from a non-naïve T cell. 
In agreement with previous publications (Mangan et al., 2006, Bettelli et al., 2006, 
Veldhoen et al., 2006a), the development of IL-17-producing T cells upon Dectin-1 
stimulation of BMDCs requires TGF-β (Fig 3.2c). Notably, Tregs are essential but this 
cannot be fully explained by TGF-β production (Fig 3.2d). These results suggested that 
Tregs themselves might respond to Dectin-1 activated BMDCs to produce IL-17. 
3.3.2 Dectin-1 signalling renders BMDCs competent to convert Tregs into 
Foxp3+IL-17+T cells 
Experiments presented in Figures 3.1 and 3.2 were done using a mixture of CD4+CD25- 
and CD4+CD25+ T cells as previously described for in vitro differentiated Th17 cells in 
cultures containing TLR agonists (Veldhoen et al., 2006a). Experiments showed in Fig 
3.3a-b demonstrate that Curdlan-stimulated BMDCs promote the appearance of a large 
frequency of IL-17-producing T cells in cultures containing CD4+CD25+ T cell as the 
starting population. Notably, a small population of naïve T cells (0.5%) differentiate 
into Th17 cells in response to Dectin-1 activated BMDCs in absence of exogenous 
TGF-β (Fig 3.3a-b), suggesting that both subsets of T cells can differentiate to produce 
IL-17 in this condition of innate challenge, albeit at different levels. Along these lines, 
Olivier Joffre (former member of the Immunobiology lab, Cancer Research UK) has 
shown that antigen targeting to DNGR-1 leads to Th17 differentiation of adoptively-
transferred naïve T cells when curdlan is used as adjuvant in vivo (Joffre et al., 2010). 
In addition, it is important to note that the experiments presented in this chapter have 
been performed using RPMI as culture media. It has been recently noted that Iscove’s 
modified Dulbecco medium (IMDM) is an optimal culture media for in vitro generated 
Th17 cells due to the presence of an endogenous AhR ligand (Veldhoen et al., 2009). 
Therefore, changing culture media might further increase the frequencies of IL-17 
producers noticed in my experiments. 
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My data demonstrate that Dectin-1 signalling renders BMDCs competent to convert 
CD25+Foxp3+ T cells into Foxp3+IL-17+ T cells. Previous work (Xu et al., 2007, Zheng 
et al., 2008a, Yang et al., 2008b) showed that CD4+CD25+ T cells can be converted into 
IL-17 producers in vitro and in vivo but this process is accompanied by downregulation 
of Foxp3. A distinct hallmark of my study is that CD25+Foxp3+ T cells maintain the 
expression of Foxp3 while coexpressing IL-17. 
Why Dectin-1 activated BMDCs are particularly suited to induce Foxp3+-IL-17+ T 
cells? In Fig 3.2a, I showed that in conditions of curdlan stimulation, IL-23 is essential 
to induce IL-17-producing T cells from cultures containing CD4+ CD25- and 
CD4+CD25+ T cells. In addition, IL-23 signalling is also necessary to induce the 
generation of Foxp3+-IL-17+ T cells (Fig 3.6a-c). Nonetheless, the pure presence of IL-
23 in those cultures is not sufficient to sustain the phenotype and/or survival of those 
cells (Fig 3.6 d-e) indicating that other factors present in curdlan-containing cocultures 
such as IL-23 and TNF may act synergistically. On the other hand, Dectin-1 triggering 
on BMDCs leads to the production of considerable levels of IL-2, which could 
contribute to the generation of Foxp3+-IL-17+ T cells. Although IL-2 has been described 
as a negative regulator of Th17 differentiation from naïve T cells (Laurence et al., 
2007), it potentiates Foxp3 expression on Tregs (Fontenot et al., 2005). I propose that 
the unique combination of cytokines produced by Dectin-1 activated BMDCs may be 
particularly suited to the generation of Foxp3+-IL-17+ T cells, with IL-23, IL-6 and TNF 
favouring IL-17 production and IL-2 maintaining Foxp3 expression. IL-10, which is 
also present on these cultures, may help sustaining Treg markers or activity. 
Notably, we have found that Foxp3+-IL-17+ T cells arise from the Foxp3+-RORγt+ T cell 
population and not from Foxp3+-RORγt- T cell counterparts (Fig 3.5). Although Foxp3+-
RORγt+ T cells have been shown not to produce IL-17 in the steady state (Lochner et 
al., 2008, Zhou et al., 2008a), results presented in this chapter suggest that the Foxp3+-
RORγt+ T cell population can produce IL-17 in some conditions of immune challenge. 
In addition, these results suggests that Foxp3+ T cells are not being genetically 
reprogrammed to become IL-17 producers but that the appropriate milieu triggers the 
production of IL-17 in cells already precommitted to perform that function. 
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The Foxp3+-IL-17+ T cell is a population that defies classification into Tregs or Th17 
cells. Notably, a population of human Foxp3+ T cells producing IL-17 have been 
recently identified in peripheral blood (Ayyoub et al., 2009) and tonsils (Voo et al., 
2009). Those cells share some common features with Th17 cells such as expression of 
CCR6 but produce little IL-22 and conserve suppressive activity in vitro (Voo et al., 
2009, Ayyoub et al., 2009).  
The fact that fungal stimuli lead to the development of both Th17 and Foxp3+-IL-17+ T 
cell responses may have important implications. IL-17 RA deficient mice are highly 
susceptible to systemic and oropharyngeal candidiasis (Huang et al., 2004, Conti et al., 
2009) and human memory CD4+ T cells specific for C. albicans have a Th17 phenotype 
(Acosta-Rodriguez et al., 2007). Whether Foxp3+-IL-17+ T cells participate in anti-
fungal immunity or maintain their regulatory activity remains to be determined. Along 
these lines, Zymosan administration has been associated with the generation of cells 
with regulatory activity and also with the induction of Th17 cells (Dillon et al., 2006, 
Veldhoen et al., 2006b). By developing techniques for Foxp3+IL-17+ T cell isolation, 
hopefully the questions regarding their role could begin to be addressed. 
3.3.3 Foxp3+-IL-17+ T cells coexist with Foxp3+-IL-17- and Foxp3--IL-17+ T 
cells in vivo 
At present, there is evidence demonstrating Treg adaptation to microbe-exposed tissues 
(reviewed in (Wohlfert and Belkaid, 2010)). Foxp3+ T cells coexpressing T-bet and 
producing IFN-γ have been found in mice acutely infected with T.gondii (Oldenhove et 
al., 2009), although is not year clear whether they emerge as a cause or a consequence 
of the excessive immunopathology. Along these lines, Foxp3+-IL-17+ T cells are 
detected during Treg suppression of H. Hepaticus (Figure 3.7). These results suggest 
that this cell population might emerge only under conditions of immune challenge as 
very low frequencies of Foxp3+-IL-17+ T cells are found in steady state (Zhou et al., 
2008a) (Lochner et al., 2008).  
Whether the Foxp3+-IL-17+ T cell population contribute to the inhibition of intestinal 
inflammation is at present unclear. One experimental approach to address this question 
would be to test the suppressive functions of Foxp3+ cells isolated from RORγt deficient 
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mice. Those Tregs could be compared to wild type Tregs in the control of innate colitis. 
This might be a good experimental approach to elucidate the relevance of IL-17 
produced by the Foxp3+ compartment during an inflammatory response. 
The fact that curdlan had no effect in increasing the frequency of CD4-IL-17 producers 
does not mean that the Dectin-1/Syk/CARD9 pathway is dispensable for the induction 
of a type 17 response in vivo. One explanation is that the effect of curdlan was simply 
masked by the continuous presence of H. Hepaticus in the gut. It has been shown that 
the Treg presence controls intestinal pathology but does not influence the levels of 
pathogen colonisation (Maloy et al., 2003). In addition, is possible that PAMPs derived 
from H. Hepaticus activate the Syk/CARD9 pathway and favour the induction of Th17 
and Foxp3+-IL-17+ T cells via additional Syk-coupled PRRs. It is important to note that 
some bacteria express 1,3 β-glucans and that curdlan is isolated from the gram-negative 
bacteria Alcaligenes faecalis. 
The role of Syk in the generation of Th17 responses in the gut is entirely unknown. 
Furthermore, the signalling requirements for the induction of Th17 cells in the intestine 
have proven to be MyD88, Trif and RIP-2 independent (Atarashi et al., 2008, Ivanov et 
al., 2008, Ivanov et al., 2009). Whether Syk signalling has a predominant role in driving 
Th17 responses in the gut is at present unknown but will be certainly tested in the near 
future. 
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Chapter 4. Dectin-2 is a Syk-coupled PRR involved 
in the initiation of Th17 responses to fungal infection 
4.1 Introduction 
4.1.1 Pattern recognition receptors and fungi  
Innate cells express multiple PRRs that recognize fungal signatures including TLR2, 
TLR4, TLR6, TLR9, mannose receptor, Dectin-1, DC-SIGN, SIGN-R1, Dectin-2, Fcγ 
receptor, Mincle, Galectin-3, SCARF1 and CD36 among others (Netea et al., 2008, van 
de Veerdonk et al., 2008, Wells et al., 2008, Bugarcic et al., 2008, Means et al., 2009).  
Although many of these PRRs signal independently of Syk and CARD9, the 
Syk/CARD9 axis plays a non-redundant role in DC responses to fungal stimuli. Syk-/- 
DCs are unable to produce IL-2 and IL-10 in response to zymosan (Rogers et al., 2005) 
and Card9 -/- DCs are impaired at producing of IL-2, IL-6 and TNF in response to 
zymosan and C. albicans (Gross et al., 2006). Interestingly, Dectin-1 is not responsible 
for these responses, as the production of IL-2 and IL-10 to zymosan is preserved in 
Dectin-1-/- DCs (Saijo et al., 2007, Taylor et al., 2007). 
Notably, Th17 responses to C. albicans are preserved in Dectin-1-deficient mice and yet 
these responses are absent in CARD9-deficient mice (LeibundGut-Landmann et al., 
2007). These results suggest the existence of additional Syk/CARD9-coupled PRRs 
involved in DC activation by fungal stimuli. It has been recently reported that the 
mannose receptor could contribute to human Th17 responses to C. albicans (van de 
Veerdonk et al., 2009), although there is no evidence linking this receptor to the 
Syk/CARD9 pathway. 
Altogether, these observations indicate that, although Dectin-1 is a fungal PRR capable 
of coupling innate into adaptive immunity, is probably not the only Syk-CARD9 
coupled PRR involved in DC activation by fungi and induction of Th17 responses to C. 
albicans. 
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The aim of work descrbed in this chapter was to identify an additional Syk/CARD9 
PRR involved in coupling DC activation to Th17 responses to C. albicans.  
4.2 Results 
4.2.1 C. albicans preparations and comparison of antifungal agents 
As previously mentioned in this thesis, observations by the Immunobiology Laboratory 
defined a novel innate signalling pathway in DCs, which is activated in response to 
zymosan and involves Syk kinase (Rogers et al., 2005). DCs activated with zymosan 
produce IL-2 and IL-10 in a Syk-dependent manner but produce IL-12/23 p40 
independently of Syk via the TLR pathway, suggesting that Dectin-1/Syk and 
TLR2/MyD88 signalling pathways can operate independently (Rogers et al., 2005). 
I decided to test whether those previous observations might be valid in the recognition 
of a potential fungal pathogen. The model organism used is C. albicans, a human 
commensal that becomes highly pathogenic in immunocompromised individuals (Sable 
et al., 2008, Crameri and Blaser, 2002). Candida is a dimorphic fungus and coexists as 
unicellular blastopores (yeast) or multicellular germ tubes (hyphae) (Molero et al., 
1998).  
The morphology from yeast and hyphae was analyzed by microscopy. Due to the lack 
of a microscope located within the containment room, images of live organisms could 
not be generated. Figure 4.1a shows images of heat-killed yeast and hyphae. These 
images indicate that both preparations are highly pure as contaminating hyphae was 
never observed in yeast preparations and yeast presence was minor in the hyphae form. 
To prevent fungal outgrowth, antifungal agents were added to the cultures 2 hours after 
live C. albicans stimulation. I tested two classes of antifungal compounds in assays 
containing BMDCs and live fungi. Fungizone (Amphotericin B); a polyene antimycotic 
used as a standard treatment for invasive candidiasis and Caspofungin (Cancidas, 
Merck); an echinocandin used for the treatment of invasive Aspergillus infections and 
candidemia (Sable et al., 2008, Mora-Duarte et al., 2002). Fungizone associates with 
membrane components such as ergosterol and results in altered cell wall permeability 
(Sable et al., 2008, Ghannoum and Rice, 1999). Echinocandins interfere with glucan 
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synthesis by inhibiting β-(1,3)-glucan synthase (Sable et al., 2008, Ghannoum and Rice, 
1999). 
Results are shown in Figure 4.1 b. Neither the presence of Fungizone nor Caspofungin 
on their own elicited cytokine production by BMDCs in absence of stimuli. In addition, 
the presence of antifungal compounds did not modify the pattern of cytokines induced 
by curdlan. Notably, live yeast and hyphae trigger strong production of IL-2, IL-10 and 
TNF by BMDCs. Although the addition of Fungizone can lead to higher levels of IL-2, 
IL-10 and TNF compared to Caspofungin, the nature of the antifungal agent did not 
modify the quality of the responses observed. 
I chose to use Fungizone throughout the course of this chapter, as it is a compound 
accessible commercially and, unlike Caspofungin that affects β-glucan, it does not 
interfere directly with the nature of the Dectin-1 ligand. 
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Figure 4-1: Antifungal drugs have minor effects on the cytokine respose to C. albicans or to 
curdlan. 
(a) Morphology of heat-killed yeast and heat-killed hyphae. White bar denotes 100µm. (b) 1x105 BMDCs 
from wild type mice were stimulated with 1x105 live C. albicans yeast or hyphae or with 100µg/ml 
curdlan. Caspofungin (50ng/ml) or Fungizone (2.5µg/ml) were added 2hr later and cytokine levels in the 
supernatants were measured after overnight incubation. Data are mean +/- SD of duplicate wells and are 
representative of 3 independent experiments. n.a. indicates not applicable. 
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4.2.2 The induction of IL-2, IL-10 and TNF by C. albicans in BMDCs is 
dependent on Syk kinase 
To determine the relevance of Syk signalling in response to C. albicans stimulation, 
BMDCs derived from wild type mice, MyD88-TRIF double knock out mice and Syk 
knock out chimeras were cultured overnight with heat-killed or live preparations of the 
organism. As an internal control, cells were routinely tested for their ability to respond 
to a pure Dectin-1/Syk agonist (curdlan) and a pure TLR agonist (CpG) (Fig 4.2 a). As 
expected, Syk deficient BMDCs do not produce TNF in response to curdlan and Myd88-
/-Trif-/- BMDCs do not produce IL-12 p40 after CpG stimulation. 
For cultures containing fungal preparations, BMDCs were cultured overnight with live 
or heat-killed organisms in a ratio 1:1 and 5:1 (Candida: BMDC) and cytokines present 
in supernatants were analyzed by ELISA. As previously observed with zymosan 
(Rogers et al., 2005), recognition of live and heat-killed C. albicans by BMDCs leads to 
the production of significant levels of IL-2, IL-10 and TNF (figure 4.2b-c). The 
production of these three cytokines was completely dependent on Syk irrespective of 
the morphologic form or whether heat-killed or live organisms were used (Fig 4.2 b-c). 
In contrast, the production of IL-12/23 p40 in response to heat-killed and live organisms 
was dependent on the adaptors MyD88/TRIF and was largely independent of Syk (Fig 
4.2 d and not depicted). 
Interestingly, IL-2, IL-10 and TNF were induced at higher levels by hyphae than yeast, 
especially in cultures containing heat-killed organisms (Fig 4.2 b-c). 
Athough the Syk dependence for IL-2, IL-10 and TNF in all conditions is evident, a 
contribution by the MyD88-TRIF signalling pathway can be observed in two situations: 
First, the production of IL-2 in response to heat-killed hyphae reflects a dual 
dependence on Syk and MyD88-TRIF (Figure 4.2c). This observation has been 
previously noted for zymosan (Rogers et al., 2005) and may reflect exposition of TLR 
ligands during denaturation as previously reported for Candida-derived β-glucans 
(Gantner et al., 2005). Second, the production of TNF in response to live organisms also 
reveals partial dependence on TLR signalling (Figure 4.2b) which is also consistent 
with alterations in PAMP display caused by heat denaturation.  
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In contrast, the production of IL-10 remained MyD88/TRIF independent in most 
conditions as previously noted for zymosan (Rogers et al., 2005). In summary, I 
conclude that Syk signalling in BMDCs is essential for the production of IL-2, IL-10 
and TNF to C. albicans despite some possible contribution from TLR pathways. These 
three factors (termed “Syk-dependent cytokines”) can be used to monitor the activity of 
Syk-coupled PRRs for fungi in BMDCs. 
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Figure 4-2: The contribution of Syk and TLR signalling to cytokine induction by C. albicans. 
(a) BMDCs from C57BL/6 wild type (WT, blue bars), Myd88-/-/Trif-/- (green bars) or Syk-/- chimeric 
(orange bars) mice were stimulated with curdlan (50ug/ml) or CpG (0.5µg/ml) and TNF and IL-12p40 
were detected after overnight incubation. (b) BMDCs as in (a) were stimulated with 105 live C. albicans 
yeast or hyphae. Fungizone was added 2hr later and cytokine levels in the supernatants were measured 
after overnight incubation. (c) BMDCs as in (a) were stimulated overnight with 105 or 5 x 105 heat-killed 
C. albicans. (d) IL-12p40 production from BMDCs stimulated as in (c). Data are mean +/- SD of 
duplicate wells and are representative of at least 3 independent experiments. ND indicates Not Detectable. 
 
4.2.3 The production of IL-2, IL-10 and TNF in response to C. albicans is 
independent of Dectin-1 
As Dectin-1 is the archetypical example of a C-type lectin receptor that signals via Syk 
for gene induction and cytokine production (LeibundGut-Landmann et al., 2007), we 
analyzed whether Dectin-1 accounts for the production of the Syk-dependent cytokines 
to C. albicans. BMDCs from Dectin-1 deficient mice were generated and compared to 
wild type cells in their ability to produce IL-2, IL-10 and TNF to the organism. Results 
are shown in Figure 4.3. Dectin-1 deficient BMDCs produce similar levels of these 
three factors response to heat-killed or live (not shown) Candida. This is consistent with 
the notion that the production of IL-2, IL-10 and TNF is only partially affected in 
Dectin-1 deficient BMDCs stimulated with zymosan (Dr Matthew Robinson, 
Immunobiology lab, (Robinson et al., 2009)). In agreement with these observations, 
previous reports have shown that Dectin-1 expression in BMDCs is dispensable for 
zymosan recognition (Saijo et al., 2007, Taylor et al., 2007). 
The strict Syk dependence but Dectin-1 independence of IL-2, IL-10 and TNF produced 
by BMDC in response to C. albicans stimulation suggests the existence of additional 
Syk-coupled PRRs in DCs that remain active in the absence of Dectin-1. The aim of this 
chapter is to identify such a receptor. 
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Figure 4-3: The contribution of Dectin-1 to cytokine production by C. albicans. 
BMDCs from C57BL/6 wild type (WT, blue bars) or Clec7a-/- chimeric (Dectin-1 KO; grey bars) mice 
were stimulated overnight with 105 or 5 x 105 heat-killed C. albicans yeast or hyphae. Data are mean +/- 
SD of duplicate wells and are representative of at least 3 independent experiments. ND indicates Not 
Detectable. 
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4.2.4 Dectin-2 is a Syk-coupled receptor in DCs 
Dectin-2 is a C-type lectin receptor that binds to zymosan, C. albicans, M. tuberculosis, 
P. brasiliensis, H. capsulatum, M. audouinii, T. rubrum and house dust mite allergens 
(McGreal et al., 2006, Barrett et al., 2009, Sato et al., 2006). For C. albicans 
recognition, soluble Dectin-2 receptor binds preferentially to the hyphae form over the 
yeast (Sato et al., 2006) and its expression pattern is restricted to myeloid cells, 
particularly to some subsets of macrophages and inflammatory monocytes (Taylor et 
al., 2005). Despite some reports showing limited expression of Dectin-2 in DCs (Taylor 
et al., 2005), we reevaluated the expression of Dectin-2 in BMDCs and spleen DCs by 
FACS analysis. Results are shown in Fig 4.4a-b. Splenic DCs or BMDCs were stained 
with 10µg/ml of an anti Dectin-2 antibody (Clone 11E4, kindly provided by Dr Philip 
Taylor, Cardiff University) or isotype control for 30 min following by anti-Rat IgG-PE. 
Dectin-2 expression was clearly observed in CD4+, CD8+ and double negative subsets 
of splenic DCs (Fig 4.4a). As expected, BMDCs also expressed high levels of the 
receptor (Fig.4.4 b). As previously reported (Leibundgut-Landmann et al., 2008), 
Dectin-1 is also expressed in the three main subsets of splenic DCs and its expression 
pattern is similar to that of Dectin-2 (Fig 4.4c) (Robinson et al., 2009), indicating that 
splenic DCs express both fungal CLRs.  
Whether Dectin-2 is a Syk-coupled PRR involved in DC activation and gene induction 
was unknown. Work from Dr Matthew Robinson first demonstrated that Dectin-2 
signals via Syk in DCs (Robinson et al., 2009). To trigger selective Dectin-2 
stimulation, BMDCs were cultured with anti-Dectin-2 antibody (or Fab preparations) or 
isotype control immobilized on plastic. Contact of BMDCs with anti-Dectin-2 surfaces 
led to phosphorylation of Syk and MAPK cascades and production of cytokines 
(Robinson et al., 2009). Remarkably, Dectin-2 cross-linking triggered accumulation of 
IL-2, IL-10 and TNF in a manner dependent on Syk and CARD9 but independent of 
MyD88-TRIF (Robinson et al., 2009) (Fig 4.4d produced by Matthew Robinson and 
reproduced with kind permission here, and not depicted). These experiments 
demonstrate that triggering endogenous Dectin-2 in BMDCs results in Syk and CARD9 
activation and cytokine production independently of TLR stimulation (Robinson et al., 
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2009). In addition, Dectin-2 can couple to Syk to trigger the production cysteinyl 
leukotrienes in response to house dust mites (Barrett et al., 2009). 
In contrast to Dectin-1, Dectin-2 does not contain any ITAM or hemITAM motif within 
its short intracellular tail that would enable direct interaction with Syk. However, it has 
been reported that Dectin-2 over expressed in RAW and COS cells 
coimmunoprecipitates with γ chain of Fc receptor, which contains a conventional ITAM 
motif (Sato et al., 2006). Furthermore, the expression of Dectin-2 is enhanced when 
cotransfected with FcRγ chain (Barrett et al., 2009). Work from Matthew Robinson 
further demonstrated that the presence of FcRγ chain is required for appropriate surface 
expression of Dectin-2 in DCs and showed that its ITAM motif is responsible for 
Dectin-2 signalling (Robinson et al., 2009). Altogether, these experiments identified 
Dectin-2 as a second Syk-coupled PRR involved in DC activation. 
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Figure 4-4: Dectin-2 is expressed by DCs and signals via Syk and CARD9. 
(a) CD11c enriched splenocytes were stained for CD11c, CD4, CD8 and anti-Dectin-2 or isotype-
matched control. The upper left panel shows gating of CD11chi conventional DC populations into CD4+, 
CD8+ and double negatives. Other panels are histograms of anti-Dectin-2 (black line) or isotype control 
(shaded area) staining in the gated subpopulations. (b) Staining of GMCSF-derived BMDCs with anti-
Dectin-2 (black line) or isotype control (shaded area). (c) As in A except that cells were stained with anti-
Dectin-1. Data are representatives of 3 (b) or 2 (a and c) independent experiments. (d) Work of Dr 
Matthew Robinson. Wild type C57BL/6 (WT; grey bars), Myd88-/-/Trif-/- (MyD88/TRIF DKO; white 
bars), Syk-/- chimeric (Syk KO; white bars) and Card9-/- (Card9 KO; white bars) BMDCs were stimulated 
overnight with plated anti-Dectin-2 or control Fab as above and IL-10 levels in the supernatants were 
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measured. Representatives of at least 3 independent experiments are shown. Cytokine data are mean +/- 
SD of duplicate wells. ND indicates Not Detectable. 
 
4.2.5 Induction of the Syk-dependent cytokines in DCs requires Dectin-1 
and Dectin-2 
The results discussed above suggest that in the context of fungal stimulation, Dectin-2 
might act in conjunction with Dectin-1 to promote Syk-CARD9–dependent responses in 
DCs. To test this hypothesis, WT and Dectin-1 deficient BMDCs were incubated with 
soluble anti-Dectin-2 antibody to abrogate receptor function, or with an isotype control 
antibody. In contrast to the cell activation method triggered by anti-Dectin-2 
immobilized on plastic described above (Robinson et al., 2009), incubation of BMDCs 
with anti-Dectin-2 antibody in solution can be used as a blocking reagent, as previously 
noticed for Dectin-1 (Herre et al., 2004). Effective blockade of Dectin-2 was achieved 
by preincubating BMDCs with anti-Dectin-2 or isotype control antibody for 2 hrs 
before stimulation with fungi. WT and Dectin-1-/- BMDCs with or without Dectin-2 
function were incubated with C. albicans overnight and cytokines were measured in 
supernatants. 
Results are shown in Figure 4.5. As previously shown in Figure 4.3, wild type and 
Dectin-1 deficient BMDCs produce similar levels of IL-2, IL-10 and TNF in response 
to heat-killed and live forms of the organism. Although a partial contribution of Dectin-
1 can be observed for IL-2 and IL-10 to heat-killed Candida, this effect was modest and 
variable and was not observed in stimulations with live organisms. Is important to note 
that fresh fungal preparations and newly generated BMDCs were used for each 
independent experiment described on this thesis and this might account for the subtle 
differences observed between experiments. Nonetheless, these data confirms that 
Dectin-1 deficiency has no major effect in Syk-dependent responses to C. albicans. 
Similar results were obtained after blockade of Dectin-2 function in wild type cells: 
modest and variable reductions in IL-2, IL-10 and TNF were observed as compared to 
wild type cells.  
However, blockade of Dectin-2 in Dectin-1 deficient BMDCs led to a profound 
reduction in the production of the three Syk-dependent cytokines, mimicking the 
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decrease observed in Syk deficient BMDCs (Figure 4.2). This observation is seen for 
heat-killed and live organisms and was highly reproducible. The exception was TNF 
produced in response to live C. albicans, which was only partially dependent on the two 
CLRs, probably reflecting the TLR dependency observed in Figure 4.2. As expected, 
absence of Dectin-1 and Dectin-2 did not reduce IL-12/23p40 in response to live C. 
albicans and heat killed hyphae albeit a small reduction was observed with heat-killed 
yeast (Fig 4.5 d).  
These results indicate that Dectin-1 and Dectin-2 are not primarily involved in the 
induction of IL-12/23 p40 but are required for the induction of IL-2, IL-10 and TNF in 
response to C. albicans. 
Notably, Matthew Robinson obtained similar results using zymosan as stimulus: loss of 
each receptor individually led to modest reductions in the Syk-dependent cytokines. 
However, dual absence of Dectin-1 and Dectin-2 in BMDCs led to a drastic abrogation 
of IL-2, IL-10 and TNF, approaching previous observations noted in Syk deficient 
BMDCs (Robinson et al., 2009, Rogers et al., 2005). Together, these results indicate 
that Dectin-1 and Dectin-2 are required for the induction of the cytokines controlled by 
Syk signalling. 
Chapter 4. Dectin-2 is a Syk-coupled PRR 
 119 
 
Chapter 4. Dectin-2 is a Syk-coupled PRR 
 120 
Figure 4-5: Dectin-1 and -2 mediate Syk-dependent responses to C. albicans. 
(a) BMDCs from wild type C57BL/6 (WT) or Clec7a-/- chimeric (Dectin-1 KO) mice were treated with 
10µg/ml anti-Dectin-2 or isotype control for 2 hr prior to stimulation with 105 live C. albicans yeast or 
hyphae. Fungizone was added 2hr after stimulation, and the cytokines levels in the supernatants measured 
after overnight incubation. (b) BMDCs pretreated with mAbs as in (a) were stimulated overnight with 105 
or 5 x 105 heat-killed C. albicans. (c) BMDCs pretreated with mAbs as in (a) were stimulated overnight 
with 105 or 5 x 105 heat-killed or live C. albicans and IL-12p40 production was measured after overnight 
stimulation. Data are mean +/- SD of duplicates wells and representative of at least 3 experiments. ND 
indicates Not Detectable. 
 
Triggering Dectin-1 in isolation results in the production of IL-23p19 but little IL-
12p35 by BMDCs (LeibundGut-Landmann et al., 2007). Thus, I sought to investigate 
whether Dectin-1 and Dectin-2 could regulate the production of IL-12p35 and IL-23p19 
in BMDCs activated with fungi. RNA from cells was extracted 3 hrs after stimulation 
with C. albicans. Results are shown in Fig 4.6. Whereas IL-12p35 was at the limit of 
detection (data not shown), the induction of transcripts encoding IL-12p19 was also 
dually dependent on Dectin-1 and Dectin-2. Notably, blockade of Dectin-2 in wild type 
cells led to a considerable reduction in the levels of IL-12 p19 transcript, particularly in 
response to the yeast form, suggesting that Dectin-2 might have a predominant role in 
coordinating the induction of IL-23 in response to the organism. 
 
 
Figure 4-6: Dectin-1 and -2 mediate C. albicans induction of IL-23. 
4x105 BMDCs from wild type C57BL/6 (WT) or Clec7a-/- (Dectin-1 KO) mice were treated with 10µg/ml 
anti-Dectin-2 or isotype control for 2 hr prior to stimulation with 4x105 live C. albicans yeast or hyphae. 
IL-23 p19 mRNA was quantitated by quantitative PCR after 3hrs. Fungizone was added 2hr for the final 
1 hr of stimulation. Data are mean +/- SD of duplicate wells and representative of 2 independent 
experiments. 
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To address the role of Dectin-2 in fungal recognition by an independent means, I used 
short hairpin RNA (shRNA) to knock down Dectin-2 expression in BMDCs. The 
shRNA construct for mouse Dectin-2 was chosen based on a previous publication 
(Barrett et al., 2009). Lentiviral particles containing Dectin-2 or scramble shRNA used 
in this study were obtained through collaboration with Dr Luis F Moita (Instituto de 
medicina molecular, Universidade de Lisboa, Portugal). Infection of bone marrow from 
wild type and Dectin-1 deficient mice with shRNA-containing lentiviruses was 
performed on day 2 of culture and cells were stimulated on day 6. BMDC populations 
are shown on Figure 4.7a. Infection with a lentivirus containing the Dectin-2 shRNA 
construct resulted in similar frequencies of viable CD11c-expressing cells as compared 
to scramble shRNA control. After puromycin selection, CD11c-expressing cells 
infected with Dectin-2 shRNA-containing lentivirus expressed lower levels of the 
receptor and reduced the mean fluorescence intensity of Dectin-2 to 56.8 ± 9.16% as 
compared to scramble shRNA (Figure 4.7b-c). 
Lentivirus-infected cells were stimulated with heat-killed C. albicans and the 
production of IL-2, IL-10 and TNF was assessed by ELISA after overnight stimulation. 
Results are shown in Fig 4.7d. As previously observed with the blocking anti-Dectin-2 
antibody, knockdown of Dectin-2 in wild type cells led to similar levels of the Syk-
dependent cytokines compared to scramble shRNA control. Notably, knock down of 
Dectin-2 in Dectin-1 deficient cells resulted in marked reduction of IL-2, IL-10 and 
TNF to the organism, in agreement with results showed in Fig 4.5. Overall, these results 
indicate that Dectin-1 and Dectin-2 account for the Syk-dependent cytokines in 
BMDCs. 
Chapter 4. Dectin-2 is a Syk-coupled PRR 
 122 
 
Figure 4-7: Lentiviral knockdown of Dectin-2 in Dectin-1 deficient DCs abrogates Syk-dependent 
responses to C. albicans. 
(a) BMDCs from wild type 129/Sv (WT) or Clec7a-/- (Dectin-1 KO) mice were infected with lentivirus 
encoding Dectin-2 shRNA or a scrambled control shRNA. After puromycin selection (except for 
uninfected samples, left panel), cells were stained for CD11c and 7AAD and analyzed by FACS on day 6. 
(b) BMDCs infected with lentivirus as in (a) assessed for Dectin-2 levels by FACS on day 6. (c) 
Geometric mean fluorescence in FL2 from cells described in (b) was plotted for WT and Dectin-1 KO 
cells infected with scramble shRNA or Dectin-2 shRNA-containing lentiviruses. Results are represented 
as mean+ SEM from three independent experiments. (d) BMDCs infected as in (a) were stimulated with 
105 heat-killed C. albicans and cytokines levels in the supernatants measured after overnight incubation. 
Data are mean +/- SD of duplicates wells and representative of 3 independent experiments. 
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Notably, Matthew Robinson observed that binding of fluorescent zymosan was greatly 
decreased when Dectin-2 was blocked in Dectin-1 deficient BMDCs. This result 
indicates that in addition to the loss of the Syk-dependent cytokines, Dectin-1 and 
Dectin-2 are the primary binding receptors for fungal stimuli. This raises a caveat with 
the interpretation that signals derived from Dectin-1 and -2 cause Syk-dependent DC 
activation. In turn, the loss of cytokines observed with Dectin-2 blockade in Dectin-1 
deficient cells could be caused by lack of binding of fungal particles, which would 
prevent engagement of additional Syk-coupled PRRs. To address this point, Matthew 
Robinson transduced Dectin-1 deficient BMDCs with a Y15F mutant form of Dectin-1, 
which binds avidly to zymosan but does not signal via Syk (Rogers et al., 2005). 
Whereas the blockade of Dectin-2 in Y15F-transduced cells did not inhibit binding to 
zymosan, the production of IL-2, IL-10 and TNF was markedly decreased. Blockade of 
Dectin-2 in Y15F mutant cells or in mock-transduced Dectin-1 deficient BMDCs led to 
a comparable reduction in the levels of the Syk-dependent cytokines (Robinson et al., 
2009). This result demonstrates that Dectin-2 nearly blocks Syk-dependent cytokine 
responses in a scenario in which Dectin-1 promote high degree of fungal particles but is 
unable to signal. This demonstrates that the requirement of Dectin-1 and -2 in Syk-
dependent DC activation by fungi is caused by signals propagated by these receptors 
and not just by their ability to bind to fungal stimuli (Robinson et al., 2009). 
4.2.6 Dectin-2 is crucial for Th17 responses to Candida infection 
In light of our in vitro observations with BMDCs, we sought to determine the role of 
Dectin-2 in the induction of T helper responses during C. albicans infection. As Dectin-
2 deficient mice were unavailable at that time, we blocked Dectin-2 in vivo by 
administering the anti-Dectin-2 antibody intraperitoneally. Wild type and Dectin-1 
deficient mice were injected i.p. with anti-Dectin-2 or isotype matched control 6 hrs 
before, 2 and 4 days after systemic (i.v.) infection with C.albicans. The dose of 
pathogen used was 3x104 colony forming units (CFU), which is sublethal in wild type 
mice and is tolerated by CARD9 deficient mice within the first 4 days of infection 
(Gross et al., 2006). To assess the nature of the T cell response generated in response to 
the organism, splenocytes from Candida-infected mice were collected on day 7 after 
infection and restimulated with different doses of heat killed C. albicans for 2 days. The 
presence of Th1 and Th17 cells was monitored by measuring IFN-γ and IL-17 
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respectively. Is important to note that this method of restimulation is strictly dependent 
on the presence of CD4+ T cells in the well, as IL-17 and IFN-γ are not detected when 
using CD4-depleted splenocytes from infected mice as the responding population 
(LeibundGut-Landmann et al., 2007). These experiments were performed together with 
Matthew Robinson and were executed in the Laboratory of Dr Philip Taylor in Cardiff 
University (Cardiff, Wales), who provided reagents and the infection facility required to 
carry out these types of experiments. 
Results are shown in Figure 4.8. No cytokines were detected in wells containing 
splenocytes from infected mice cultured in medium only (Figure 4.8a). After 
restimulation with 105 heat-killed C. albicans per well, IL-17 and IFN-γ were readily 
detected in splenocytes from wild type infected mice treated with isotype control 
(Figure 4.8b). Remarkably, anti-Dectin-2 administration into wild type mice led to a 
drastic reduction in the levels of IL-17 produced in response to C. albicans. This 
observation was also seen at a higher dose of the organism used for restimulation 
(Figure 4.8c), indicating that Dectin-2 plays a non-redundant role in coordinating Th17 
responses to C. albicans. Notably, anti-Dectin-2 treatment in wild type mice did not 
modify the Th1 response to Candida (Figure 4.8b and 4.8c).  
Comparison between wild type and Dectin-1 deficient mice treated with isotype control 
showed no differences in the overall Th17 and Th1 response to the organism, 
confirming previous findings indicating Dectin-1 redundancy in T cell responses to C. 
albicans (LeibundGut-Landmann et al., 2007). Nonetheless Dectin-1 is not completely 
dispensable for T cell immunity to Candida in these experimental settings, as Dectin-1 
deficient mice without Dectin-2 function produce significantly less IFN-γ when 
restimulating with 105 particles per well (Figure 4.8b). This decrease is no longer 
observed in cultures restimulated with higher doses of the pathogen (Figure 4.8c) 
suggesting these two CLRs may modulate Th1 responses in a quantitative manner. It is 
possible that additional PRRs contribute to the initiation of this type of response at 
saturating concentrations of the organism. 
We conclude that Dectin-2 is crucial for the initiation of Th17 responses to Candida 
infection and together with Dectin-1, can modulate Th1 responses to the organism. 
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Figure 4-8: Dectin-2 is required during systemic C. albicans infection for Th17 responses 
Wild type 129/Sv (WT) or Clec7a-/- (Dectin-1 KO) mice were given anti-Dectin-2 or isotype-matched 
control mAb intraperitoneally before and after intravenous C. albicans infection. After 7 days, 
splenocytes were restimulated with (a) medium alone, (b) 105 heat-killed C. albicans or (c) 106 heat-
killed C. albicans for 2 days. IFNγ and IL-17 production in the supernatants was measured by ELISA. 
The data are pooled from 2 independent experiments and each symbol represents the mean of triplicate 
stimulations from an individual mouse. Statistically different groups are indicated by * 0.01<P<0.05; ** 
0.001<P<0.01 and *** P<0.001. 
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4.2.7 Blockade of Dectin-2 does not lead to impairment of innate 
immunity to C. albicans 
During the course of infection, mice were weighed on a daily basis and at the end of the 
experiment, and fungal growth was quantified in kidneys. Dr Philip Taylor kindly 
measured these parameters. Results are shown in Figure 4.9. Despite the dramatic effect 
of Dectin-2 in the initiation of Th17 responses to Candida, wild type mice treated with 
anti-Dectin-2 showed similar fungal burdens and body weight as compared to isotype 
control treated wild type mice. The same observation was made in Dectin-1 deficient 
mice, independently of Dectin-2 function. These results indicate that, at day 7 after 
infection, loss of Dectin-1 and -2 does not impair resistance to C. albicans and suggest 
that there might be additional PRRs involved in coordinating innate immunity to 
Candida. These observations will be clarified in Dectin-2 deficient animals. 
 
Figure 4-9: Dectin-2 is not required for containing early renal fungal burden in systemic C. albicans 
infection. 
Wild type 129/Sv (WT) or Clec7a-/- (Dectin-1 KO) mice were treated with anti-Dectin-2 or isotype-
matched control mAb and infected with C. albicans intravenously. After 7 days, mice were sacrificed. (a) 
Kidney fungal burden and (b) percentage of original weight at time of sacrifice.  
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4.3 Discussion 
4.3.1 Dectin-2 is a Syk-coupled CLR involved in DC activation by fungi. 
Upon pathogen recognition, PRRs trigger intracellular signalling events that result in 
gene induction and cytokine/chemokine production and initiation of immunity. 
Members of the TLR, NLR or RLR families are well accepted PRRs but Dectin-1 was 
the only member of the CLR family fulfilling the criterion of a signalling PRR. My 
work, together with the work of Matthew Robinson, showed that Dectin-2 is an 
additional Syk/CARD9-coupled CLR that signals for DC activation.  
Matthew Robinson showed that triggering of this receptor in isolation leads to cytokine 
production by DC in FcRγ chain/Syk and CARD9-dependent manner and results in 
MAPK activation (Robinson et al., 2009). My results demonstrate that Dectin-2 
accounts for the Syk-dependent yet Dectin-1-independent responses of DCs stimulated 
with fungi. Although macrophages express Dectin-1 and Dectin-2 (Taylor et al., 2002, 
Brown et al., 2002, Taylor et al., 2005), they depend mainly on Dectin-1 for the 
production of IL-10 and IL-12p40 in response to zymosan (Taylor et al., 2007) 
indicating that in the context of microbial sensing, the usage of PRRs might be cell-type 
specific. Along these lines, it has been shown that DCs from mesenteric lymph nodes 
stimulated with C. albicans produce IL-10 in a TRIF dependent manner (De Luca et al., 
2007). In the case of BMDCs, I have showed that Dectin-1 and Dectin-2 are responsible 
for the production of IL-2, IL-10 and TNF to fungal stimuli. Notably, these receptors 
are expressed in CD4+, CD8+ and double negative subsets of spleen DCs (fig 4.4) 
suggesting that conventional DCs might also depend on Dectin-1 and -2 to sense fungal 
stimuli. 
Is important to note that Dectin-1 and Dectin-2 are remarkably different; they belong to 
different CLR groups and present a full sequence homology of only 19.6% (Robinson et 
al., 2006, Ariizumi et al., 2000a). Furthermore, these receptors recognize ligands of 
diverse nature. Whereas the CTLD of Dectin-1 binds to 1,3 β-glucans in a calcium-
independent manner (Brown and Gordon, 2001), the carbohydrate recognition domain 
of Dectin-2 binds to high mannose structures in a calcium-dependent mode (McGreal et 
al., 2006). Binding of the CRD of Dectin-2 to zymosan is inhibited by the 
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monosaccharides fucose and mannose whereas binding to C. albicans is inhibited by 
mannans but not galactans (McGreal et al., 2006). This evidence suggests that the CRD 
of Dectin-2 has specificity for high mannose structures such as mannans.  
Although many PRRs have been loosely classified as mannan-specific, they recognize 
different signatures within the polysaccharide structures. O-linked yeast mannans are 
short linear chains consisting of one to five α-linked mannoses that can be recognized 
by TLR4 (Netea et al., 2006) (reviewed in (Netea et al., 2008)). Alternatively, N-linked 
mannans are long-chain and highly branched residues that can be sensed by multiple 
receptors such as mannose receptor, SIGNR1, DC-SIGN, TLR2 and Dectin-2 (Netea et 
al., 2006) (reviewed in (Netea et al., 2008)). Nonetheless, competition studies have 
demonstrated that the lectin activity of Dectin-2 is different from that of SIGNR1 and 
mannose receptor (McGreal et al., 2006), indicating that these receptors bind to 
different residues within the oligomannose chains. Indeed, a recent publication has 
demonstrated Dectin-2 is a receptor specific for α-linked mannans derived from C. 
albicans (Saijo et al., 2010). 
Previous publications have suggested that Dectin-1 and Dectin-2 recognize different 
morphological stages of C. albicans. β-glucan exposition during yeast but not hyphae 
cell division favours detection by Dectin-1 (Gantner et al., 2005) whereas Dectin-2 have 
shown to bind preferentially to the hyphae form of C. albicans (Sato et al., 2006). 
Although results presented in this chapter show that the hyphal form elicits higher 
cytokine response than yeasts, my results clearly demonstrate that Dectin-2 mediates 
cytokine production to yeasts and that Dectin-1 also participates in hyphal sensing. 
These two independent sets of data might seem contradictory at first glance, however 
the use of soluble Dectin-1 and -2 receptors as tools for ligand identification might not 
necessarily predict the outcome of the cytokine response in DC activated with fungi. In 
addition, McGreal et al has shown that soluble Dectin-2-Fc can bind to C. albicans 
yeast (McGreal et al., 2006). 
The generation of the Dectin-2 deficient mice has been recently described (Saijo et al., 
2010). That report shows that the production of IL-6, TNF, IL-1β, IL-10, IL-23 and IL-
12p70 by BMDCs stimulated with heat-killed yeast is dependent on Dectin-2 (Saijo et 
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al., 2010). Whether the Dectin-2-dependency of those cytokines is caused by lack of 
signals propagated by Dectin -2 or is the consequence of a decrease in fungal binding is 
unclear. 
Data by Saijo et al also indicates that Dectin-2 acts as a yeast receptor, in agreement 
with our previous findings. In response to hyphal stimulation, Dectin-2 -/- BMDCs are 
only partially impaired at producing the same subset of cytokines (Saijo et al., 2010), 
probably reflecting Dectin-1 activity as proposed throughout this chapter. Notably, this 
report illustrates that IL-2, IL-10, TNF and IL-23 are just a fraction of the spectrum of 
cytokines regulated by Dectin-2 (Saijo et al., 2010). 
In contrast to the data provided by Saijo et al, my results indicate that Dectin-2 is not 
the only Syk/CARD9 PRR for yeast as functional blockade of this receptor or shRNA 
gene silencing in wild type cells does not markedly affect the production of IL-10 and 
TNF to heat-killed yeast (Figs 4.5 and 4.7). One plausible explanation to this 
discrepancy might be the use of different strains of C. albicans and the effectiveness of 
the receptor inhibition achieved in my experiments. In addition, the contribution of 
Dectin-2 to the recognition of live organisms was not provided in the paper of Saijo et al 
(Saijo et al., 2010). 
The hallmark cytokines controlled by the Syk/CARD9 pathway to fungal stimuli 
presented in this chapter and elsewhere are IL-2, IL-10 and TNF ((Rogers et al., 2005, 
Robinson et al., 2009) and this chapter). As mentioned above, these factors represent 
only a small fraction of the cellular aspects controlled by Syk signalling in response to 
fungal challenge. I showed that transcripts encoding IL-23 are regulated by Dectin-1 
and -2 (Fig 4.6) and it is known that Syk signalling controls synthesis and processing of 
IL-1β in response to Candida (Gross et al., 2009). In addition, Dectin-2 mediates the 
production of cysteinyl leukotrienes in response to house dust mite allergens (Barrett et 
al., 2009). These results indicate that the “Syk signature” in DCs might include multiple 
factors that will have to be analyzed by using genome-wide screens.  
4.3.2 Dectin-2 is essential for Th17 generation to Candida infection 
At the time of starting this project, the role of Dectin-2 in the context of fungal infection 
was not elucidated. Results presented in figure 4.8 first demonstrated that Dectin-2 is 
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essential to coordinate Th17 responses to C. albicans infection. This result raises the 
question as to why Dectin-2 is crucial to generate a Th17 response to Candida. 
Although my results indicate that the Syk-dependent cytokines IL-2, IL-10 and TNF are 
dually dependent on Dectin-1 and Dectin-2, I have observed that the transcripts 
encoding IL-23 are markedly affected in the absence of Dectin-2 (Fig 4.6). In addition, 
others have reported that the production of IL-6, IL-1β and IL-23 in Candida-stimulated 
BMDCs is largely dependent on Dectin-2 (Saijo et al., 2010). All those cytokines have a 
strong impact on the generation of Th17 responses in vitro and in vivo (Bettelli et al., 
2006, Veldhoen et al., 2006a, Langrish et al., 2005, Chung et al., 2009). 
The analysis of the Dectin-2 deficient mice has also showed that this C-type lectin is 
required for the initiation of Th17 responses to C. albicans (Saijo et al., 2010), 
confirming our previous findings (Fig 4.8). Nonetheless, the precise mechanism of 
Th17 induction is still unresolved. 
Despite the marked effect of Dectin-2 on the generation of Th17 responses to Candida 
in vivo, our data indicate that Dectin-2 blockade did not lead to an increase in kidney 
fungal burden (Fig 4.9), not even in absence of Dectin-1. These results contrast with the 
CARD9 deficiency (Gross et al., 2006), and indicate that Dectin-1 and -2 are redundant 
for host innate defense within the first seven days of infection. Consistent with this 
notion, Dectin-1 deficient mice infected i.v. with C. albicans do not display higher 
fungal burden in the kidney early in infection (Taylor et al., 2007). 
In the absence of Dectin-2 deficient mice available at that time, we were restricted to do 
seven-day infection experiments with an anti-Dectin-2 antibody used as a functional 
blocking reagent. In this experimental setting, any beneficial or detrimental effect of 
Th17 cells might be masked by innate resistance mechanisms. Nevertheless, Saijo et al 
(Saijo et al., 2010) have recently reported the role of this receptor in host defense to C. 
albicans. Although Dectin-2-/- mice show increased susceptibility to systemic infection 
with the organism, the differences in fungal burden and survival only become apparent 
at day 10-11 after systemic infection (Saijo et al., 2010). These data are highly 
consistent with our results showing a lack of effect by the anti-Dectin-2 antibody 
treatment at day 7 after systemic infection (Fig 4.9). 
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The fact that Dectin-2 is involved in host defense to C. albicans is an important 
statement and distinguishes it from that of the mannose receptor, which is reported to 
coordinate human Th17 responses to Candida (van de Veerdonk et al., 2009) but has no 
impact in host defense during fungal infection in mice (Lee et al., 2003). 
Whether the deficiency in the Th17 compartment observed in Dectin-2 deficient mice is 
responsible for the increased susceptibility to infection is at present unclear. 
Furthermore, the role of Th17 cells during fungal infections is not clearly elucidated. 
Mice deficient in IL-17RA are susceptible to systemic and oropharyngeal candidiasis 
(Huang et al., 2004, Conti et al., 2009) and human memory CD4+ T cells specific for C. 
albicans have a Th17 phenotype (Acosta-Rodriguez et al., 2007, Zhou et al., 2008b). 
Nonetheless, the Th17 responses have also been argued to promote inflammation and 
susceptibility to an intragastric model of candidiasis (Zelante et al., 2007). Along these 
lines, I have demonstrated that activation of the Dectin-1 pathway in BMDCs results in 
Foxp3+-IL-17+ T cell generation (Osorio et al., 2008), a cell type with an undefined 
function during immune challenge.  
A clearer picture of the role of Th17 responses during fungal infections comes from 
studies in humans. Chronic mucocutaneous candidiasis (CMC) is commonly associated 
with T cell immunodeficiency. Interestingly, patients with mutations in STAT3 fail to 
generate Th17 cells and suffer from recurrent CMC and S. aureus infections (Ma et al., 
2008, Milner et al., 2008, de Beaucoudrey et al., 2008). Similarly, APECED patients 
with CMC display high titers of autoantibodies against IL-17A, IL-17F and IL-22 (Puel 
et al., 2010, Kisand et al., 2010), highlighting the role of IL-17 immunity to the control 
of mucosal Candida infection. 
The connection between the C-type lectin receptor pathway and susceptibility to fungal 
infections in humans has recently been reported. Patients with an early stop mutation in 
Dectin-1 or a homozygous point mutation in CARD9 are more susceptible to CMC 
(Ferwerda et al., 2009, Glocker et al., 2009). In sum, our findings together with the 
evidence in humans strongly indicate that signalling downstream of fungal C-type lectin 
receptors is an essential innate axis for the establishment of antifungal Th17 responses.  
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Chapter 5. Tools to study antigen-specific T cell 
responses to C. albicans-associated antigens 
5.1 Introduction 
By analyzing endogenous responses to C. albicans, results from the Immunobiology 
Laboratory demonstrated that the generation of Th17 responses to the organism is 
dependent on the adaptor CARD9 (LeibundGut-Landmann et al., 2007). Furthermore, 
we have identified Dectin-2 as an essential member of the Syk/CARD9 pathway 
responsible for the induction of Th17 responses during systemic C. albicans infections 
(Figure 4.8, (Robinson et al., 2009)). Although those experiments provided invaluable 
information regarding the role of Syk-coupled CLRs in the coordination of effector T 
cell responses, many questions remain unresolved. What is the role of anti-fungal Th17 
cells to the resolution of infection? Are the signals derived from the CLR/Syk/CARD9 
pathway relevant for priming of naïve CD4+ T cells? What is the impact of innate 
signalling pathways to the expansion and trafficking of T cells to the site of infection? 
If we were able to study T cell immunity to C. albicans in an antigen-specific manner, 
those questions could be easily addressed. The study of defined T cell populations is a 
very powerful approach to dissect the contribution of innate signalling pathways in 
recruitment, priming, expansion and trafficking of cells during immune challenge. 
One example comes from studies of the immune response to A. fumigatus, in which the 
generation of an A. fumigatus specific CD4+ TCR-transgenic mouse helped revealing 
the kinetic of fungus-specific CD4+ T cells during the course of the infection (Rivera et 
al., 2006). In that model, MyD88-dependent signals contributed to the production of 
IFN-γ but not to proliferation and trafficking of A. fumigatus-specific CD4+ T cells 
(Rivera et al., 2006). 
In the absence of a C. albicans-specific CD4+ TCR-transgenic mouse, an alternative 
approach to study antigen-specific T cell dynamics to the organism would be to design a 
transgenic strain of Candida expressing a model antigen. Conventional genetic analysis 
in C. albicans is difficult due to its unusual parasexual cycle, its diploid genome and the 
usage of a non canonical genetic code, in which CUG codons are translated into serine 
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rather than leucine ((Santos and Tuite, 1995) and reviewed in (Noble and Johnson, 
2007)). Nonetheless, technological advances have substantially improved our current 
understanding of C. albicans basic biology. The development of transformation 
techniques has enabled genetic manipulation such as gene deletions, fusions or 
insertions. The instability of episomal plasmids has been circumvented by the 
development of integrative vectors, which promote efficient gene expression and 
stability (Murad et al., 2000). In addition, auxotrophic strains of C. albicans have 
become useful reagents for genetic transformation (Fonzi and Irwin, 1993). To date, 
some reporter genes including GFP, luciferase or the β-galactosidase lacZ gene have 
been optimized for gene expression studies in C. albicans and have proven to be 
effective in infection settings (Uhl and Johnson, 2001, Barelle et al., 2004, Enjalbert et 
al., 2009). 
Given these advances, we decided to generate transgenic strains of C. albicans 
expressing peptides from the model antigen ovalbumin.  
The aim of this chapter is to generate tools that allow the visualization, priming and 
trafficking of T cells specific for a C. albicans–derived antigen. The main purpose 
behind the generation of these strains is to pinpoint the contribution of Dectin-1 and -
2/Syk/CARD9 to antigen-specific CD4+ and CD8+ T cell responses to fungal infection. 
5.2 Results 
5.2.1 Development of transgenic C. albicans strains expressing OVA323-339 
and SIINFEKL peptides derived from Ovalbumin. 
Due to the lack of suitable tools to study natural C. albicans CD4+ and CD8+ T cell 
immunodominant epitopes, I sought to generate two model transgenic organisms 
expressing the peptides from ovalbumin OVA257-264 and OVA323-339. OVA257-264 is the 
MHC class I H-2Kb-restricted SIINFEKL peptide that can be detected by OT-I 
transgenic CD8+ T cells and OVA323-339 is a MHC class II H-2b and H-2d epitope that is 
recognized by both OT-II and DO11.10 transgenic CD4+ T cells (Robertson et al., 
2000). 
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To generate these new strains, we based our strategy in a previously described strain of 
C. albicans expressing a yeast-enhanced version of GFP (Barelle et al., 2004). This 
strain was generated by transformation of the C. albicans strain CAI4 with the vector 
pACT1-GFP. CAI4 is a ura3- derivative of the strain Ca5314 generated by targeted 
mutagenesis, in which the coding region of the URA3 gene was replaced with a 3kb 
fragment of the imm4 region of λgt10 (ura3Δ::imm434/ ura3Δ::imm434) (Fonzi and 
Irwin, 1993). URA3 encodes the enzyme orotidine-5’-phosphate (OMT) decarboxylase, 
which is involved biosynthesis of pyrimidine ribonucleotides by converting OMT into 
uridine monophosphate (Flynn and Reece, 1999). Thus, CAI4 is an auxotrophic strain 
that requires medium supplemented with uridine for appropriate growth. 
The vector pACT1-GFP is derived from the integrative vector CIp10 (Candida 
Integrating plasmid 10)(Murad et al., 2000) and contains the marker CaURA3, the 
ribosomal coding protein 10 region (RPS10) that provides homology to target 
chromosomal integration, and a codon-optimized yeast enhanced GFP (Cormack et al., 
1997) driven by the actin (ACT1) promoter region (Barelle et al., 2004). 
A schematic representation of the pACT1-GFP vector is illustrated in figure 5.1a. 
The pACT1-GFP vector (kindly provided from Dr Alistair Brown, University of 
Aberdeen, Aberdeen UK) was used as a template to generate the vectors pACT1-GFP-
OVA323-339 and pACT1-GFP-SIINFEKL. 
The gene fusions GFP-OVA323-339 and GFP-SIINFEKL were generated by PCR using a 
sense oligonucleotide that binds upstream of the GFP coding region and antisense 
oligonucleotide that contain the full coding sequence of OVA323-339 or SIINFEKL 
peptides respectively (for sequence details refer to materials and methods). During the 
oligonucleotide design, I selected those codons that are preferentially used by C. 
albicans (Brown et al., 1991) and avoided the use of CTG codons, as they are translated 
into serine instead of leucine by the organism (Santos and Tuite, 1995). The gene 
fusions GFP-OVA323-339 and GFP-SIINFEKL were cloned as HindIII/NheI fragments 
and placed in place of GFP in the plasmid pACT1-GFP to generate pACT1-GFP-
OVA323-339 and pACT1-GFP-SIINFEKL (Figure 5.1a). The integrity of the newly 
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generated vectors was assessed by digestion with restriction enzymes and by DNA 
sequencing. 
The vectors described above were linearised by digestion with the blunt endonuclease 
StuI and used to transform the strain CAI4 (kindly provided from Dr Alistair Brown, 
University of Aberdeen, Aberdeen UK) using the lithium acetate protocol. Uridine 
prototrophs were selected on minimal synthetic medium (full details are described in 
materials and methods section). 
As pACT1-GFP is a CIp10 derivative, genomic integration occurs at the RPS10 locus. 
Proper genomic integration was assessed by genomic PCR and is illustrated in Figure 
5.1b. As previously described for C. albicans expressing pACT1-GFP (Barelle et al., 
2004), pACT1-GFP-SIINFEKL and pACT1-GFP-OVA323-339 -containing cells have 
integrated the plasmid within the RPS10 region as demonstrated by the presence of an 
amplification product. A second PCR reaction designed to detect tandem integrated 
plasmids exclusively (Barelle et al., 2004) was carried out with no amplification product 
detected (data no shown), indicating that the transformants integrated a single copy of 
the plasmid.  
The expression of GFP in the newly generated strains was assessed by western blot 
(Figure 5.1c). Cells expressing the OVA323-339 or SIINFEKL peptides fused to GFP 
expressed similar levels of the protein as to compared to C. albicans pACT1-GFP. 
The activity of these GFP fusions was assessed by flow cytometry and fluorescence 
microscopy and illustrated in figure 5.1d-e. After fixation with PFA, C. albicans 
expressing GFP, GFP-OVA323-339, and GFP-SIINFEKL expressed higher levels of GFP 
fluorescence than the parental strain CAI4 as assessed by FACS (Figure 5.1d). 
Fluorescence microscopy of live organisms also indicates strong GFP fluorescence in 
all transgenic strains, although the fluorescence level produced by the GFP-SIINFEKL 
strain was slightly lower than the two counterparts (Fig 5.1 d-e). Nonetheless the three 
strains emitted a positive fluorescence for GFP. 
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Altogether, these results indicated that two new strains of C. albicans expressing 
peptides for MHC-I and MHC-II presentation have been successfully generated and 
were ready to be tested in assays containing antigen-specific T cells. 
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Figure 5-1: Generation of Candida albicans strains expressing OVA323-339 and SIINFEKL peptides. 
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(a) Schematic representation of pACT1-GFP, pACT1-GFP-SIINFEKL and pACT1-GFP-OVA323-339. 
pACT1-GFP is a CIp10 derivative that contains the C. albicans URA3 transformation marker. Upon 
digestion with the restriction enzyme Stu I, pACT1-GFP integrates at the C. albicans locus RPS10. The 
gene fusions GFP-SIINFEKL or GFP-OVA323-339 were generated by PCR and cloned as a HindIII/NheI 
fragment in place of GFP. (b) Plasmid integration at the RPS10 locus was confirmed by PCR using the 
oligonucleotides described in (Barelle et al., 2004). (c) GFP expression in C. albicans strains was 
confirmed by western blot using an anti-GFP polyclonal antibody. (d) FACS analysis of C. albicans 
strains carrying various GFP constructs. Prior to acquisition, cells were fixed in 4%PFA. (e) Microscopic 
analysis of live C. albicans strains carrying pACT1-GFP, pACT1-GFP-SIINFEKL and pACT1-GFP-
OVA323-339 constructs. Scale bar represents 20µm. 
 
5.2.2 C. albicans expressing GFP-SIINFEKL is a useful tool to measure 
proliferation and priming of OT-I CD8+ T cells in vitro  
To test whether BMDCs process and present antigens derived from SIINFEKL-
expressing C. albicans to antigen-specific CD8+ T cells, I carried out a T cell 
proliferation assay in vitro. BMDCs were incubated two hours with various doses of 
heat-killed C. albicans GFP-SIINFEKL, C. albicans GFP, or SIINFEKL peptide 
followed by the addition of CFSE-labelled OT-I T cells. CD8+ T cell proliferation was 
used to measure antigen processing and presentation. Results are shown in figure 5.2 a-
c. BMDCs stimulated with heat-killed Candida expressing SIINFEKL induced 
proliferation of OT-I cells, albeit at low levels and only in wells containing high doses 
of the organism (Fig 5.2a). This effect was antigen-specific, as it was not observed in 
wells containing C. albicans GFP (Fig 5.2 b-c). In contrast, maximal OT-I proliferation 
and expansion was observed in wells containing high doses of SIINFEKL peptide (Fig 
5.2 b-c). These results indicate that GFP-SIINFEKL associated with heat-killed C. 
albicans is not a potent inducer of CD8+ T cell proliferation. 
To determine whether processing of live organisms leads to strong CD8+ T cell 
responses, BMDCs were exposed to live C. albicans GFP-SIINFEKL for 2 hours prior 
to the addition of fungizone and CFSE-labelled OT-I T cells. In contrast to cultures 
containing heat-killed organisms, BMDCs activated with SIINFEKL-expressing 
Candida plus fungizone triggered strong proliferation of OT-I T cells (Figure 5.2 d-e). 
This was observed at doses as low as 0.33 Candida per BMDC and was accompanied 
by great expansion of CD8+ T cells (Fig 5.2 e-f). As a result, high levels of IFN-γ were 
detected in cultures containing live organisms (Fig 5.2 g-h). The remarkable differences 
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between heat-killed and live organisms as source of antigen for OT-I proliferation and 
intracellular IFN-γ are illustrated in figure 5.2 i. 
Altogether these results indicate that antigens derived from live C. albicans are 
efficiently presented by BMDCs to CD8+ T cells in vitro. 
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Figure 5-2: DCs pulsed with C. albicans GFP-SIINFEKL stimulate CD8+ OT-I T cell proliferation 
in vitro. 
(a) 1x104 wild-type C57BL/6 BMDCs were stimulated for 2 hrs with various doses of heat-killed C. 
albicans GFP-SIINFEKL and cultured with 5x104 CFSE-labeled OT-I T cells. Histograms show CFSE 
dilution on day 5 of culture. (b) BMDCs as in (a) were stimulated for 2 hrs with various doses of heat-
killed C. albicans GFP-SIINFEKL, C. albicans GFP or SIINFEKL peptide and cultured with 5x104 
CFSE-labeled OT-I T cells. Graph shows the percentage of dividing CD8+ T cells at day 5. (c) CD8+ T 
cell counts per well from the experiment shown in (b). (d) BMDCs as in (a) but stimulated with live C. 
albicans GFP-SIINFEKL for 2 hrs prior to the addition of fungizone. Then cells were cultured with 5x104 
CFSE-labeled OT-I T cells. Histograms show CFSE dilution on day 5 of culture. (e) Percentage of 
dividing CD8+ T cells obtained on day 5 from cultures containing C. albicans GFP-SIINFEKL, C. 
albicans GFP or various doses of SIINFEKL peptide in presence of fungizone. (f) CD8+ T cell counts per 
well from the experiment shown in (e). (g) Cells as in (b) were restimulated on day 5 for 48 hr with 
coated α-CD3 (5µg/ml) and IFN-γ production was determined by sandwich ELISA. (h) Cells as in (e) 
were restimulated as in (g). (i) CD8+ T cells from cultures containing heat killed or live C. albicans GFP-
SIINFEKL in a ratio 9/1 (Candida/BMDC) were restimulated with PMA, ionomycin and BFA and the 
presence of IFN-γ was analyzed by flow cytometry. Data in (g) and (h) are mean + SD of duplicate wells. 
Data in (b), (c), (e) and (f) are mean + SEM of three independent experiments. Data are representative of 
three independent experiments. 
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5.2.3 Antigens derived from C. albicans GFP-SIINFEKL are presented to 
OT-I CD8+ T cells during the course of systemic infection. 
To determine whether systemic infection with C. albicans leads to proliferation and 
priming of CD8+ T cells, C57BL/6 mice that had received CFSE-labelled OT-I T cells 
were subsequently infected with C. albicans GFP-SIINFEKL or C. albicans GFP 
intravenously. Spleen, renal lymph node (RLN) and kidney were harvested 5 days after 
infection and OT-I T cell proliferation was measured. OT-I T cells were found to 
proliferate extensively in RLN of mice infected with Candida expressing SIINFEKL 
(Figure 5.3 a). Highly proliferating cells were detected in the spleen and kidney as 
expected, albeit at lower levels than in RLN. To analyse whether proliferating OT-I 
cells have become IFN-γ producers after infection, spleen and RLN were taken and 
were pulsed with 1µM of SIINFEKL peptide ex vivo in presence of brefeldin A. The 
production of intracellular IFN-γ was analyzed by FACS. Notably, OT-I T cells that 
proliferate in response to systemic infection with C. albicans GFP-SIINFEKL produce 
large amounts of IFN-γ (Figure 5.3b). Overall these results show that C. albicans 
expressing GFP-SIINFEKL is a useful tool to track antigen-specific OT-I T cells during 
the course of systemic infection. 
This C. albicans strain could also be used to monitor endogenous SIINFEKL-specific 
CD8+ T cells by using a H-2Kb SIINFEKL tetramer.  
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Figure 5-3: Infection with C. albicans GFP-SIINFEKL leads to proliferation and priming of CD8+ 
OT-I T cells. 
(a) 1x106 CFSE-labelled OT-I CD45.1 T cells were transferred i.v. into Wild-type C57BL/6 (WT) mice. 
One day later, mice were infected intravenously with 5x104 C. albicans GFP or C. albicans GFP-
SIINFEKL. On day 5 after infection, OT-I cells from spleen, renal LN and kidney analyzed by FACS. 
Graphs show CFSE dilution versus CD45.1 in CD8+ population. (b) Cells from renal LN and spleen 
shown in (a) were pulsed for 3 hrs with medium alone or 1µM SIINFEKL in the presence of BFA. 
Graphs show CFSE dilution versus intracellular IFN-γ. 
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5.2.4 Antigens derived from heat-killed C. albicans GFP-OVA323-339 are 
efficiently presented to OT-II CD4+ T cells in vitro  
I sought to determine the ability of BMDC to present antigens derived from C. albicans 
GFP-OVA323-339 to OT-II CD4+ T cells. As previously shown for OT-I T cells, BMDCs 
were exposed for 2 hrs to various doses of heat-killed C. albicans GFP-OVA323-339, 
following by the addition of CFSE-labelled naïve OT-II T cells. Results are illustrated 
in figure 5.4 a-c. BMDCs that had phagocytosed heat killed OVA323-339 –containing 
fungi induce strong proliferation and expansion of OT-II T cells as depicted in the 
CFSE profiles and cell numbers obtained at the end of the culture. This was 
accompanied by production of IL-17 and IFN-γ after restimulation with α-CD3 for 48hr 
(Figure 5.4 d-e). Is important to note that the levels of cytokine are modest, as low 
levels of IL-17 and IFN-γ are detected at on a per cell basis (Figure 5.4 f). In addition, 
no IL-4 was detected on cultures containing the fungus (data not shown). These results 
indicate that processing of antigens associated to heat-killed C. albicans by BMDCs 
leads to proliferation and priming of naïve CD4+ T cells in vitro. 
In contrast to cultures containing heat-killed organisms, BMDCs stimulated with live 
Candida-OVA323-339 plus fungizone induced CD4+ T cell proliferation and but failed to 
induce T cell expansion (Figure 5.4 g-i). This effect is not associated with fungizone 
toxicity as control wells containing OT-II T cells, BMDCs and OVA peptide were not 
affected by addition of the antifungal agent (Figure 5.4 i, j). As a consequence, no 
effector cytokines are detected by ELISA (data not shown) or intracellular staining 
(Figure 5.4 j). 
These results indicate that BMDCs stimulated with live C. albicans expressing a 
cytosolic antigen are not competent to promote CD4+T cell expansion and priming in 
vitro. 
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Figure 5-4: DCs stimulated with heat-killed C. albicans GFP-OVA323-339 induce priming of CD4+ 
OT-II T cells in vitro. 
(a) 1x104 wild-type C57BL/6 BMDCs were stimulated for 2 hrs with various doses of heat-killed C. 
albicans GFP-OVA 323-339 and cultured with 5x104 CFSE-labeled OT-II T cells. Histograms show CFSE 
dilution on day 5 of culture. (b) BMDCs as in (a) were stimulated for 2 hrs with various doses of heat-
killed C. albicans GFP-OVA 323-339, C. albicans GFP or OVA 323-339 peptide and cultured with 5x104 
CFSE-labelled OT-II T cells. Graph shows the percentage of dividing CD4+ T cells at day 5. (c) CD4+ T 
cell counts per well from the experiment shown in (b). Cells as in (a) were restimulated on day 5 for 48 
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hr with coated α-CD3 (5µg/ml) and the production IFN-γ (d), and IL-17 (e), was determined by sandwich 
ELISA. (f) Cells as in (b) were restimulated on day 5 with PMA, Ionomycin and BFA and the presence of 
intracellular IFN-γ and IL-17 was analyzed by flow cytometry. 
(g) BMDCs as in (a) but stimulated with live C. albicans GFP-OVA 323-339 for 2 hrs prior to the addition 
of fungizone. Then 5x104 CFSE-labeled OT-II T cells were added to the cultures. Histograms show CFSE 
dilution on day 5 of culture. (h) Percentage of dividing CD4+ T cells obtained on day 5 from cultures 
containing various doses of C. albicans GFP-OVA 323-339, C. albicans GFP or OVA 323-339 peptide in 
presence of fungizone. (i) CD4+ OT-II T cell counts per well from the experiment shown in (h). (i) Cells 
as in (g) were restimulated on day 5 with PMA, Ionomycin and BFA and the presence of intracellular 
IFN-γ and IL-17 was analyzed by flow cytometry. Data in (d) and (e) are mean + SD of duplicate wells. 
Data in (b), (c), (h) and (i) are mean + SEM of three independent experiments. Data are representative of 
three independent experiments. 
 
5.2.5 OT-II T cells proliferate primarily in the renal lymph node of C. 
albicans infected mice. 
To track antigen specific CD4+ T cells during the course of C. albicans systemic 
infection, CFSE-labelled naïve OT-II T cells were transferred into C57BL/6 mice that 
were subsequently infected with C. albicans GFP-OVA323-339 or C. albicans GFP. On 
day 5 after infection, spleen, renal, brachial, inguinal and mesenteric lymph nodes were 
collected and OT-II CD4+ T cell proliferation was assessed by FACS. In response to 
infection with Candida-expressing OVA323-339, a small but noticeable population of 
proliferating OT-II T cells can be detected in spleen, brachial, inguinal and mesenteric 
lymph nodes (Figure 5.5.a). Notably, a high proportion of proliferating T cells 
accumulate primarily on the renal lymph node of infected mice (Figure 5.5 a) indicating 
the kidney-draining lymph node is the primary site for T cell priming to Candida-
associated antigens. This effect is dependent on the infection dose, as the percentage of 
dividing cells decreases when infecting with a lower dose of the pathogen (Fig 5.5 b-c).  
This experiment demonstrates that antigens derived from C. albicans are presented to 
CD4+ T cells in vivo. Furthermore, this strain of Candida allowed the identification of 
the renal lymph node as the primary site of antigen presentation during the course of a 
systemic infection. 
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Figure 5-5: OT-II T cells accumulate primarily in the renal lymph node after systemic infection 
with C. albicans OVA323-339. 
(a) 2x106 CFSE-labelled naïve OT-II CD45.1+ CD4+ T cells were transferred i.v. into wild-type C57BL/6 
(WT) mice. One day later, mice were infected intravenously with 1x105 or 3x104 C. albicans GFP-OVA 
323-339 or 3x104 C. albicans GFP. On day 5 after infection, OT-II T cells were analyzed by FACS. Graphs 
show CFSE dilution versus CD45.1 gated in the CD4+ population. Percentage of dividing cells in 
response to infection with 1x105 (b) or 3x104 (c) C. albicans. The data in (b) and (c) are mean +SEM of 
two independent experiments and each dot represents one mouse. 
 
5.2.6 The frequency of antigen-specific CD4+ T cells decreases during the 
course of infection. 
To have a better understanding of the kinetics of the CD4+ T cell response during C. 
albicans infections, I carried out a time course experiment. Mice that received naïve 
OT-II T cells were infected with C. albicans GFP-OVA323-339 and were sacrificed at day 
4, 8 and 12 post infection. Lymph nodes, kidney and spleen from each mouse were 
processed for flow cytometric comparison. On day 4, CD4+CD45.1+ double positive 
OT-II T cells are readily detected in most lymphoid tissues with particular accumulation 
in the renal lymph node (Fig 5.6 a-b). By day 8, the frequency of OT-II T cells had a 
remarkable contraction in most organs analyzed (Fig 5.6 a). Notably, whilst 
proliferating OT-II clearly accumulate in renal lymph nodes by day 4-5 (Fig 5.5), 
migrating OT-II T cells were never found in kidneys of infected mice on day 4 or 8 (Fig 
5.6 b). By day 12, OT-II T cells were almost undetectable (Fig 5.6 a). 
To test whether OT-II T cell contraction correlates with clearance of C. albicans GFP-
OVA323-339, fungal colonies were quantified in kidneys from infected mice (Fig 5.6 c). 
Presence of the pathogen was detected on day 4, 8 and 12 indicating that, despite the 
continuous presence of the fungal organism, the OT-II T cell response contracts and 
declines over time. 
These results indicate that a weak and transient OT-II T cell response is generated to a 
strain of C. albicans expressing intracellular OVA323-339.  
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Figure 5-6: Frequency of OT-II CD4+ T cells decline during the course of C.albicans  GFP-OVA323-
339 infection. 
(a) 1.5x106 CFSE-labelled naïve OT-II CD45.1+ CD4+ T cells were transferred i.v. into wild-type 
C57BL/6 (WT) mice. One day later, mice were infected intravenously with 1x105 C. albicans GFP-OVA 
323-339 . The graph shows the percentage of CD4+CD45.1+ OT-II T cells within FSC/SSC gate on day 4, 8 
or 12 after infection. Each dot represents one mouse. (b) CD4+CD45.1+ OT-II T cells in renal lymph node 
and kidney on day 4 and 8. (c) Fungal burden measured of mice analyzed in (a) at different time points. 
 
5.2.7 OT-II T cells do not produce detectable levels of IFN-γ , IL-17 or 
Foxp3 after systemic infection with C. albicans GFP-OVA323-339. 
Having framed the kinetics of OT-II T cell responses during Candida infection, I 
decided to assess whether antigen-specific CD4+ T cells acquire an effector phenotype. 
CFSE-labelled OT-II T cells present in renal lymph nodes from infected mice were 
analyzed at day 5 and cytokine production was measured by FACS after restimulation 
with PMA/Ionomycin and brefeldin A. Results are shown in figure 5.7. As previously 
noted (Figure 5.5), dividing OT-II CFSE+ T cells do not undergo more than four 
division cycles and do not produce detectable levels of IL-17 and IFN-γ as measured by 
intracellular staining (Figure 5.7a-b). In contrast, endogenous CD4+ CFSE- T cells from 
mice infected with Candida-GFP or Candida- GFP-OVA323-339 produce notable levels 
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of both cytokines with this method of restimulation (Figure 5.7a-b). Furthermore, OT-II 
T cells do not become regulatory T cells under these experimental conditions as 
assessed by Foxp3 staining (Figure 5.7 c) 
These results indicate that, upon infection with a strain of C. albicans expressing an 
intracellular antigen, antigen specific CD4+ T cells do not proliferate extensively and do 
not acquire a measurable effector function. 
In sum, these results suggest that the tools generated here are not optimal to study the 
contribution of innate signalling pathways to the coordination of adaptive immunity to 
C. albicans. Improvements to this current approach will be proposed in the discussion 
section of this chapter. 
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Figure 5-7: OT-II T cells do not express detectable levels of IL-17, IFN-g or Foxp3 after systemic 
infection with C. albicans GFP-OVA323-339. 
2x106 CFSE-labelled naïve OT-II CD45.1+ CD4+ T cells were transferred i.v. into wild-type C57BL/6 
(WT) mice. One day later, mice were infected intravenously with 5x104 C. albicans GFP-OVA 323-339 or 
C. albicans GFP. On day 5 after infection, OT-II T cells were analyzed by FACS. Graphs show CFSE 
dilution versus IL-17 (a), IFN-γ (b) or Foxp3 (c), gated in the CD4+ population.
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5.3 Discussion 
In this chapter, I have generated two transgenic strains of C. albicans for the study of 
CD4+ and CD8+ T cell responses during fungal infections. This is, to my knowledge, the 
first attempt to study antigen-specific T cell immunity to this organism. Nonetheless, 
analysis of T cell responses during infection with transgenic strains of Candida requires 
further improvement, as the approach provided in this chapter is not fully effective to 
study CD4+ T cell dynamics to the organism. 
Our strategy was based on the use of the pACT1-GFP integrative vector, in which the 
actin promoter region drives the expression of intracellular GFP (Barelle et al., 2004). 
Expression of GFP fused to either SIINFEKL or OVA323-339 peptides in the newly 
generated strains of C. albicans was successful as confirmed by PCR, sequencing, 
western blot, FACS analysis, fluorescence microscopy and T cell proliferation analysis. 
5.3.1 C. albicans GFP-SIINFEKL is a potent source of antigen for 
proliferation and priming of CD8+ T cells in vitro and in vivo 
Although the reason for studying CD8+ T cells during the context of fungal infections 
may not seem straightforward, activation of Dectin-1 by β-glucans leads to efficient 
priming of cytotoxic T cell responses (Leibundgut-Landmann et al., 2008) and CD8 
deficient mice are highly susceptible to oropharyngeal candidiasis (Conti et al., 2009). 
Furthermore, antifungal CD8+ T cells to H. capsulatum or C. neoformans can limit 
fungal replication and confer protection in absence of CD4+ T cells. These responses are 
thought to be IFN-γ-mediated (Lin et al., 2005, Lindell et al., 2005). These data suggest 
that CD8+ T cells might play an important role in the immune control of C. albicans 
infection and future work is needed to elucidate their function. 
My results indicate that BMDCs exposed to live Candida-SIINFEKL (followed by the 
addition of fungizone) are more efficient than those exposed to heat-killed organisms to 
promote OT-I T cell activation. This marked distinction between heat-killed and live 
organisms in the activation of CD8+ T cells have been previously noted for other 
pathogens including the parasites Toxoplasma gondii and Leishmania major 
(Goldszmid et al., 2009, Bertholet et al., 2005). Although L. major and T. gondii gain 
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access to the MHC I pathway by different mechanisms (reviewed in (Goldszmid and 
Sher, 2010)), infection with live parasites is necessary in both cases or efficient cross-
presentation of pathogen-associated antigens (Goldszmid et al., 2009, Bertholet et al., 
2005). 
In contrast to intracellular protozoan parasites, C. albicans has an extracellular life 
style. Nonetheless, others and myself have observed that DCs are fully competent to 
phagocytose yeast and establish contacts with hyphae (data not shown and (d'Ostiani et 
al., 2000)). These observations suggest that whilst the mechanisms of antigen 
presentation between intracellular parasites and extracellular fungi might seem 
obviously different, DC interaction with live fungus might also divert the antigenic 
cargo and favour access to the MHC I pathway. Along these lines, CD8+ T cells were 
efficiently primed during systemic infection with Candida-SIINFEKL (Fig 5.2). 
Whether functional memory CD8+ T cells arise as consequence of C. albicans infection 
remains an open question that is beyond the scope of this thesis. Nonetheless this strain 
could be used for future studies of CTL responses to C. albicans. Those experiments are 
not provided in this thesis, as I was more interested in the induction of CD4+ T cell 
responses to the organism. 
5.3.2 C. albicans expressing a model antigen expressed in the cytosol 
does not trigger an efficient CD4+ T cell response  
In contrast to the strong CD8+ T cell responses observed against live fungus, processing 
of heat-killed but not live C.albicans-GFP-OVA323-339 induced efficient CD4+ 
proliferation in vitro. These results suggest that antigens derived from dead pathogens 
might be more accessible to the MHC-II pathway. In favour of this notion, dead T. 
gondii has also been shown to be potent antigenic source for CD4+ T cells (Goldszmid 
et al., 2009). 
Early after systemic infection with C. albicans-GFP-OVA323-339, CD4+ OT-II T cells 
accumulate in the renal lymph node. However, they do not proliferate extensively and 
do not become effector T cells. There may be various reasons that explain why this 
strain induces poor CD4+ T cell responses. Live organisms may produce factors that 
inhibit processing and presentation of Candida-derived antigens to CD4+ T cells. An 
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additional possibility is that the cytosolic localisation of OVA323-339 is not an efficient 
source of antigen. It is worth noticing that most transgenic parasites used in studies of 
CD4+ T cell immunity deliberately express model antigens as membrane-bound or as 
secreted forms (reviewed in (Goldszmid and Sher, 2010)). In the case of T. gondii, only 
OVA secreted to the parasitophorus vacuole but not a cytosolic OVA form is efficiently 
presented on MHC II molecules (Pepper et al., 2004). Similar observations have been 
described for L. major: surface localisation of OVA is strictly required to drive an 
effective OT-II CD4+ response whereas processing of cytosolic antigens is a highly 
inefficient process (Prickett et al., 2006). Although is well established that most 
endogenous CD4+ T cells specific for L. major recognize a single peptide derived from 
the cytosolic protein LACK (reviewed in (Sacks and Noben-Trauth, 2002)), is 
important to note that this peptide is edited by the nonclassical MHC class II molecule 
DM (Kamala and Nanda, 2009). In addition, for intracellular bacteria such as Listeria 
monocytogenes, peptides derived from the secreted proteins lysteriolysin o and p60 are 
immunodominants epitopes for CD4+ and CD8+ T cells (Geginat et al., 2001). 
Altogether, this evidence indicates that for pathogens-derived antigens, the subcellular 
localisation might determine the outcome of a T cell response. Proteins located on the 
cell surface might gain rapid access to the endosomal compartment responsible for 
antigen processing, facilitating the presentation process. 
5.3.3 Revised strategy for the generation of transgenic strains of C. 
albicans to study optimal T cell responses. 
At the time of generating the strain of C. albicans expressing cytosolic GFP-OVA323-339, 
we were restricted to use the vector pACT1-GFP. Nonetheless, novel approaches for the 
study of fungal infections have been developed in recent times. In this context, a 
reporter system designed for imaging C. albicans infections has been published recently 
(Enjalbert et al., 2009). In that system, a codon-optimized version of luciferase was 
targeted to the C. albicans cell surface to favour accessibility to its substrate 
coelenterazine (Enjalbert et al., 2009). The strategy takes advantage of the PGA59 gene, 
which encodes the small GPI-linked cell wall protein Pga59 (Moreno-Ruiz et al., 2009). 
Fungal GPI-anchored proteins are inserted in the outer layer of the cell wall through 
their glycolipid region. These proteins are characterized by the presence of a signal 
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sequence that directs the protein into the endoplasmic reticulum, a mature domain, and 
a C-terminal region involved in GPI-anchoring (Mayor and Riezman, 2004). The GPI 
anchor of Pga59 is covalently linked to β-(1,6)-glucans present in the cell wall of C. 
albicans and the protein is evenly distributed in the cell surface of yeast and hyphae 
(Moreno-Ruiz et al., 2009). Due to its small size (113 aminoacids), Pga59 is a protein 
that can be easily manipulated. In the work reported by Enjalbert et al, the luciferase 
gene (without the stop codon) was cloned within the Pga59 gene, between the sequence 
encoding for the second and third aminoacid of the mature Pga59 (Enjalbert et al., 
2009). Therefore, the luciferase gene was placed in frame downstream of the Pga59 
signal sequence and upstream of the Pga59 GPI-containing region (Enjalbert et al., 
2009). This gene fusion was subsequently cloned in the vector CIp10, downstream the 
pACT1 promoter region to allow efficient expression. This was done following the 
same cloning strategy to that I provided in this chapter. This reporter strain express high 
levels of luciferase at the cell wall and has proven to be a highly convenient and 
sensitive tool for in vivo imaging of C. albicans infections (Enjalbert et al., 2009).  
To circumvent the limitations of my current approach and to direct antigens to the cell 
wall, I propose to clone the gene fusions GFP- OVA323-339 and GFP-SIINFEKL 
downstream of the Pga59 signal sequence following the same strategy provided by 
Enjalbert et al (Enjalbert et al., 2009) (Figure 5.8). The constructs Pga59-GFP-OVA323-
339 and Pga59-GFP-SIINFEKL can be subsequently cloned as HindIII/NheI fragments 
in pACT1-GFP vector in place of GFP. This will allow high expression of the gene 
fusions. 
  
Figure 5-8: Revised strategy for the generation of C. albicans strains expressing OVA peptides 
targeted to the cell surface. 
Similar to the strategy provided in (Enjalbert et al., 2009), the gene fusions GFP- OVA323-339 and GFP-
SIINFEKL (without the stop codon) can be cloned in frame within the PGA59 gene between the 
sequence encoding the aminoacids 2 and 3 of the mature Pga59 protein. As the GFP gene fusions lack the 
stop codon, the resulting Pga59-GFP-OVA peptide construct will contain the signal peptide, the Pga59 
mature domain, and the GPI-anchor region. 
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I hypothesize that the OVA peptides derived from Candida strains expressing Pga59-
GFP-OVA323-339 and Pga59-GFP-SIINFEKL would be efficiently presented to antigen-
specific T cells during infection. In histopathological sections of C. albicans infected 
mice, all C. albicans forms (yeast, pseudohyphae and hyphae) can be detected (Romani, 
2004), albeit the hyphae form is predominant in my experiments (unpublished 
observations). Therefore, DCs might process material derived from both forms for 
antigen presentation to T cells. In this scenario, the fact that Pga59 is expressed at the 
cell wall of yeast and hyphae might favour the presentation of C. albicans derived 
antigens during infections.  
Altogether, this revised approach may substantially facilitate the study of T cell 
responses to the C. albicans and eventually, the contribution of Syk/CARD9 signalling 
pathway to the coordination and priming of adaptive immunity to the organism. 
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Chapter 6. Final discussion and future perspectives. 
 
Results presented in this thesis unveiled the mechanisms by which Dectin-1-activated 
DCs initiate a type 17 response. The purified agonist curdlan has proven to be a very 
useful reagent to delineate the contribution of Dectin-1 in isolation to the coordination 
of adaptive immunity. Having defined the requirements for the development of IL-17-
producing cells in response to Dectin-1 ligation in DCs (Chapter 3), we decided to 
investigate the contribution of additional Syk-coupled CLRs to Th17 responses during 
fungal infections. To address this question in such a complex scenario, it was first 
required the identification of an additional Syk-coupled PRR that accounted for the Syk 
dependent but Dectin-1 independent aspects of fungal recognition by DCs. Results 
presented in this thesis in collaboration with those generated by Dr Matthew Robinson 
revealed that Dectin-2 is the additional Syk-coupled PRR that fulfils this criteria. We 
found that Dectin-2 is not redundant for the initiation of anti-fungal Th17 responses 
during systemic C. albicans infection. Finally, this thesis presents a strategy to study 
antigen-specific T cell responses to C. albicans. Although this plan requires further 
refinement, these tools will provide invaluable information regarding priming and 
trafficking of antigen-specific T cells to the site of infection. In this section, I will 
discuss some of the questions that remain open and will provide my views about the 
future perspectives in the field. 
6.1 Dectin-1/Syk signalling in DCs couples to the induction of 
IL-17-producing CD4+ T cells. 
Dectin-1, the archetypal CLR that signals via Syk and CARD9 for gene induction and 
cytokine production in DCs (LeibundGut-Landmann et al., 2007), induces IL-17-
producing CD4+ T cells in an IL-23 dependent mechanism (Chapter 3, Fig 3.2 and 3.6). 
β-glucan stimulation leads to the production of large amounts of IL-23 and decreased 
amounts of IL-12 by DCs (LeibundGut-Landmann et al., 2007, Gerosa et al., 2008). 
This differential regulation of IL-23 over IL-12 is observed in stimulations with Dectin-
1 and TLR2 agonists and contributes to the coordination of adaptive immunity (Gerosa 
et al., 2008). 
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Although Dectin-1 ligation leads to the induction of a small fraction of Th17 cells 
differentiated from naïve precursors (Figure 3.3 and (LeibundGut-Landmann et al., 
2007)), a large proportion of IL-17 producers emerge from the CD4+CD25+ T cell 
population (Fig 3.3). Further characterization of the responding population in vitro 
demonstrated that Foxp3+RORγt+ T cells, a cell subset that produce low levels of IL-17 
in steady state (Lochner et al., 2008, Zhou et al., 2008a), are a main source of IL-17 
upon culture with Dectin-1 activated DCs. Because most of our studies were performed 
in vitro, it was unclear whether our findings fully represented an in vivo situation. For 
this reason we decided to evaluate the T cell behaviour during Treg control of murine 
colitis induced by H. Hepaticus. Notably, Foxp3+IL-17+ T cells were clearly noticed 
under this experimental setting and coexisted with Foxp3+IL-17- T cells in vivo, 
indicating that the former population can emerge under some conditions of immune 
challenge. The fact that Foxp3+IL-17+ T cells were present in mice that suppressed the 
development of intestinal inflammation, suggests that Foxp3+IL-17+ T cells may not be 
detrimental for the resolution of the disease (Figure 3.7). Further studies are required to 
address this point, as Foxp3+IL-17+ T cells constitute a small fraction of the total 
Foxp3+ population, which complicates functional studies. As discussed in chapter 3, the 
fact that curdlan administration did not alter the frequency of IL-17-producing cells 
does not indicate that the Dectin-1 innate signalling pathway does not play a role in this 
response. This aspect can be further studied in CD11cΔSyk mice (for a detailed 
description, see below). 
The production of IL-17 by Foxp3+ cells is an intriguing finding that highlights the 
plasticity of T cell subsets at microbe-exposed sites. The outcome of this ‘adaptation’ 
during an immune response is not fully understood. The acquisition of transcription 
factors and cytokines previously attributed to effector T helper subsets might render 
Tregs competent to control a particular type of immune response. In favour of this 
notion, it has been recently reported that Tregs require signalling via Stat3 to control 
excessive Th17 responses (Chaudhry et al., 2009). In addition, IL-17 produced by 
Foxp3+ T cells might contribute to processes including tissue repair and the restore of 
cellular homeostasis. Results presented in this thesis indicate that Tregs and naïve T 
cells are responsive to the same environmental cues. This might confer Tregs the ability 
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to migrate and survive in the same location with the cells they must regulate (reviewed 
in (Wohlfert and Belkaid, 2010)).  
Notably, Dectin-1 ligation by β-glucans is the first innate recognition system that 
triggers IL-17 production from various T cell subsets in mice and also by human CD4+ 
T cells (LeibundGut-Landmann et al., 2007, Osorio et al., 2008, Martin et al., 2009, 
Gerosa et al., 2008). In vivo, this pathway may operate in sites where Foxp3+ T cells 
and Th17 are highly abundant such as the gut. Although β-(1,3)-glucan has been 
recognized as an essential constituent of fungal cell walls, this molecule is also found in 
the periplasmic space of some proteobacteria species (Lee et al., 2009). As such, β-
(1,3)-glucans contained in commensal or pathogenic organisms could be sensed by 
Dectin-1 expressing DCs, which may promote IL-17 production from three different 
CD4+ T cell subsets (Figure 6.1). Dectin-1 activated DCs can prime a small fraction of 
naïve T cells via the production of IL-6 and IL-23 plus TGF-β present in the 
environment (point 1, figure 6.1). Secondly, Dectin-1 activated DCs might induce the 
production of IL-17 from Foxp3+RORγt+ T cells in an IL-23 dependent manner. In this 
setting, IL-2 signalling might help maintaining the expression of Foxp3 (see point 2, Fig 
6.1). Finally, a considerable amount of IL-17 might be derived from effector T cells, 
which express CD25 and are IL-23 responsive (point 3, Fig 6.1).  
In addition to CD4+ T cells, Dectin-1 ligation can also trigger the production of IL-17 
from an innate source. A subset of γδ T cells express Dectin-1 and sense β-(1,3)-glucans 
directly to produce IL-17 (Martin et al., 2009). Whether they utilise the Syk and 
CARD9 axis to produce IL-17 is currently unclear. Altogether, the production of IL-17 
from various cell sources might be an efficient manner to coordinate the immune 
responses to microbes. Whether the findings reported in this thesis represent an in vivo 
situation, particularly at mucosal sites, remains to be addressed. 
An important statement derived from this thesis is that some CLRs compensate for each 
other by engaging the same protein cascade, which generates a high degree of 
redundancy at the receptor level. Such is the case of Dectin-1 and Dectin-2 in the 
context of fungal recognition. Is it is known that Dectin-1 deficiency does not affect the 
development of Th17 responses during fungal infections (LeibundGut-Landmann et al., 
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2007). It is therefore conceivable that the coordination of more than one signalling CLR 
contribute to the initiation of Th17 responses to commensals or to pathogenic 
organisms. Thus, a relevant tool to continue the findings presented in this thesis will be 
to study the development of Th17 responses in CD11cCre x Syk fl/fl mice (named 
CD11cΔSyk mice and described in the appendix section). The Immunobiology 
Laboratory has recently obtained this strain of mice and my results indicate that Syk is 
specifically ablated in the CD11c compartment (See appendix figure 7.1). These mice 
might be a useful tool to dissect the contribution of Syk and CLR signalling by DCs in 
the initiation of adaptive Th17 cells, which was shown to be a MyD88, TRIF and RIP-2 
independent process (Atarashi et al., 2008, Ivanov et al., 2008, Ivanov et al., 2009). The 
contribution of Syk to the initiation of Th17 cells in the gut is a rather unexplored area 
that requires further investigation. 
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Figure 6-1:Proposed model of IL-17 production in vivo in response to Dectin-1 ligation. 
β‐(1,3)‐glucan derived from microbes can be sensed by Dectin‐1 expressing DCs, which may activate 3 adaptive sources of IL‐17. (1) Dectin‐1 activated DC prime a small fraction of naïve T cells via IL‐6 and IL‐23 and TGF‐β present in the environmental milieu (LeibundGut‐Landmann et al., 2007, Joffre et al., 2010). (2) Dectin‐1 activated DCs induce the production of IL‐17 from Foxp3+RORγt+ T cells present at mucosal sites. This process requires IL‐23 but might need additional factors such as IL‐2 in order to sustain and enhance Foxp3 expression and promote cell survival/expansion (Osorio et al., 2008). (3) Effector CD4+ T cells are IL‐23 responsive and could respond to Dectin‐1 activated DCs by producing IL‐17. IL‐17 produced by all these cell types might contribute to tissue repair mechanisms and homeostasis. (4) In addition to the adaptive sources of IL‐17, Dectin‐1 signalling can activate a subset of γδ T cells directly (Martin et al., 2009). Additional studies are required to demonstrate the contribution of CLR signalling to the development of IL‐17 producing cells in vivo. 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6.2 Dectin-2 is essential for the initiation of Th17 responses to 
C. albicans. 
Results presented in this thesis revealed that Dectin-2 is a second Syk-coupled CLR 
involved in fungal recognition by DCs and initiation of anti-fungal Th17 responses. 
Dectin-1 and Dectin-2 couple to the same innate signalling pathway and control the 
production of the cytokines IL-2, IL-10, TNF and IL-23 (Fig 5.5 to 5.7 and Figure 6.2). 
Furthermore, Dectin-2 is essential for the induction of Th17 cells during infection with 
C. albicans (Figure 5.8, (Robinson et al., 2009)). These findings have been confirmed in 
the recently generated Dectin-2 deficient mice, which do not generate Th17 responses to 
Candida and are susceptible to infection with the same organism (Saijo et al., 2010). 
Experiments presented in chapter 4 have opened new avenues for the study of fungal 
Syk-coupled CLRs. Many interesting questions remain unanswered. Dectin-2, in 
contrast to Dectin-1, is not redundant for the establishment of a Th17 response to 
systemic infection with C. albicans. This is an intriguing finding that suggests that there 
might subtle differences in the signalling requirements downstream of hemITAM or 
ITAM-coupled CLRs, which may result in differential immune outcomes. Saijo et al 
recently reported that Dectin-2 but not Dectin-1 deficient DCs fail to produce IL-23 to 
fungal stimulation (Saijo et al., 2010). Although these differences are not apparent in 
the experiments conducted in this thesis with a blocking anti-Dectin-2 antibody, it 
would be interesting to formally characterize the proximal signalling events 
downstream of hemITAM and ITAM-dependent CLRs. It has been recently shown that 
α-mannan derived from the C. albicans cell wall acts as an agonist for Dectin-2 (Saijo 
et al., 2010). If this molecule is further validated as a purified Dectin-2 agonist in the 
near future, it will become an important reagent for studying ITAM-coupled CLRs. 
Analysis of signalling protein cascades and gene transcription programs induced in 
response to Dectin-1 or Dectin-2 ligation will provide better insights in the 
understanding of C-type lectin receptor biology. 
Syk deficient DCs do not produce IL-2, IL-10 and TNF in response to fungal 
stimulation (Figure 4.2). Furthermore, our results clearly indicate that Dectin-1 and 
Dectin-2 are required for this process. An additional unanswered question derived from 
these studies is to identify what are the additional Syk-dependent aspects of CLR 
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ligation in DCs. As previously mentioned, IL-2, IL-10, TNF, IL-1β and IL-23 are 
probably a small fraction of the Syk-dependent signature induced by DCs in response to 
fungal challenge. One approach is to carry out a microarray-based genome-wide screen 
of WT and Syk deficient DCs stimulated with fungal particles. Additionally, MyD88-
TRIF doubly deficient DCs could be included in this analysis to distinguish the profile 
of genes expressed in absence of TLR signalling. Nonetheless, the fact that Syk controls 
cellular aspects at multiple levels including survival, proliferation, differentiation, 
cytokine production and cytoskeletal rearrangements among others indicate that a 
genetic profile will not provide a complete answer to this question. Syk activation in 
response to CLR ligation might also influence phagocytosis, migration, processing and 
presentation of fungal-derived antigens, and ROS production. Each one of these aspects 
requires a particular experimental setting. On-going work is examining these 
possibilities. 
 
Figure 6-2: In response to fungal recognition, Dectin-1 and Dectin-2 couple to Syk for activation of 
CARD9, NFAT and MAPK and production of the Syk dependent cytokines in DCs. Summary of the results obtained in Chapter 5 together with data from Dr Matthew Robinson (Immunobiology Laboratory, Cancer Research UK)(Robinson et al., 2009). Study of the signalling requirements downstream of hemITAM and ITAM coupled CLRs will provide better insights in the study of CLR biology. 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The experiments provided in this thesis together with those from another group 
elucidated the role of Dectin-2 in the generation of an anti-fungal Th17 response 
(Robinson et al., 2009, Saijo et al., 2010). As the Dectin-2 deficiency affected every 
Dectin-2 expressing cell in the organism, a caveat derived from those studies is that 
they do not allow addressing the relevance of Dectin-2-dependent signalling in DCs. To 
address the contribution of the CLR signalling in DCs to the generation of immune 
responses to fungi, infection studies in CD11cΔSyk mice will of vital relevance. This 
strain of mice could be subjected to systemic candidiasis, but perhaps more importantly, 
to the experimental model of oropharyngeal candidiasis (OPC) that is a model where 
adaptive T cells play a predominant role (Conti et al., 2009). We are currently trying to 
obtain the animal license to be able to establish this model in the Immunobiology 
Laboratory, and we are also collaborating with Dr Salomé LeibundGut-Landmann 
(ETH Zurich, Switzerland) to answer some of those questions. 
6.3 Syk signalling in the innate control of antifungal immunity. 
CARD9 deficient mice are much more susceptible to systemic candidiasis than Dectin-1 
or Dectin-2 deficient mice (Gross et al., 2006, Saijo et al., 2007, Taylor et al., 2007, 
Saijo et al., 2010), suggesting that these receptors might be redundant for early 
antifungal resistance to C. albicans. Indeed, our data indicate that even the absence of 
both Dectin-2 and Dectin-1 function does not recapitulate the phenotype observed in 
CARD9 knock out mice, which have significantly impaired innate resistance to C. 
albicans (Figure 4.9). An important question derived from these studies is to address 
whether Syk signalling in DCs accounts for the CARD9 dependent aspects of antifungal 
defense. Remarkably, results presented in the appendix section demonstrate that Syk 
kinase expressed by the CD11c compartment is necessary for the control of 
disseminated candidiasis (Figure 7.2, appendix). Due to the early stage of this project, 
these results do not constitute part of the thesis body. CD11cΔSyk mice succumb within 
5 days to systemic Candida infection and have large increases in fungal burden, 
resembling the phenotype observed in Card9-/- mice (Gross et al., 2006). Furthermore, 
heavy fungal colonisation and a high degree of tissue damage are detected in kidneys of 
CD11cΔSyk mice infected C. albicans (Figure 7.2, appendix). These results indicate 
that although Dectin-1 and Dectin-2 were redundant for antifungal resistance during the 
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first week of infection, absence of Syk in the CD11c compartment renders mice highly 
susceptible to systemic infection with the same organism. 
Thus, a single non-TLR innate signalling pathway in a defined population of cells is key 
for the establishment of antifungal immunity. Clearly, these are preliminary 
observations and much remains to be addressed. Syk signalling in CD11c+ cells might 
be involved in the regulation of many functions that could result in impaired antifungal 
immunity. Those aspects vary from the production of a soluble mediator involved in 
immune activation, to the production of components with direct antifungal activity (e.g. 
ROS) by CD11c-expressing cells. In addition, Syk insufficient CD11c+ cells might be 
less competent to phagocytose fungal pathogens at early time points, allowing fungal 
spread and invasion. An additional aspect that requires investigation is to demonstrate 
that the CD11c-expressing cell responsible for anti-Candida immunity is indeed a DC. 
CD11c is mainly expressed by conventional DCs but is also detected in a small subset 
of NK cells, macrophages and monocyte-derived DCs (Caton et al., 2007). 
Reconstitution of CD11cΔSyk mice with various types of wild type CD11c+ cells will 
permit the identification of the cell subset responsible for antifungal resistance. On-
going work is currently trying to address all those possibilities. 
Throughout this thesis, I have presented evidence demonstrating that the members of 
the CLR innate signalling pathway Dectin-1, Dectin-2 and Syk coordinate different 
levels of the anti-fungal immune response. Dectin-1 and Dectin-2 are expressed in DCs 
and are closely involved in the regulation of adaptive immunity to Candida. On the 
other hand, Syk decodes the information triggered by multiple PRRs and its functions 
within the CD11c compartment also encompass innate resistance to fungi. Altogether, 
results presented in this thesis underscore the relevance of this innate recognition 
system in the coordination of innate and adaptive immunity to fungi.
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Appendix  
Syk kinase in the CD11c compartment mediates antifungal 
immunity. 
Results presented in this section do not constitute an integral part of the thesis body. 
Nonetheless, I considered they are of relevance for a deep understanding of the role of 
Syk in the initiation of antifungal defense. These data should be considered as ‘work in 
progress’ as they belong to my current project in the laboratory. 
To address the relevance of Syk in DCs and its contribution to an antifungal immune 
response, the laboratory has crossed the strain of mice Syk fl/fl to mice carrying the 
CD11c Cre+ transgene, which is highly expressed in DCs (Caton et al., 2007). Sykfl/fl x 
CD11cCre+ mice will be referred to here as CD11cΔSyk mice whereas the littermates 
Sykfl/fl x CD11cCre- will be referred as wild type littermates. 
CD11cΔSyk mice have normal frequencies of DC subsets in the spleen (Figure 7.1a). In 
addition, no gross abnormalities have been detected in the CD4+, CD8+, NK1.1+, and 
B220+ populations in the spleen (data not shown). To verify deletion of Syk protein in 
the CD11c compartment, spleen DC subsets were enriched using CD11c beads 
(Miltenyi Biotec) and were subsequently sorted into CD11c+CD4+ (CD4+ DC), 
CD11c+CD8+ (CD8+ DC) and CD11c+CD4-CD8- (double-negative DC) subsets. The 
expression of Syk protein was assessed by Western blot. As a positive control, B220-
expressing B cells were isolated in the same experiment. Results are shown in figure 
7.1b. Whereas high levels of Syk protein are detected in the three main subsets of 
splenic DCs isolated from wild type littermates, Syk protein was drastically reduced in 
DC subsets isolated from CD11cΔSyk mice. This observation was less obvious in the 
double negative subset from CD11cΔSyk mice, which expressed low levels of the 
protein (Figure 7.1b). B220+ cells from wild type and CD11cΔSyk mice express similar 
levels of Syk indicating that Syk deletion is restricted to the CD11c compartment. To 
obtain a functional readout of Syk deficiency, GM-CSF-derived BMDC from WT and 
CD11cΔSyk mice were stimulated with curdlan, LPS and CpG and the production of 
the Syk dependent cytokines IL-2, IL-10 and TNF was analyzed. As expected, wild type 
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BMDCs produce large amounts of IL-2, IL-10 and TNF in response to curdlan 
stimulation. The production of IL-10 and TNF in response to the Dectin-1 agonist was 
abrogated in CD11cΔSyk BMDC indicating effective Syk deletion. Surprisingly, 
CD11cΔSyk and wild type BMDC stimulated with curdlan produced similar levels of 
IL-2. One reason accounting for this difference might be that Syk is not entirely deleted 
in GM-CSF cultures, which might affect IL-2 production particularly. Altogether, Syk 
protein is efficiently deleted from the CD11c compartment of CD11cΔSyk mice 
validating this strain as a good tool to study antifungal immunity. 
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Figure 7-1: Deletion efficiency in CD11cΔSyk mice. (a) CD11c enriched splenocytes from WT littermate and CD11cΔSyk were labelled with CD11c, CD8 and CD4 antibodies and analyzed by FACS. (b) Splenic DC subsets and B220 expressing cells from WT littermate and CD11cΔSyk were lysed and immunoblotted for total Syk. Syk protein levels are compared to β‐actin. (c) BMDC from WT littermate and CD11cΔSyk were stimulated o.n. with curdlan, LPS or CpG and cytokines were quantified by sandwich ELISA. 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CD11cΔSyk mice succumb to systemic C. albicans infection. 
Dectin-1 and Dectin-2 do not account for the CARD9 dependent aspects of antifungal 
innate immunity (chapter 5). One possibility is that additional Syk-CARD9 fungal 
PRRs expressed by additional cells including neutrophils, granulocytes and 
macrophages may be involved in early anti-fungal immunity. Another possibility is that 
Dectin-1 and Dectin-2 do not fully account for the Syk-dependent aspects in DCs. In 
fact, the contribution of DCs to innate resistance to fungal infection has not been 
addressed so far. To address whether Syk signalling in DCs contributes to early 
resistance to disseminated candidiasis, we infected CD11cΔSyk mice and wild type 
littermates with 5x104 C. albicans i.v. and compared their susceptibility to infection 
(Figure 7.2). Surprisingly, all CD11cΔSyk mice reached the end point within 5-6 days 
of infection whereas most wild type counterparts survived. Data from 2 independent 
experiments is depicted in figure 7.2a. Higher fungal burden was found in kidney, lung 
and liver from CD11cΔSyk mice compared to wild type littermates (Figure 7.2b). This 
phenotype is highly reminiscent to that observed in CARD9 knock out mice (Gross et 
al., 2006). The Histopathology Laboratory at Cancer Research UK performed 
histological analysis of kidneys from infected mice. Periodic acid Schiff staining (PAS) 
was used to detect C. albicans and Hematoxylin and Eosin (H&E) staining was used to 
detect leukocyte infiltration. Kidneys from infected CD11cΔSyk mice showed heavy 
fungal abscesses localized to the cortical zone that were accompanied by enhanced 
leukocyte infiltration (Figure 7.2c, see PAS and H&E). In contrast, kidneys from wild 
type counterparts were largely free of hyphae and when pathogen was found, it was 
completely restricted to the urinary tract (data not shown). Data in Figure 7.2d shows a 
high degree of hyphal infiltration and tissue disruption in infected CD11cΔSyk mice. 
Collectively these data indicates that Syk kinase in the CD11c compartment is strictly 
required for innate antifungal immunity. 
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Figure 7-2: CD11c Syk mice show defective anti-fungal immunity. (a) WT (Sykfl/fl x CD11cCre‐) and CD11cΔSyk (Sykfl/fl x CD11cCre+) mice were infected with 5x104 C. 
albicans i.v. Mice were monitored on a daily basis for survival. (b) Kidney fungal burden from mice in (a) was quantified. The data are pooled from 2 independent experiments depicted in (a) (**, 0.001< P<0.01)(c­d) histological analysis of kidneys of C. albicans‐infected mice on day 4 (CD11cΔSyk) or day 6 (WT). Histology is representative of 5 CD11cΔSyk mice and 3 WT mice. White bars indicate 500µm (c) or 100µm(d). 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The sensing of pathogens by innate immune 
cells is mediated by germline-encoded pattern 
recognition receptors (PRRs) that recognize 
pathogen-associated molecular patterns (PAMPs; 
Janeway, 1989). Although some PRRs may be 
involved primarily in phagocytic clearance of 
invading organisms, others engage a plethora of 
signaling pathways that lead to the expression 
of genes that encode chemokines, cytokines, and 
other mediators of innate immune responses to 
infection. In addition, PRR signaling in DCs 
renders them competent to prime T cells, 
thereby initiating adaptive immunity (Reis e 
Sousa, 2004). Established families of PRRs reg-
ulating both innate and adaptive immunity in-
clude the Toll-like receptors (TLRs), NOD-like 
receptors (NLRs), and RIG-I–like receptors 
(RLRs; Akira et al., 2006; Lee and Kim, 2007; 
Pichlmair and Reis e Sousa, 2007). However, 
recent work by us and others has indicated that 
Dectin-1 and related members of the C-type 
lectin receptor (CLR) family may also function 
as PRRs that can signal to regulate immunity 
(Brown, 2006; Robinson et al., 2006).
Dectin-1 is expressed primarily by neutro-
phils, macrophages, and DCs, and recognizes 
-glucans present in cell walls of fungi and 
some bacteria (Brown and Gordon, 2001; 
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Innate immune cells detect pathogens via pattern recognition receptors (PRRs), which 
signal for initiation of immune responses to infection. Studies with Dectin-1, a PRR for 
fungi, have defined a novel innate signaling pathway involving Syk kinase and the adaptor 
CARD9, which is critical for inducing Th17 responses to fungal infection. We show that 
another C-type lectin, Dectin-2, also signals via Syk and CARD9, and contributes to den-
dritic cell (DC) activation by fungal particles. Unlike Dectin-1, Dectin-2 couples to Syk 
indirectly, through association with the FcR chain. In a model of Candida albicans infec-
tion, blockade of Dectin-2 did not affect innate immune resistance but abrogated Candida-
specific T cell production of IL-17 and, in combination with the absence of Dectin-1, 
decreased Th1 responses to the organism. Thus, Dectin-2 constitutes a major fungal PRR 
that can couple to the Syk–CARD9 innate signaling pathway to activate DCs and regulate 
adaptive immune responses to fungal infection.
© 2009 Robinson et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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activating this signaling pathway could regulate DC-dependent 
Th17 responses to fungal infection.
Dectin-2 is a type II transmembrane CLR that was origi-
nally cloned from a DC line (Ariizumi et al., 2000a) but is 
most abundantly expressed on tissue macrophages and in-
flammatory monocytes and has specificity for high mannose 
structures (Taylor et al., 2005; McGreal et al., 2006). Dectin-2 
lacks any obvious signaling motif within its short cytoplasmic 
domain and, despite its name, is only 20–25% homologous 
to Dectin-1 (Ariizumi et al., 2000a). Nevertheless, like 
Dectin-1, Dectin-2 can bind to zymosan and to many fungi, 
including C. albicans, Cryptococcus neoformans, Histoplasma cap-
sulatum, Microsporum audouinii, and Trichophyton rubrum, dis-
playing a preference for the hyphal form over yeast (McGreal 
et al., 2006; Sato et al., 2006). Notably, Dectin-2 can associ-
ate with the immunoreceptor tyrosine-based activation motif 
(ITAM)–bearing FcR chain (Sato et al., 2006; Barrett et al., 
2009), and Dectin-2–transfected macrophages respond to 
hyphal stimulation with protein tyrosine phosphorylation, 
NF-B activation, and secretion of TNF and IL-1ra (Sato 
et al., 2006). Whether this reflects signaling by Dectin-2 or is 
a consequence of fungal binding allowing engagement of 
other signaling receptors has not been explored (Sato et al., 
2006) but led us to hypothesize that Dectin-2 might substi-
tute for Dectin-1 in activating Syk and CARD9 in DCs in 
response to fungal presence.
In this paper, we demonstrate that Dectin-2, together with 
Dectin-1, explains most of the Syk- and CARD9-dependence 
of DC responses to fungal stimuli. We show that triggering of 
endogenous Dectin-2 in DCs activates Syk and the MAPK 
cascades, and leads to CARD9- and Syk-dependent cytokine 
production. Furthermore, by blocking Dectin-2 in vivo, we 
identify a role for this CLR in the induction of adaptive 
immune responses, particularly Th17, in a model of systemic 
C. albicans infection. These results not only confirm Dectin-2 
as a PRR for fungi but also describe it as another Syk-coupled 
myeloid CLR involved in regulating DC function and the 
nature of the adaptive immune response to fungal infection.
RESULTS
Induction of IL-2, IL-10, and TNF by fungal stimuli in DCs  
is dependent on Syk but not on Dectin-1
In previous studies using DCs stimulated with zymosan, we 
found that production of IL-10 and IL-2 but not production 
of IL-12/23 p40 depends on Syk (Rogers et al., 2005). 
In more recent experiments, we have found that zymosan- 
induced production of TNF is also Syk dependent and inde-
pendent of MyD88 and TRIF, two adaptors essential for TLR 
signaling (Fig. S1 A). To extend those studies to a potential 
fungal pathogen, we compared the response of GM-CSF– 
cultured bone marrow–derived DCs (BMDCs) to different 
preparations of C. albicans (Fig. S2 A). As for zymosan, both 
live and heat-killed yeast and hyphal forms of C. albicans 
elicited production of IL-2, IL-10, and TNF by BMDCs. 
Production of these cytokines was not greatly affected by the 
antifungal agents used to prevent overgrowth in cultures with 
Dennehy and Brown, 2007). The intracellular tail of Dec-
tin-1 contains a single YxxL motif, termed a hemITAM, 
that is able to recruit and activate Syk upon engagement by 
agonist ligands (Rogers et al., 2005; Underhill et al., 2005). 
Dectin-1 coupling to Syk leads to downstream activation of 
MAPKs, NFAT, and, via the adaptor CARD9, NF-B, 
which coordinate the transcription of innate response genes 
(Gross et al., 2006; Goodridge et al., 2007; LeibundGut-
Landmann et al., 2007). In DCs, the pattern of cytokines 
triggered by selective Dectin-1 engagement is somewhat 
different from that induced by agonists of TLR, RLR, or 
NLR pathways, and is typified by robust induction of 
proinflammatory cytokines such as TNF, IL-6, and IL-23 
accompanied by high levels of IL-2 and IL-10 (LeibundGut-
Landmann et al., 2007). Consistent with its stimulatory ef-
fects on DCs, a Dectin-1 agonist acts as an adjuvant in vivo 
to induce adaptive immune responses against a coadminis-
tered model antigen, resulting in induction of antigen- 
specific Th1 and Th17 cells, as well as CTL and antibody 
responses (LeibundGut-Landmann et al., 2007; LeibundGut-
Landmann et al., 2008). In addition, Dectin-1–activated 
DCs are able to convert regulatory T cells into IL-17 pro-
ducers (Osorio et al., 2008). In view of its immunomodula-
tory activities, Dectin-1 is therefore thought to modulate 
both the innate and adaptive responses to fungal infection. 
In line with this notion, Dectin-1–deficient mice display 
increased susceptibility to Candida albicans and Pneumocystis 
carinii infection in some models (Saijo et al., 2007; Taylor 
et al., 2007).
Innate immune cells express many receptors that can po-
tentially recognize fungi, including TLR-2, TLR-4, Dectin-2, 
mannose receptor, DC-SIGN, SIGN-R1, and Mincle 
(Netea et al., 2008; Willment and Brown, 2008). Although 
many of these receptors signal independently of Syk, Syk-
deficient DCs fail to produce IL-2 and IL-10 upon stimula-
tion with zymosan, a heat-killed and trypsinized preparation 
of Saccharomyces cerevisiae (Rogers et al., 2005). This would be 
consistent with a dominant role for Dectin-1 in DC responses 
to fungi, as we have observed in macrophages (Taylor et al., 
2007). However, surprisingly, Dectin-1–deficient DCs dis-
play only a mild impairment in their ability to produce the 
same two cytokines in response to zymosan (LeibundGut-
Landmann et al., 2007; Saijo et al., 2007; Taylor et al., 2007). 
Along the same lines, Card9/ mice appear to be much 
more susceptible to infection by C. albicans (Gross et al., 
2008) than Dectin-1–deficient mice (Saijo et al., 2007; Taylor 
et al., 2007). In addition, CARD9-deficient mice fail to 
mount a Candida-specific Th17 response, yet this response is 
preserved in mice lacking Dectin-1 (LeibundGut-Landmann 
et al., 2007). Finally, a recent paper suggests that the man-
nose receptor contributes to human Th17 responses to 
C. albicans (van de Veerdonk et al., 2009), although there is as 
yet no evidence linking that receptor to the Syk–CARD9 
pathway. Collectively, these different observations imply 
that Dectin-1 is not the only Syk–CARD9–coupled fungal 
PRR in DCs and suggest that multiple receptors capable of 
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yeast form of C. albicans, especially when the organisms were 
subjected to heat inactivation (Fig. 1). The latter also unmasked 
a MyD88/TRIF dependence for IL-2 induction, which was 
not seen with live organisms (Fig. 1, A and B). The dual 
dependence of IL-2 on Syk and MyD88/TRIF pathways has 
been previously noted for zymosan (Rogers et al., 2005), and 
may reflect denaturation of some PAMPs and exposure of 
others during the heat inactivation process (Gantner et al., 2005). 
Consistent with PAMPs being altered by boiling, the MyD88/
TRIF adaptors contributed partially to TNF induction by live 
but not heat-inactivated C. albicans (Fig. 1). IL-10 remained 
live C. albicans, although slight variations between samples 
treated with fungizone and with caspofungin were noted 
(Fig. 1 and Fig. S2 B). However, none of the antifungal agents 
stimulated cytokine production on their own or altered the 
response to curdlan, a selective Dectin-1 agonist (Fig. S2 B). 
Notably, IL-2, IL-10, and TNF were strictly dependent on 
Syk whether live or heat-killed organisms were used (Fig. 1). 
In contrast, the production of IL-12/23 p40 and IL-6 was de-
pendent on MyD88/TRIF adaptors and largely independent 
of Syk (not depicted). Interestingly, the three Syk-dependent 
cytokines were more strongly induced by the hyphal than the 
Figure 1. The contribution of Syk and TLR signaling to cytokine induction by C. albicans. (A) BMDCs from C57BL/6 wild-type (WT, black 
bars), Myd88//Trif / (MyD88/TRIF DKO, white bars), or Syk/ chimeric (Syk KO, gray bars) mice were stimulated with 105 live C. albicans yeast or 
hyphae. Fungizone was added 2 h later, and cytokine levels in the supernatants were measured after overnight incubation. (B) BMDCs as in A were 
stimulated overnight with 105 or 5 × 105 heat-killed C. albicans. Data are means ± SD of duplicate wells and are representative of at least three inde-
pendent experiments. ND, not detectable.
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deficient in MyD88 and TRIF (Fig. 3 B). We therefore ex-
plored the notion that Dectin-2 might signal via the Syk–
CARD9 pathway. Consistent with that hypothesis, Dectin-2 
cross-linking completely failed to induce IL-2, IL-10, and 
TNF from Syk- or CARD9-deficient BMDCs (Fig. 3, C and D) 
despite the fact that those cells expressed normal levels of 
Dectin-2 and responded normally to stimulation with TLR 
agonists (not depicted). We conclude that triggering of en-
dogenous Dectin-2 in DCs is sufficient to activate Syk and 
downstream signaling pathways in DCs, leading to TLR-
independent production of cytokines.
largely MyD88/TRIF independent regardless of the fungal 
stimulus (Fig. 1), consistent with our data using zymosan 
(Rogers et al., 2005). We conclude that, independently of 
possible contributions from TLR pathways, IL-2, IL-10, and 
TNF production by BMDCs in response to fungal stimuli re-
quires signaling via Syk and can be used to monitor the activity 
of Syk-coupled PRRs for fungi that are expressed on DCs.
Dectin-1 can trigger the production of IL-2, IL-10, and 
TNF upon engagement by agonistic -glucans (Yoshitomi 
et al., 2005; LeibundGut-Landmann et al., 2007), so we next 
analyzed whether the Syk-dependent responses were attrib-
utable to Dectin-1. Compared with wild-type cells, Dectin-1–
deficient BMDCs produced similar levels of IL-2, IL-10, 
and TNF in response to heat-killed (Fig. 2) or live C. albicans 
(not depicted). Similarly, in response to zymosan, the induc-
tion of the Syk-dependent cytokines was only marginally re-
duced by Dectin-1 deficiency (Fig. S1 B). This is consistent 
with previous observations made in DCs (LeibundGut-
Landmann et al., 2007; Saijo et al., 2007; Taylor et al., 2007) 
but, interestingly, contrasts with data indicating that in macro-
phages induction of TNF by zymosan and Candida is pre-
dominantly mediated by Dectin-1 (LeibundGut-Landmann 
et al., 2007; Saijo et al., 2007; Taylor et al., 2007). The near 
complete Syk dependence and the relative Dectin-1 inde-
pendence of TNF, IL-2, and IL-10 responses to fungal stim-
uli suggests the existence of additional Syk-coupled fungal 
PRRs in DCs that remain active in triggering this signaling 
pathway in the absence of Dectin-1.
Dectin-2 is a Syk-coupled receptor in DCs
Dectin-2 is capable of binding both C. albicans and zymosan 
(McGreal et al., 2006) and could therefore potentially act as a 
PRR for fungi. Despite previous reports of limited expression 
of Dectin-2 on DCs (Taylor et al., 2005; Carter et al., 2006), 
using a more sensitive detection method we found surface 
expression by the CD4+, CD8+, and double-negative subsets 
of splenic DCs (Fig. S3 A). As reported recently (Barrett et al., 
2009), BMDCs also expressed Dectin-2 (Fig. S3 B). This 
broad expression of Dectin-2 on conventional DCs is similar 
to that of Dectin-1 (Fig. S5 C; LeibundGut-Landmann et al., 
2007; Saijo et al., 2007; Taylor et al., 2007). Next, we cul-
tured BMDCs with anti–Dectin-2 immobilized on plastic to 
assess whether selective stimulation through Dectin-2 alone 
was sufficient to promote DC activation. F(ab)2 preparations 
of secondary antibody and Fab preparations of anti–Dectin-2 
were used to avoid Fc receptor engagement, but in all cases, 
similar data were obtained with intact antibodies (unpub-
lished data). Contact of DCs with the anti–Dectin-2 surfaces 
induced phosphorylation of Syk and of ERK, p38, and JNK 
MAPKs, whereas no increase above basal phosphorylation 
was observed with control antibodies (Fig. 3 A). In addition, 
overnight stimulation with plated anti–Dectin-2 induced ac-
cumulation of high levels of IL-2, IL-10, and TNF in culture 
supernatants (Fig. 3, B–D). This was not caused by contami-
nation of the Fab/F(ab)2 preparations with TLR agonists, 
because a similar response was observed with BMDCs doubly 
Figure 2. The contribution of Dectin-1 to cytokine induction by  
C. albicans. BMDCs from C57BL/6 wild-type (WT, black bars) or Clec7a/ 
chimeric (Dectin-1 KO, gray bars) mice were stimulated overnight with 
105 or 5 × 105 heat-killed C. albicans yeast or hyphae. Data are means ± 
SD of duplicate wells and are representative of at least three independent 
experiments. ND, not detectable.
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Figure 3. Syk- and CARD9-dependent activation of DCs by Dectin-2. (A) Activation of Syk and MAPK cascades by plated anti–Dectin-2. C57BL/6 
BMDCs were centrifuged onto wells coated with anti–Dectin-2 Fab or control Fab. After the indicated times, the cells were lysed and immunoblotted for active 
(phosphorylated) and total Syk, p38, ERK, or JNK. (B) Wild-type C57BL/6 (WT, gray bars) or Myd88//Trif/ (MyD88/TRIF DKO, white bars) BMDCs were stim-
ulated overnight with anti–Dectin-2 or control Fab as in A, and cytokines levels in the supernatants were measured. (C and D) BMDCs from Syk/ chimeric 
(Syk KO, white bars; C) and Card9/ (Card9 KO, white bars; D) mice were stimulated as in B, and cytokine levels were compared with those made by WT cells 
(gray bars). Representatives of at least three independent experiments are shown. Cytokine data are means ± SD of duplicate wells. ND, not detectable.
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Dectin-2 signals through association with FcR chain
Unlike Dectin-1, Dectin-2 does not have an intracellular 
hemITAM motif that would allow it to couple directly to 
Syk. However, exogenously expressed Dectin-2 in myeloid 
cells coimunoprecipitates with the ITAM-bearing  chain of 
the Fc receptor (Sato et al., 2006), and its surface expression is 
increased by FcR cotransfection (Barrett et al., 2009). To 
analyze the interaction between Dectin-2 and possible signal-
ing adaptors, including FcR chain, DAP-10, or DAP-12, we 
used B3Z T hybridoma cells, which express a -galactosidase 
NFAT reporter of ITAM signaling (Karttunen et al., 1992). 
Dectin-2–transduced B3Z cells expressed modest amounts of 
receptor at the cell surface that were not significantly increased 
by previous transduction with DAP-10 or DAP-12 (Fig. 4 A). 
However, in B3Z cells coexpressing FcR chain, cell-surface 
staining of Dectin-2 was greatly enhanced (Fig. 4 A). This in-
crease in surface expression conferred the ability to bind fluo-
rescent zymosan, which was not detectable in the other B3Z 
cell lines (Fig. 4 A). To analyze whether endogenous Dectin-2 
expression similarly required FcR chain, BMDCs from wild-
type and FcR chain–deficient mice were analyzed. Surface 
expression of Dectin-2 was not detectable on FcR chain– 
deficient BMDCs (Fig. 4 B), which also failed to respond to 
plated anti–Dectin-2 Fab stimulation (Fig. S4). Collectively, 
these results demonstrate that association with FcR chain is 
necessary for functional surface expression of Dectin-2.
To analyze the ability of FcR chain to mediate Dectin-2 
signaling, we stimulated B3Z cells with zymosan and mea-
sured activation of the NFAT reporter. Reporter activity was 
seen in B3Z cells cotransduced with Dectin-2 and FcR 
chain but not in B3Z cells expressing either protein alone 
(Fig. 4 C). To dissect the role of the ITAM motif of FcR 
chain on Dectin-2 signaling, we mutated the two key tyro-
sines to phenylalanines. The double tyrosine mutation did 
not impair the ability of FcR chain to promote Dectin-2 
cell-surface expression or zymosan binding (Fig. S5). How-
ever, B3Z cells expressing the mutant FcR chain and Dectin-2 
were unable to signal in response to zymosan, as determined 
by induction of the NFAT reporter (Fig. 4 C). We conclude 
that the ITAM motif of the FcR chain mediates signaling 
by Dectin-2.
Induction of Syk-dependent cytokines by fungal stimuli 
requires Dectin-1 and -2
These results suggested that, through its association with FcR 
chain, Dectin-2 might potentially function as a Syk-coupled 
PRR and contribute, in conjunction with Dectin-1, to Syk–
CARD9–dependent DC activation by fungal stimuli. To test 
this hypothesis, we compared fungal stimulation of Dectin-1–
sufficient and –deficient BMDCs with or without Dectin-2 
function. As has been observed for many antibodies against 
other ITAM-coupled receptors, anti–Dectin-2 did not trigger 
activation unless immobilized on plastic or beads (unpublished 
data). Instead, in solution, the mAb caused down-regulation 
of Dectin-2 and could consequently be used as a blocking re-
agent (unpublished data). Therefore, we treated BMDCs with 
anti–Dectin-2 or an isotype-matched irrelevant antibody con-
trol for 2 h before stimulation with zymosan. As with loss of 
Dectin-1, down-regulation of Dectin-2 in wild-type DCs only 
modestly reduced the levels of IL-2, IL-10, or TNF produced 
in response to zymosan (Fig. 5, A and B). However, blockade 
of Dectin-2 in Dectin-1–deficient BMDCs led to a profound 
reduction in the same cytokines (Fig. 5, A and B), approaching 
the decrease observed in Syk-deficient cells (Fig. S1 A; Rogers 
et al., 2005). Similar results were obtained using live C. albicans: 
blockade of Dectin-2 in wild-type BMDCs or genetic loss 
of Dectin-1 led to modest and variable reductions in the levels 
of IL-2 and IL-10, but blockade of Dectin-2 in Dectin-1–
deficient BMDCs caused an almost complete loss in pro-
duction of all three Syk-dependent cytokines (Fig. 6 A). The 
exception was TNF, which was only partially dependent on 
the two CLRs (Fig. 6 A), possibly reflecting the TLR contri-
bution noted in Fig. 1 A. Induction of IL-2, IL-10, and TNF 
by heat-killed C. albicans was mediated by Dectin-1 and -2, as 
seen with zymosan. We also analyzed the induction of IL-12 
and IL-23 and found that IL-12 p35 mRNA was at the limit 
of detection (unpublished data), whereas IL-23p19 mRNA 
was elicited by Candida stimulation in a manner dually depen-
dent on Dectin-1 and -2 (Fig. S6). To verify the contribution 
of Dectin-2 by an independent means, we used short hairpin 
RNA (shRNA) to knock down Dectin-2 expression (Barrett 
et al., 2009). Infection of BMDCs with a lentivirus encoding 
Dectin-2 shRNA but not with a lentivirus encoding a scram-
bled control insert reduced the surface expression of Dectin-2 
by >50% as determined by flow cytometry (not depicted). 
Notably, knockdown of Dectin-2 in Dectin-1–deficient cells 
almost completely prevented the induction of IL-2, IL-10, and 
TNF by heat-killed C. albicans (Fig. 6 C). These results suggest 
that signaling by Dectin-1 and -2 together could account for 
the Syk–CARD9 dependence of DC activation by fungi.
In addition to the loss of Syk-dependent cytokines, we 
noted that binding of fluorescent zymosan was markedly de-
creased when Dectin-2 function was blocked in Dectin-1–
deficient BMDCs (Fig. S7). These results indicate that the 
primary binding receptors for zymosan on DCs are Dectin-1 
and -2. At the same time, they raise a caveat with the inter-
pretation that Syk-dependent DC activation is caused by 
signals propagated by Dectin-1 and -2 because the loss 
of cytokines seen with Dectin-2 blockade in Dectin-1–
deficient cells could, at least in principle, be caused by lack of 
binding of fungal particles, which would then prevent trig-
gering of any other Syk-coupled receptors. To address this 
possibility, we transduced Dectin-1–deficient BMDCs with 
a Y15F mutant form of Dectin-1 that allows restoration of 
zymosan binding without Syk signaling (Rogers et al., 2005). 
The transduced cells bound zymosan even more avidly than 
wild-type controls, and in this setting, the binding was 
only marginally decreased by Dectin-2 blockade (Fig. S7). 
Yet, production of IL-2, IL-10, and TNF was profoundly 
compromised by the same Dectin-2 blockade (Fig. 5 B). In-
deed, anti–Dectin-2 blocked cytokine production by Y15F-
transduced cells to the same extent as in Dectin-1–deficient 
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by signals propagated by these receptors and not just by their 
ability to mediate binding of fungal particles.
Dectin-2 and -1 direct the Th cell response  
to fungal infection
In light of our in vitro results with DCs, we assessed the contri-
bution of Dectin-2 to adaptive immunity to Candida infection 
mock-transduced cells (Fig. 5 B). Thus, anti–Dectin-2 nearly 
completely blocks Syk-dependent cytokine responses in a 
condition in which Dectin-1 is unable to signal but pro-
motes a high degree of binding of fungal particles. This, in 
turn, argues against a major contribution from other signal-
ing receptors and indicates that the requirement for Dectin-1 
and -2 in Syk-dependent DC activation by fungi is caused 
Figure 4. Dectin-2 requires FcR chain for surface expression and signaling. (A) B3Z cells (No Adaptor) or sublines derived by transduction with 
DAP-10, DAP-12, or FcR chain were subsequently transduced with Dectin-2–IRES–EGFP. (top) Anti–Dectin-2 staining of GFP-positive parental, DAP-10, 
DAP-12, or FcR chain (open histogram) cell lines compared with isotype control (shaded histogram). (bottom) Cy5-zymosan binding to the same cell lines. 
(B) BMDCs from C57BL/6 (WT) or Fcer1g/ (FcR chain KO) mice stained with anti–Dectin-2 (open histogram) or an isotype-matched control mAb (shaded 
histogram). (C) B3Z cells expressing Dectin-2, wild-type FcR chain (FcR (WT)), Dectin-2 and FcR chain (Dectin-2 + FcR (WT)), or Dectin-2 and a signal-
ing-deficient mutant of FcR chain (Dectin-2 + FcR (YY/FF)) were stimulated with or without 100 µg/ml zymosan. NFAT activity was measured using a 
-galactosidase reporter. Data are means ± SD of duplicate wells (C), and are representative of two (C) or at least three (A and B) independent experiments.
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used for restimulation (Fig. S8 A), which indicates that, in 
this model, Dectin-2 is required for driving the Th17 response 
to the organism. In contrast, little effect of Dectin-2 blockade 
was apparent on the Th1 response to the same pathogen, 
although when anti–Dectin-2 was used in combination with 
Dectin-1 deficiency, a statistically significant decrease in IFN- 
production was observed in cells restimulated with the lower 
but not the higher dose of heat-killed C. albicans (Fig. 7 and 
Fig. S8 A). Splenocytes from Dectin-1–deficient mice given 
isotype-matched control mAb produced similar levels of IFN- 
and IL-17 upon restimulation as similarly treated wild-type 
animals (Fig. 7 and Fig. S8 A), consistent with previous data 
(LeibundGut-Landmann et al., 2007). Therefore, Dectin-2 
in vivo. As seen in vitro, anti–Dectin-2 antibody was able to 
promote clearance of Dectin-2 from the cell surface of DCs in 
vivo (unpublished data). Wild-type and Dectin-1–deficient 
mice were therefore injected with the mAb 6 h before and 2 
and 4 d after systemic infection with a sublethal dose of C. albi-
cans and were compared with mice injected with an isotype-
matched irrelevant control mAb. Th1 and Th17 responses 
were monitored by measuring IFN- and IL-17, respectively, 
after restimulation of splenocytes with heat-killed C. albicans 
for 2 d (LeibundGut-Landmann et al., 2007). Remarkably, the 
Th17 response to C. albicans was markedly reduced in mice 
treated with anti–Dectin-2, independent of Dectin-1 defi-
ciency (Fig. 7). This was seen even at a higher dose of C. albicans 
Figure 5. Dectin-1 and -2 mediate Syk-dependent responses to zymosan. (A) BMDCs from wild-type C57BL/6 (WT) or Clec7a/ chimeric (Dectin-1 
KO) mice were treated with 10 µg/ml anti–Dectin-2 or isotype-matched control mAb for 2 h before stimulation with increasing doses of zymosan overnight. 
(B) BMDCs from Clec7a/ chimeric mice were transduced with signaling-deficient Dectin-1 (Dectin-1 KO + Dectin-1 (Y15F)) or mock transduced (Dectin-1 
KO). These cells, as well as mock-transduced C57BL/6 BMDCs (WT) were then stimulated overnight with 33 µg/ml zymosan. Cytokines in the supernatants 
were quantified by ELISA. Data are means ± SD of duplicate wells and are representative of at least three independent experiments. ND, not detectable.
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sufficiency or deficiency (Fig. S8 C). Therefore, in this model 
of systemic disease, Dectin-2 blockade does not impair resis-
tance, and Dectin-2 may therefore be redundant for innate 
immunity to C. albicans infection.
DISCUSSION
In the broadest sense of the term, PRRs include all receptors 
that detect PAMPs (Janeway, 1989). However, a subset of 
PRRs possesses the ability to trigger intracellular signaling 
pathways that lead to expression of innate response genes, in-
cluding those encoding chemokines and cytokines. These 
types of PRRs play a key role in orchestrating the innate and 
adaptive immune responses to infection, and have previously 
is required for Th17 responses to Candida and, with Dectin-1, 
contributes to Th1 cell differentiation in response to the 
same organism.
Dectin-2 blockade does not impair innate resistance  
to C. albicans infection
Despite the marked impact of Dectin-2 blockade on Th17 
responses to C. albicans, mice receiving anti–Dectin-2 showed 
similar kidney fungal burdens at day 7 after infection as mice 
receiving isotype-matched control antibody (Fig. S8 B). This 
was true even in mice deficient for Dectin-1 (Fig. S8 B). In 
addition, weight loss during the course of infection was also 
not affected by Dectin-2 blockade independently of Dectin-1 
Figure 6. Dectin-1 and -2 mediate Syk-dependent responses to C. albicans. (A) BMDCs from wild-type C57BL/6 (WT) or Clec7a/ chimeric (Dec-
tin-1 KO) mice were treated with 10 µg/ml anti–Dectin-2 or isotype control for 2 h before stimulation with 105 live C. albicans yeast or hyphae. Fungizone 
was added 2 h after stimulation, and the cytokines levels in the supernatants were measured after overnight incubation. (B) BMDCs pretreated with mAbs 
as in A were stimulated overnight with 105 or 5 × 105 heat-killed C. albicans. (C) BMDCs from wild-type 129/Sv (WT) or Clec7a/ (Dectin-1 KO) mice were 
infected with lentivirus encoding Dectin-2 shRNA or a scrambled control. After puromycin selection, cells were stimulated overnight with 105 heat-killed 
C. albicans. Data are means ± SD of duplicate wells and are representative of at least three (A and B) or two (C) independent experiments. ND, not detectable.
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2003; Taylor et al., 2004; Cambi et al., 2008). Dectin-2 may 
fall in the same group, although competition studies suggest 
that the molecular pattern recognized by Dectin-2 is distinct 
from that bound by SIGNR-1 and mannose receptor 
(McGreal et al., 2006). Thus, different receptors may sense 
different forms of mannan, which could be differentially ex-
pressed during the fungal life cycle. Indeed, Sato et al. (2006) 
have shown that Dectin-2 preferentially binds the hyphal 
form of C. albicans and suggested that the ligand may not be 
expressed or could be concealed in the yeast form. Our 
results, however, show that, although hyphae induce the 
Dectin-1/2–dependent cytokines more strongly than yeasts, 
Dectin-2 is also involved in the sensing of the latter. Consis-
tent with the notion that Dectin-2 can act as a yeast recep-
tor, we have previously reported that the recombinant 
C-type lectin domain of Dectin-2 binds to zymosan and to 
the yeast form of C. albicans (McGreal et al., 2006). Finally, 
the PAMPs recognized by Dectin-2 may not be restricted to 
fungi, as this receptor appears to play a role in the response 
to house dust mite allergens (Barrett et al., 2009) and the ex-
tracellular domain of Dectin-2 is capable of binding bacterial 
polysaccharides (McGreal et al., 2006).
Stimulation through Dectin-2 defines a new mechanism 
for DC activation by a PRR. We show that Dectin-2 
requires association with the FcR chain to be expressed on 
the surface of cells but, more critically, we provide evidence 
that the ITAM of this adaptor is required for signaling. Cross-
linking of Dectin-2 triggered the activation of Syk and the 
MAPK cascades, leading to cytokine production. The latter 
process was dependent on CARD9, the adaptor necessary for 
induction of NF-B downstream of Dectin-1 and other 
ITAM-signaling myeloid receptors (Gross et al., 2006; Hara 
et al., 2008). However, in contrast to Dectin-1 that binds Syk 
directly, Dectin-2 couples to Syk in trans, through association 
been described as belonging to the TLR, RLR, and NLR 
families. The C-type lectin Dectin-1 constituted a notable 
exception, as it is not a member of any of these families yet it 
is able to induce immunity via a Syk and CARD9-dependent 
pathway. In this study, we identify Dectin-2 as an additional 
Syk–CARD9–coupled C-type lectin that mediates DC acti-
vation by fungi. Notably, we show that Dectin-2 accounts 
for the seemingly paradoxical Syk- and CARD9-dependent 
yet Dectin-1–independent aspects of DC activation by fungal 
stimuli. This is in contrast to most macrophages that respond 
to C. albicans primarily through Dectin-1 (Taylor et al., 2007) 
and to some types of DCs that may rely primarily on TLR 
signaling via TRIF to respond to the same organism (De Luca 
et al., 2007). The importance of Dectin-2 in DC function 
is underscored by the fact that in vivo blockade of Dectin-2 
severely reduces Th17 responses to C. albicans infection 
and, in the context of Dectin-1 deficiency, affects Th1 
immunity to the same organism. Thus, Dectin-2 constitutes 
a major receptor regulating T cell responses to fungi by engag-
ing the Syk–CARD9 pathway in DCs.
The fungal PAMP recognized by Dectin-2 has not been 
fully identified. The C-type lectin domain of Dectin-2, un-
like that of Dectin-1, possesses a classical carbohydrate rec-
ognition site that coordinates Ca2+ and specifically recognizes 
high mannose structures (McGreal et al., 2006). Binding of 
this domain to zymosan is blocked by mannose, fucose, or 
mannan, suggesting that the yeast ligand is probably a high-
mannose–like structure such as mannan (McGreal et al., 2006). 
Both O- and N-linked yeast mannans possess immuno-
stimulatory properties, and the activity of the former has 
been ascribed to its ability to engage TLR4 (Netea et al., 2006). 
In contrast, many innate receptors, including SIGNR-1, 
DC-SIGN, mannose receptor, and TLR2, have been pro-
posed to bind structures within N-mannan (Jouault et al., 
Figure 7. Dectin-1 and -2 are required during systemic C. albicans infection for subsequent splenocyte recall responses. Wild-type 129/Sv 
(WT) or Clec7a/ (Dectin-1 KO) mice were given anti–Dectin-2 or isotype-matched control mAb intraperitoneally before and after i.v. C. albicans infec-
tion. After 7 d, splenocytes were restimulated with heat-killed C. albicans for 2 d, and IFN- and IL-17 accumulation in the supernatants was measured 
by ELISA. The data are pooled from two independent experiments, and each symbol represents the mean of triplicate stimulations from an individual 
mouse. Statistically different groups are indicated (**, 0.001 < P < 0.01; and ***, P < 0.001).
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However, combined Dectin-2 blockade and Dectin-1 de-
ficiency impaired the Th1 response to the organism, indicat-
ing that Dectin-1 is not fully dispensable for adaptive immunity 
to Candida. This is an identical phenotype to that seen previ-
ously in the CARD9-deficient mice (LeibundGut-Landmann 
et al., 2007), implying that Dectin-1 and -2 account for most 
of the CARD9-dependent adaptive immune response to 
Candida infection.
In contrast to Th1 and Th17 induction, Dectin-1 and -2 
do not fully account for the CARD9-dependent innate im-
mune response to C. albicans. Indeed, we observed no signifi-
cant increase in renal fungal burden, even when Dectin-2 was 
blocked in Dectin-1–deficient mice, which indicates that Dec-
tin-2 function may be redundant for antifungal resistance dur-
ing the first week of systemic infection. This is consistent with 
previous data showing that fungal burden in the kidneys of 
Dectin-1–deficient mice infected i.v. with similar doses was 
significantly increased only in those mice that succumbed to 
the infection and not at these early time points (Taylor et al., 
2007). In contrast, Card9/ mice are highly susceptible to a 
similar dose of the fungus and have large increases in kidney 
mass and fungal burden as early as 4 d after infection (Gross 
et al., 2006). As it is believed that resistance to disseminated 
candidiasis in acute infection primarily reflects the activity of 
innate immunity (Romani, 2008), it seems likely that addi-
tional Syk–CARD9–coupled receptors are expressed by other 
immune cells, such as granulocytes, which are involved in the 
killing of Candida organisms during the acute phase of the an-
tifungal response. A distinct question is whether the adaptive 
Th17 response to Candida infection is involved in protection 
from infection. In favor of that notion, a recent paper has 
shown that mice deficient in IL-23p19, a critical cytokine for 
Th17 responses, or in IL-17RA are very susceptible to oropha-
ryngeal candidiasis (Conti et al., 2009). This is in agreement 
with earlier observations that IL-17RA–deficient mice are 
very susceptible to the organism (Huang et al., 2004). Notably, 
human memory CD4+ T cells specific for C. albicans are 
skewed toward Th17 (Acosta-Rodriguez et al., 2007; Zhou 
et al., 2008), and STAT3-mediated Th17 deficiency in humans 
is associated with increased susceptibility to C. albicans infection 
(Ma et al., 2008). However, Th17 responses have also been ar-
gued to contribute not to protection but to Candida-associated 
immunopathology (Zelante et al., 2007). In addition, we have 
recently found that IL-17 responses initiated by Dectin-1–acti-
vated DCs can involve FoxP3+ cells that, by other criteria, 
would be classified as regulatory and thought to have a down-
modulatory effect on immunity (Osorio et al., 2008). There-
fore, the protective role of type 17 immunity in fungal infection 
remains controversial (Zelante et al., 2009). It should be noted 
that any protective effect of Th17 immunity might only be 
apparent in a longer term follow up of animals infected with 
sublethal doses of C. albicans. Unfortunately, in the absence of a 
Dectin-2–deficient mouse, we are restricted to short-term 
experiment infection with mAb blockade such as described 
in this paper, in which any protective (or detrimental) effect of 
Th17 cells may be masked by innate resistance mechanisms.
with FcR chain. In this regard, Dectin-2 behaves like lym-
phocyte antigen receptors and activatory Fc receptors, all of 
which engage Syk or ZAP-70 indirectly, through association 
with ITAM-bearing signaling chains (Isakov, 1997). Like-
wise, other myeloid receptors, including Mincle, MAIR-II, 
TREM-1, TREM-2, OSCAR, and DCAR, engage ITAM 
pathways through association with FcR chain or DAP12 
(Bouchon et al., 2001; Kanazawa et al., 2003; Hara et al., 
2007; Yamasaki et al., 2008). All of these receptors can be 
easily triggered by means of antibody cross-linking, as shown 
in this study for Dectin-2. In contrast, antibody cross-linking 
does not induce measurable Dectin-1–mediated cytokine re-
sponses. Thus, although our study highlights the equivalence 
of Dectin-1 and -2 in activating the Syk–CARD9 pathway, 
hemITAM and ITAM receptors may have distinct signaling 
requirements, which could lead to subtle differences in 
downstream responses not apparent in our study.
As shown in this paper, IL-2, IL-10, and TNF, the hall-
mark cytokines triggered by either Dectin-1 or -2 engagement 
in DCs, are the same cytokines that are critically dependent 
on Syk and CARD9 for induction in response to fungal stim-
uli. Why TLR signaling in response to agonists present in 
fungal particles (Hohl et al., 2006; Netea et al., 2008) is un-
able to mimic Syk-dependent signals in eliciting IL-2, IL-10, 
and TNF but can induce IL-6 and IL-12 p40 is at present 
unclear. This phenomenon may be DC subtype dependent, 
as TLR signaling via TRIF can also lead to IL-10 production 
by mesenteric lymph node DCs in response to Candida 
(De Luca et al., 2007). However, it is consistent with our pre-
vious study showing a marked dependence of zymosan- 
induced IL-2 and IL-10 on ERK, which was predominantly 
activated via Syk but not MyD88 (Slack et al., 2007). Also, 
C. albicans and zymosan activate NFAT via Dectin-1 and not 
via TLRs in macrophages, and this NFAT activation is re-
quired for IL-2 and IL-10 production (Goodridge et al., 
2007). Therefore, a robust engagement of the ERK and 
NFAT pathways by Dectin-1 and -2 may underlie the induc-
tion of the Syk-signature cytokines.
It is important to note that IL-2, IL-10, and TNF may be 
only part of the Syk–CARD9 “signature” of DC activation 
by fungi, which will need to be investigated fully using 
genome-wide screens. Interestingly, a recent report indicates 
that, in DCs, Dectin-2/Syk signaling can additionally couple 
to the generation of cysteinyl leukotrienes (Barrett et al., 
2009). The contribution of Dectin-2 to DC activation by 
fungi is not fully elucidated, but in vivo, it maps out at the 
level of the Th17 response to the organism. This follows from 
previous work in which we found that systemic infection 
with C. albicans induces potent Th1 and Th17 responses and 
that the latter but not the former are completely abrogated 
in CARD9-deficient mice (LeibundGut-Landmann et al., 
2007). In this paper, we show that Dectin-2 is the major reg-
ulator of the Th17 response to systemic Candida infection and 
confirm earlier evidence that Dectin-1–deficient mice show lit-
tle or no impairment in this response in the absence of concomi-
tant Dectin-2 blockade (LeibundGut-Landmann et al., 2007). 
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A single colony of C. albicans strain SC5314 was grown overnight at 
30°C in yeast peptone dextrose media. The cells were washed twice with 
PBS before use as live yeasts or were heat-killed by boiling for 30–45 min. 
For the hyphal forms, the washed yeast were resuspended at 107 cells/ml in 
RPMI 1640 with 10% FCS and grown overnight. After washing in PBS, the 
hyphae were used for live stimulations or were heat killed as described. The 
morphology was verified by differential interference contrast microscopy us-
ing a 40× objective (Plan Fluor; Nikon; Fig. S2). Zymosan was purchased 
from InvivoGen and labeled with Cy5 as previously described (Rogers et al., 
2005). Curdlan was purchased from Wako Chemicals USA, Inc.
The cDNA for FcR chain, DAP-10, and DAP-12 was amplified 
from either the RAW264.7 macrophage cell line or C57BL/6 bone mar-
row cells and cloned into the retroviral vector pMX-IP (a gift from 
T. Kitamura, University of Tokyo, Tokyo, Japan; Kitamura et al., 2003). The 
signaling-defective FcR chain was made by mutating tyrosines 65 and 76 
to phenylalanine by standard molecular biology techniques and verified 
by sequencing. The full-length  isoform of Dectin-2 was cloned from 
wild-type BMDC cDNA by PCR, sequenced, and subcloned into pFB-
IRES-EGFP (donated by R. Germain, National Institute of Allergy and 
Infectious Diseases, Bethesda, MD).
B3Z cells containing a reporter plasmid for NFAT coupled to -galac-
tosidase activity have been previously described (Karttunen et al., 1992) and 
were a gift from N. Shastri (University of California, Berkeley, Berkeley, CA). 
B3Z cells were retrovirally transduced with the pMX-IP vectors separately 
and selected under 10 µg/ml puromycin (Sigma-Aldrich) for at least 7 d. 
These lines were subsequently retrovirally transduced with pFB–Dectin-2–
IRES–EGFP or the empty vector. For functional assays, the cells were FACS 
sorted based on EGFP expression.
The anti–Dectin-2 mAb, clone D2.11E4 (Taylor et al., 2005), and a rat 
IgG2a isotype-matched control (BD) were used in vitro. For the in vivo 
model of C. albicans infection, the rat IgG2a clone OX11 was used as the 
isotype-matched control. F(ab) preparations of D2.11E4 and control anti-
body (Y13-259, a rat IgG1 raised against p21 V-ras; CRUK Monoclonal 
Antibody Service) were made using immobilized papain digestion followed 
by protein G depletion of Fc and undigested antibody (Thermo Fisher 
Scientific). All immunoblotting antibodies were rabbit polyclonal antibodies 
purchased from Cell Signaling Technology, with the exception of those 
against phospho-JNK (Promega) and total Syk (Turner et al., 1995).
DC stimulations. For analysis of cytokine production, 105 BMDCs were 
cultured overnight in a 96-well U-bottomed plate with 105 live C. albicans, 
105 or 5 × 105 heat-killed C. albicans, or increasing doses of zymosan. In 
blocking experiments, the BMDCs were preincubated for 2 h with 10 µg/ml 
D2.11E4 or isotype-matched control mAb before addition of the stimuli. 
2.5 µg/ml fungizone (Invitrogen) or 50 ng/ml caspofungin (Merck) was added 
to the cultures 2 h after live C. albicans stimulation. Cytokine levels in the 
supernatant were measured by sandwich ELISA.
For stimulation with plated antibodies, UV-irradiated MaxiSorp plates 
(Thermo Fisher Scientific) were coated overnight with 40 µg/ml goat F(ab)2 
anti–rat F(ab)2 (Jackson ImmunoResearch Laboratories) in PBS. After wash-
ing, the plates were incubated with 10 µg/ml of control or anti–Dectin-2 
F(ab) for 1–3 h at 37°C before washing with PBS. 2 × 105 BMDCs were 
incubated on the plate overnight and cytokines were measured as described.
Immunoblotting. BMDCs were stimulated by plated F(ab) as described, 
except that 2.5 × 105 cells were spun at 233 g onto the coated plate. At the 
times after centrifugation indicated in the figures, the medium was removed 
and the cells were lysed for 30 min on ice in RIPA buffer (50 mM Tris [pH 
7.5], 1% Nonidet-P40, 0.5% deoxycholic acid, 0.1% SDS, 150 mM NaCl, 
10 mM NaF, 1 mM Na3VO4, 2 mM Na4P2O7, and a mixture of protease 
inhibitors; Roche). Insoluble material was discarded and a fixed amount of 
lysate was mixed with sample buffer (LeibundGut-Landmann et al., 2007) 
before separation by SDS-PAGE. After transfer to a polyvinyldifluoride 
membrane (Millipore), proteins were analyzed by immunoblotting and visu-
alized by enhanced chemiluminescence (Thermo Fisher Scientific).
Dectin-1 was previously considered an exception as it does 
not belong to the three most prominent families of PRRs, 
namely the TLRs, NLRs, and RLRs. Given our present and 
past findings, we propose that Dectin-1 and -2 may repre-
sent a novel class of myeloid innate receptors characterized by 
Syk–CARD9 coupling that can function to initiate immunity. 
It is important to note that Dectin-1 and -2 possess structurally 
different C-type lectin domains, fall into different subgroups 
of the CLR family, and use markedly different strategies for 
engaging the Syk pathway. Therefore, members of this class of 
CLRs will need to be defined by reference to function rather 
than structure. A possible candidate to be included in this fam-
ily is Clec5a, which has recently been shown to be a receptor 
for Dengue virus involved in the induction of proinflamma-
tory cytokines, including TNF (Chen et al., 2008). Clec5a 
associates with DAP-12 (Bakker et al., 1999), an ITAM-bear-
ing adaptor similar to the FcR chain, and therefore may link 
to Syk. In addition, Mincle, an inducible myeloid CLR, was 
recently implicated in macrophage sensing of C. albicans and 
Malassezia species and the subsequent induction of proinflam-
matory mediators (Wells et al., 2008; Yamasaki et al., 2009). 
Interestingly, Mincle has also been shown to associate with the 
FcR chain and signal via CARD9 in response to self-ligands 
such as the ribonucleoprotein SAP130 released by necrotic 
cells (Yamasaki et al., 2008). Notably, both Dectin-1 and -2 
have also been reported to possess an endogenous ligand 
(Ariizumi et al., 2000b; Aragane et al., 2003), and DNGR-1, 
an additional hemITAM-bearing CLR, mediates Syk-depen-
dent crosspriming responses to dead cells (Sancho et al., 2009). 
Thus, Syk-coupled CLRs may have additional functions not 
only as PRRs but also as innate receptors for initiating proin-
flammatory responses to sterile injury.
MATERIALS AND METHODS
Mice. Wild-type C57BL/6 and Myd88//Trif / mice were bred at 
Cancer Research UK in specific pathogen-free conditions. The bone mar-
row from Clec7a/ mice (Taylor et al., 2007) and fetal liver cells from 
Syk/ embryos were used to generate radiation chimeras in C57BL/6 
hosts, as described previously (Rogers et al., 2005). Card9/ mice (Gross 
et al., 2006) were bred at the Technische Universität München, and 
Fcer1g/ (FcR chain knockout) mice (Park et al., 1998) were bred at the 
Leiden University Medical Center. All mice were on a C57BL/6 back-
ground with the exception of those used for knockdown and infection 
studies. For these, both Clec7a/ and wild-type mice were on a 129/Sv 
genetic background with breeding, and the in vivo experiments were per-
formed at Cardiff University. All animal protocols were approved by the 
London Research Institute Animal Ethics Committee or the Cardiff 
University Local Ethical Review Process, and were performed under the 
authority of the Animal Scientific Procedures Act 1986 (UK).
Cells, fungal stimuli, constructs, and antibodies. Culture medium was 
RPMI 1640 supplemented with glutamine, penicillin, streptomycin, 2-mer-
captoethanol (all from Invitrogen), and 10% heat-inactivated fetal calf serum 
(Autogen Bioclear). Mouse BMDCs were generated using GM-CSF (Inaba 
et al., 1992) and purified from bulk cultures by magnetic selection with anti-
CD11c microbeads. This routinely gave purities of >98%. Retroviral trans-
duction of BMDCs has previously been described (LeibundGut-Landmann 
et al., 2007). Spleen cells were prepared by digestion with liberase and DN-
ase, followed by enriching for conventional DCs by positive selection with 
anti-CD11c microbeads.
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for FcR chain in anti–Dectin-2 triggering of cytokine production. In Fig. S5, 
cell-surface expression of Dectin-2 and the subsequent binding of fluores-
cent zymosan is similarly enhanced by expression of either wild-type or an 
ITAM-mutated FcR chain. Fig. S6 demonstrates that combined loss of 
Dectin-1 and blockade of Dectin-2 abolishes the up-regulation of IL-23p19 
mRNA by heat-killed C. albicans. Fig. S7 shows that both Dectin-1 and -2 
contribute to the binding of fluorescent zymosan by BMDCs and that 
this is increased by transduction of the signaling-defective Dectin-1. Fig. S8 
shows that anti–Dectin-2 mAb treatment of C. albicans–infected mice, 
but not Dectin-1 deficiency, compromises IL-17 but not IFN- produc-
tion in an assay in which splenocytes are restimulated with a high dose 
of C. albicans. It further shows that the kidney fungal burden and mouse 
weight loss are not significantly different in wild-type and Dectin-1–defi-
cient mice with and without anti–Dectin-2 treatment early after C. albicans 
infection. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20082818/DC1.
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DC activated via dectin-1 convert Treg into IL-17
producers
Fabiola Osorio1, Salome´ LeibundGut-Landmann1, Matthias Lochner2,
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Th cells producing IL-17 play a pro-inflammatory role at mucosal surfaces. Treg at the same
sites dampen inflammation and prevent immunopathology. Th cells producing IL-17 (Th17)
and Treg are thought to be distinct populations defined by expression of the transcription
factors ROR-ct and Foxp3, respectively. Here, we show that mouse CD25+Foxp3+ Treg can be
converted into a hybrid T-cell population characterized by the expression of Foxp3 and
ROR-ct and the production of IL-17. Conversion was observed upon coculture with DC
selectively activated via dectin-1, a C-type lectin receptor involved in fungal recognition,
and depended on IL-23 produced by DC. Within the Foxp3+ population, only Foxp3+ROR-ct+
T cells but not Foxp3+ROR-ct-–T cells become Foxp3+IL-17+ T cells. These results indicate
that some Foxp3+ T cells can produce IL-17 while retaining Foxp3 expression and suggest
that Treg could play an unexpected pro-inflammatory role in some settings.
Key words: DC . Dectin-1 . Th17 . Treg
Introduction
Our immune system identifies pathogens in part by recognizing
signatures present in microbes, so-called PAMP, via specific
germline encoded PRR [1]. Recognition of PAMP by PRR leads to
an immediate innate response designed to contain infection and
may also result in the mobilization of adaptive defense mechan-
isms. The translation of PAMP presence into adaptive immunity is
carried out by specialized leukocytes called DC and results in
distinct responses matched to the nature of the offending
microbe. For CD4+ T cells, infection with intracellular bacteria
tends to induce responses dominated by Th1 cells, whereas
extracellular parasites often promote Th2-biased responses.
Some bacteria and fungi promote a third type of response
defined by the induction of Th cells producing IL-17 (Th17)
[2–4]. Th17 cells are pro-inflammatory cells characterized by the
expression of IL-17A, IL-17F, IL-21, IL-22, IL-23R and the
transcription factors ROR-gt and ROR-a [5–7]. They have been
implicated in several models of autoimmunity [8–11] but
under normal conditions may play a role in protection from
infection at mucosal surfaces [2]. IL-6 and TGF-b are key
cytokines required for lineage commitment of murine Th17
[2, 8, 12] whereas IL-23 is a critical factor for sustaining these
cells and is required for the acquisition of their pathogenic
function in vivo [9, 13].
Treg are important regulators of potentially detrimental
responses against normal self-constituents or commensal
microbes and loss of Treg function leads to autoimmune and
inflammatory diseases [14, 15]. Treg are characterized by the
expression of CD25 and Foxp3, the latter being a transcription
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factor required for the maintenance of the Treg lineage
[15, 16]. Like Th1, Th2 and Th17 cells, Foxp3+ Treg can be
generated in the periphery from newly activated CD4+ T cells.
The differentiation pathways of such inducible Treg and those of
Th17 cells are closely related as both processes require the
presence of TGF-b [8]. Notably, it has recently been found that
fully differentiated Treg can themselves be converted into Th17
cells in mice [17–19] and humans [20]. This process is accom-
panied by extinction of Foxp3 expression and upregulation of
ROR-gt [18]. Interestingly, some cells in the mouse can coexpress
Foxp3 and ROR-gt [21, 22] and could represent an intermediate
in this process or, alternatively, an intermediate cell in the
differentiation of naı¨ve T cells into Th17/Treg. Foxp3+ROR-gt+
cells behave as bona fide Treg, like their ROR-gt counterparts,
and produce IL-10 but not IL-17 [22]. Thus, the available data
suggest that, although Foxp3 and ROR-gt can be coexpressed in
CD4+ T cells, Foxp3 expression and IL-17 production are
mutually exclusive. This has led to the notion that regulatory and
inflammatory T-cell programs are antagonistic [18, 21].
Dectin-1 is a Syk-coupled C-type lectin receptor for b-glucans
involved in the innate recognition of fungi and some bacteria.
Activation of the dectin-1 pathway in DC leads to the generation
of Th17 cells both in vitro and in vivo [4]. Here, we show that
dectin-1-activated DC can directly interact with CD25+Foxp3+
Treg and instruct them to become IL-17-producers. Notably, in
contrast to previous studies, we find that such Treg do not
extinguish the expression of Foxp3. Instead, they become a
population of Foxp3+IL-17+ T cells that defies classification
as either Treg or Th17 and could play an important role in
inflammation.
Results
CD4+CD25+ T cells become IL-17 producers in response
to curdlan-stimulated DC
We have previously reported the induction of Th17 cells in
cocultures of CD4+ T cells and DC stimulated with the dectin-1
agonist, curdlan [4]. The emergence of a substantial fraction of
IL-17-producing cells required the presence of both CD4+CD25
and CD4+CD25+ cells [4]. To further investigate the role of CD4+
CD25+ cells, we purified naı¨ve (CD4+CD25CD62LhiCD44lo) or
CD4+CD25+ T cells from C57BL/6 mice and cultured each
population individually with BM-derived DC (BMDC) plus
a-CD3 mAb in the presence of curdlan or CpG (a TLR9 agonist).
In cultures in which naı¨ve T cells were the starting population,
inclusion of CpG induced development of T cells that preferen-
tially produced the Th1 cytokine IFN-g rather than IL-17 upon
restimulation (Fig. 1A and B). The inverse was observed in the
presence of curdlan (Fig. 1A and B), as previously reported [4].
Notably, in CD4+CD25+ T-cell cultures, neither curdlan nor CpG
led to the development of IFN-g-producing cells but curdlan
promoted the appearance of a large frequency and absolute
number of cells able to produce IL-17 upon restimulation
(Fig. 1A–C). This was accompanied by greater expansion of total
CD4+CD25+ T cells in curdlan-containing cultures when
compared with cultures containing CpG or lacking any innate
stimulus (Fig. 1C), suggesting that factors produced by DC in
response to curdlan favor proliferation and/or survival of
CD4+CD25+ T cells and induce development of an IL-17-
producing population.
Curdlan-activated DC induce the generation of
Foxp3+IL-17+ T cells
CD4+CD25+ T cells include activated T cells as well as a large
population of Treg expressing Foxp3 [23]. We therefore set up
cultures with a pure Foxp3+ T-cell population isolated by cell
sorting from depletion of regulatary T-cell (DEREG) mice (or
from radiation chimeras bearing BM from DEREG mice), which
express GFP fused to the primate diphteria toxin receptor under
the control of foxp3 gene regulatory regions [24]. As for the
total CD4+CD25+ T cells used previously, CD25+GFP+ DEREG T
cells proliferated more extensively when curdlan was included in
the cultures than when no innate stimulus was present (Fig. 2A).
To account for a possible role of proliferation, we compared
curdlan with IL-2 (Fig. 2A, Treg control), which acts as a Treg
mitogen, and independently analyzed the blast and the resting T-
cell population for expression of Foxp3 and the ability to produce
IL-17 upon restimulation. Blast and non-blast cells were
selected by forward- and side-scatter criteria, whereas
Foxp3 expression was assessed by nuclear staining with a specific
mAb to directly measure the presence of the protein at the
time of analysis. As expected, we observed Foxp3+IL-17 cells in
Treg control cultures and Foxp3IL-17+ cells in Th17 control
cultures. However, in curdlan-containing cultures of Foxp3+
T cells and DC, we observed an accumulation of Foxp3+IL-17+
double-positive cells, which were especially noticeable
in the blast fraction (Fig. 2B). T cells producing IL-17 and
coexpressing Foxp3 continued to accumulate over time in
curdlan-containing cultures and represented one-fourth of the
cells by day 7 (Fig. 2C). At both time points, we detected
the presence of transcripts associated with Th17 cell fate
such as ROR-gt, IL23R and, to a lesser extent, IL-17F (Fig. 2D).
Foxp3 transcripts were also found in these cultures, consistent
with the staining data (data not shown). We conclude that, in
response to BMDC stimulated with curdlan, Foxp3+ cells can give
rise to a T cell capable of coexpressing Foxp3 and IL-17, which
constitutes a distinct phenotype from classical Th17 or Treg.
Foxp3+ROR-ct+ but not Foxp3+ROR-ct T cells become
Foxp3+IL-17+ T cells
Foxp3+ Treg are heterogeneous and include a fraction that
coexpresses ROR-gt and produce little or no IL-17 [21, 22]. Given
the importance of ROR-gt in differentiation of conventional
Th17 CD4+ T cells [5], we wondered whether Foxp3+ROR-gt+
Eur. J. Immunol. 2008. 38: 3274–3281 HIGHLIGHTS 3275
& 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
cells might represent the source of Foxp3+IL-17+ double-positive
cells. We therefore compared ROR-gt+ and ROR-gt Treg
isolated from chimeric mice reconstituted with BM from Rorc(gt)-
GfpTG mice, in which GFP reports ROR-gt expression [22]. To obtain
Treg from those mice, we sorted cells based on the expression of
CD4, CD25 and folate receptor 4, which closely mirrors Foxp3
expression [25]. We confirmed that the majority of sorted
CD25+FR4+ CD4+ T cells express Foxp3 (Fig. 3A). We then
prepared donor origin CD25+FR4+ T cells from Rorc(gt)-GfpTG
chimeric mice, which were sub-divided into GFP+ and
GFP fractions and separately cultured with BMDC and a-CD3 in
the presence of curdlan (Fig. 3B). Notably, only CD25+FR4+GFP+
and not CD25+FR4+GFP fractions were able to generate
IL-17-producing cells (Fig. 3B). The majority of these cells
coexpressed Foxp3 (Fig. 3B) as observed in experiments with
DEREG T cells (see above). In addition, a proportion of IL-17+ cells
were negative for Foxp3 (Fig. 3B), probably reflecting expansion of
contaminating ROR-gt+Foxp3 cells present in the starting popula-
tion, which correspond to Th17 cells (Fig. 3A). We conclude that the
Foxp3+ROR-gt+ but not the Foxp3+ROR-gt subset can be induced
to produce IL-17 after culture with DC in the presence of a dectin-1
agonist.
Figure 1. Curdlan-stimulated DC promote IL-17 production by CD4+CD25+ T cells. (A) FACS-sorted naı¨ve T cells or CD4+CD25+ T cells from C57BL/6
mice were cocultured for 5 days with BMDC and soluble a-CD3 in medium alone or in the presence of curdlan or CpG. Half of the content of each
well was restimulated on day 5 for 48 h with coated a-CD3 and cytokine production was determined by sandwich ELISA. (B) same as part A, but
cells were restimulated on day 5 with PMA, ionomycin and brefeldin A for 4 h and the presence of intracellular cytokines was analyzed by flow
cytometry. Data show IFN-g and IL-17 after gating on CD4+ cells. (C) Total numbers of CD4+IL-17+ T cells or CD4+ T cells obtained on day 5 in
cultures containing CD4+CD25+ T cells. Graph shows mean+SEM of three independent experiments. Data are representative of two to six
independent experiments. N.D., not done.
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IL-23 drives the generation of Foxp3+IL-17+ T cells
We have previously shown that curdlan stimulation of DC
leads to production of IL-23 but not IL-12 p70 [4]. To address
the role of IL-23 in the generation of Foxp3+IL-17+ T cells,
we cultured IL-23-deficient (p19/) or wild-type BMDC
with Foxp3+ T cells from DEREG mice in the presence of
curdlan. Notably, the frequency and number of Foxp3+IL-17+
T cells was markedly decreased when p19/ BMDC were
used as APC (Fig. 4A and B) while CD4+ T-cell expansion
was unaffected (Fig. 4B). The appearance of ROR-gt and
IL-23R transcripts in curdlan-containing cultures was also
IL-23 dependent (Fig. 4C). When curdlan was replaced with
IL-23, we obtained similar frequencies of Foxp3+IL-17+ T cells
(Fig. 4D) but T-cell expansion was reduced, resulting in
lower numbers of Foxp3+IL-17+ T cells at the end of the
culture (Fig. 4E). These data suggest that IL-23 is necessary
but not sufficient for maintaining the phenotype and/or survival
of Foxp3+IL-17+ T cells.
Discussion
Innate signals play a key role in determining the class of adaptive
immune response against infection. In this study, we have shown
that innate stimulation via the dectin-1 pathway allows DC to
Figure 2. Curdlan-stimulated DC induce the generation of Foxp3+IL-17+ T cells. (A) CFSE-labeled CD4+CD25+GFP+ DEREG T cells were cultured for 5
days with wild-type BMDC and soluble a-CD3 in the absence (NT) or presence of curdlan or rhIL-2 (‘‘Treg’’), as indicated. Plots show CFSE profile
after gating on CD4+ cells. (B) As in (A) but with the addition of a ‘‘Th17’’ control consisting of CD4+GFPCD25 T cells cultured with BMDC, a-CD3
and IL-6+TGF-b in the presence of neutralizing antibodies to IFN-g and IL-4. All cells were restimulated on day 5 with PMA, ionomycin and
brefeldin A for 4 h and the expression of Foxp3 and IL-17 was analyzed by gating separately on CD4+ cell blasts or non-blasts by flow cytometry.
(C) Analysis of parallel cultures from part B on day 7. (D) RT-PCR analysis of transcripts for ROR-gt, IL-17F and IL-23R in the indicated cultures at 5
and 7 days. Data are representative of two to six independent experiments.
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instruct CD25+Foxp3+ T cells to become Foxp3+IL-17+ T cells.
This process is distinct from the differentiation of naı¨ve T cells in
curdlan-containing cocultures [4], which generates Th17 cells
that do not express Foxp3 (data not shown). Previous
reports have demonstrated that Foxp3+ T cells can be converted
into Th17 cells in vitro and in vivo under certain conditions
[17–20]. In those studies, Foxp3+ T cells may pass through a
transient stage characterized by the coexpression of Foxp3 and
IL-17 before downregulating Foxp3. A distinct hallmark
of the cells described in this study is that they maintain or even
increase the expression of Foxp3 while acquiring the ability to
produce IL-17.
Dectin-1 signaling in DC induces the production of several
cytokines, including IL-2, IL-6, IL-10, TNF-a and IL-23 [4].
We have shown that IL-23 is essential to induce but not
sufficient to sustain the generation of Foxp3+IL-17+ T cells.
IL-23 might act synergistically with IL-6 and TNF-a, both of which
contribute to the generation of Th17 cells [12]. Dectin-1-acti-
vated DC also produce IL-2, which could contribute to the
generation of Foxp3+IL-17+ T cells. Indeed, although IL-2 acts as
an inhibitor of Th17 differentiation from naı¨ve CD4+ T cells [26],
it potentiates the expression of Foxp3 in Treg [27]. We propose
that the unique balance of cytokines induced in DC by dectin-1
stimulation may be particularly suited to the generation of
Foxp3+IL-17+ T cells, with IL-23, TNF-a and IL-6 favoring IL-17
production and IL-2 sustaining Foxp3 expression. IL-10, which is
also produced at high levels by DC stimulated via the
dectin-1/Syk pathway [4, 28, 29], could potentially help main-
tain Treg markers and/or Treg activity.
Foxp3+IL-17+ T cells arise from the Foxp3+ROR-gt+ Treg
subset and not the Foxp3+ROR-gt population, indicating that
the Foxp3+ROR-gt+ population possesses the ability to produce
IL-17 under certain conditions of innate immune challenge. In
turn, this implies that Foxp3+ T cells are not being genetically
reprogrammed to become IL-17 producers but that the appro-
priate cytokine milieu can trigger IL-17 production in cells that
already express the genetic machinery required to perform that
function.
The fact that conditions of innate stimulation with fungal
products favor the development of a novel population of
Foxp3+IL-17+ cells may have important implications. Fungal
infections have been linked to IL-17 responses [4] and
IL-17-deficient mice are more susceptible to infection with
Candida albicans [30]. In addition, human memory CD4+ T cells
specific for C. albicans are skewed toward Th17 [3, 31] and
STAT3-mediated Th17 deficiency in humans is associated
with increased susceptibility to C. albicans infection [32].
Whether Foxp3+IL-17+ T cells participate in anti-fungal
immunity or whether they retain regulatory activity that could
counteract the detrimental effects of overexuberant Th17
responses [33] remains to be determined. Consistent with the
latter possibility, it has previously been reported that DC acti-
vated by yeast particles induce T cells with regulatory activity
[29]. Notably, small numbers of cells coexpressing Foxp3, ROR-gt
and IL-17 have been previously noticed in mouse gut lamina
propria [21]. By developing techniques for enriching and isolat-
ing Foxp3+IL-17+ T cells from animals and patients, we hope that
multiple questions regarding their role can begin to be addressed.
Materials and methods
Mice
C57BL/6 mice were obtained from Charles River. DEREG mice
[24] were bred at Technische Universita¨t Mu¨nchen or at Cancer
Figure 3. Foxp3+ROR-gt+ but not Foxp3+ROR-gt- T cells become
Foxp3+IL-17+ T cells in response to curdlan-activated BMDC.
(A) FACS-sorted CD4+CD25+FR4+ and CD4+CD25-FR4- T cells from
C57BL/6 mice stained for intracellular Foxp3. (B) FACS-sorted CD4+
CD25+FR4+GFP+ and CD4+CD25+FR4+GFP T cells from Rorc(gt)-GfpTG
chimeras were cocultured with wild-type BMDC and soluble a-CD3 in
the presence of curdlan. Cells were restimulated on day 5 with PMA,
ionomycin and brefeldin A for 4 h and the expression of Foxp3 and
IL-17 on CD4+ cell blasts was analyzed by flow cytometry. Data are
representative of two independent experiments.
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Research UK in specific pathogen-free conditions. IL-23 p19-
deficient mice [34] were provided by A. MacDonald (Edinburgh,
UK) with kind permission from N. Ghilardi, Genentech, and were
bred at Cancer Research UK in specific pathogen-free conditions.
Rorc(gt)-GfpTG mice [22] were bred at Institut Pasteur. Radiation
chimeras using BM from DEREG or Rorc(gt)-GfpTG mice were
generated at Cancer Research UK. All animal experiments were
performed in accordance with national and institutional guide-
lines for animal care.
In vitro T-cell assays
CD4+CD25CD62LhiCD44lo (naı¨ve) and CD4+CD25+ cells from
C57BL/6 mice or CD4+GFP+CD25+ and CD4+GFPCD25 cells
from DEREG mice or DEREG BM chimeras were purified from
spleen and lymph nodes. CD4+GFP+CD25+FR4+CD45.1 and
CD4+GFPCD25+FR4+ CD45.1 cells from Rorc(gt)-GfpTG BM
chimeras or CD4+CD25+FR4+ and CD4+CD25FR4 cells
from C57BL/6 mice were purified from mesenteric lymph
node. Cell purification was performed by cell sorting using
a MoFlo (Dako Cytomation) or a FACSAria cell sorter (BD
Biosciences); 5 104 sorted T cells were cocultured with 2104
BMDC generated with GM-CSF as described previously [4]
and 0.2mg/mL of soluble anti-CD3e in the presence or absence
of 50mg/mL curdlan (Wako; suspended in PBS at 10 mg/mL),
0.5mg/mL CpG oligonucleotide 1668 (CpG; Sigma) or 10 ng/mL
IL-23 (eBiosciences).
Th17 control consisted of CD4+GFPCD25 T cells from
DEREG mice or DEREG BM chimeras cocultured with BMDC in the
presence of 10 ng/mL of TGF-b (Sigma), 20 ng/mL of IL-6 (RnD
systems) and neutralizing antibodies against IFN-g (2mg/mL) and
IL-4 (2mg/mL). Treg control consisted of CD4+GFP+CD25+ cells
from DEREG mice or DEREG BM chimeras cocultured with BMDC
in the presence of 100 IU/mL of rhIL-2 (RnD systems). In some
experiments, sorted CD4+GFP+CD25+ T cells were labeled with
2mM CFSE for 12 min at 371C before culture.
Cells from cultures were restimulated on day 5 or 7 for 4 h
with phorbol 12-myristate 13-acetate (10 ng/mL; Sigma), iono-
mycin (1mg/mL; Calbiochem) and brefeldin A (5 mg/mL; Sigma).
Figure 4. IL-23 drives the generation of Foxp3+IL-17+ T cells in response to curdlan-activated BMDC. (A) FACS-sorted CD4+CD25+GFP+ DEREG T cells
were cultured with wild-type or p19/ BMDC plus soluble a-CD3 in the presence of curdlan. Cells were restimulated on days 5 and 7 with PMA,
ionomycin and brefeldin A for 4 h and the expression of Foxp3 and IL-17 on CD4+ cell blasts was analyzed by flow cytometry. (B) Total numbers of
Foxp3+IL-17+ T cells and CD4+ T cells from cultures as in (A) on day 5. (C) RT-PCR analysis of transcripts encoding ROR-gt, and IL-23R in cultures as
in part A and analyzed on day 5. (D) CD4+CD25+GFP+ DEREG T cells were cultured for 5 days with wild-type BMDC plus soluble a-CD3 in the
presence of curdlan or IL-23 (10 ng/mL). Cells were restimulated on day 5 with PMA, ionomycin and brefeldin A for 4 h and the expression of Foxp3
and IL-17 on CD4+ cell blasts was analyzed by flow cytometry. (E) Numbers of Foxp3+IL-17+ T cells obtained in cultures as in part D. Data in part B
and E are mean+SEM of three independent experiments. Data are representative of two to four independent experiments. N.D., not done.
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Intracellular staining for Foxp3 and IL-17 was analyzed by flow
cytometry. Alternatively, half of the content of each well were
restimulated on day 5 on plate-bound anti-CD3e (5mg/mL) for
48 h before cytokines in the supernatant were analyzed by
sandwich ELISA.
Flow cytometry
Antibodies specific for CD4 (RM4-5), CD25 (PC61), CD62L
(MEL-14), CD44 (IM7) and CD3e (145-2C11) were from BD
Pharmingen. Antibodies against Folate receptor 4 (12A5), IL-17
(TC11-18H10.1) and Foxp3 (FJK-16s) were from eBiosciences.
For intracellular cytokine staining, cells were stained with anti-
CD4, fixed and stained with anti-mouse/rat Foxp3 staining set
(eBiosciences) containing fluorochrome-labeled antibodies. Data
were acquired on a FACSCalibur (BD Biosciences) and analyzed
using FlowJo software (Treestar).
RNA isolation and real-time RT-PCR
Total RNA was prepared with TRIzol reagent (Invitrogen). cDNA
was synthesized from total RNA with random hexamers and
Superscript II reverse transcriptase (Invitrogen). Quantitative
real-time PCR was carried out using SYBR green incorporation
(Il17f, ROR-(gt), Il23r). For SYBR green reactions, primer
sequences were as described previously [2, 5]. Measurements
were performed in duplicate wells using the ABI PRISM 7700
sequence detection system (Applied Biosystems). Normalization
was performed using 18S rRNA as a reference (primers and probe
from Applied Biosystems) and results are shown as relative
mRNA quantities.
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Syk- and CARD9-dependent coupling of innate
immunity to the induction of T helper cells that
produce interleukin 17
Salome´ LeibundGut-Landmann1, Olaf Gro2, Matthew J Robinson1, Fabiola Osorio1, Emma C Slack1,5,
S Vicky Tsoni3, Edina Schweighoffer4, Victor Tybulewicz4, Gordon D Brown3, Ju¨rgen Ruland2
& Caetano Reis e Sousa1
The C-type lectin dectin-1 binds to yeast and signals through the kinase Syk and the adaptor CARD9 to induce production
of interleukin 10 (IL-10) and IL-2 in dendritic cells (DCs). However, whether this pathway promotes full DC activation
remains unclear. Here we show that dectin-1–Syk–CARD9 signaling induced DC maturation and the secretion of proinflam-
matory cytokines, including IL-6, tumor necrosis factor and IL-23, but little IL-12. Dectin-1-activated DCs ‘instructed’ the
differentiation of CD4+ IL-17-producing effector T cells (TH-17 cells) in vitro, and a dectin-1 agonist acted as an adjuvant
promoting the differentiation of TH-17 and T helper type 1 cells in vivo. Infection with Candida albicans induced CARD9-
dependent TH-17 responses to the organism. Our data indicate that signaling through Syk and CARD9 can couple innate
to adaptive immunity independently of Toll-like receptor signals and that CARD9 is required for the development of TH-17
responses to some pathogens.
CD4+ T cells are the main regulators of adaptive immunity. Responses
by interferon-g (IFN-g)–producing CD4+ T helper type 1 (TH1) cells
promote immunity to viruses, intracellular bacteria and protozoan
parasites, whereas TH2 cells making interleukin 4 (IL-4), IL-5 and
IL-13 direct immunity to metazoan parasites1,2. Immunopathology is
also often associated with particular classes of CD4+ effector T cells:
TH2 cells are important in allergy, and TH1 cells have been thought to
drive autoimmunity. The last conclusion has been called into question
by the finding that defects in IFN-g signaling exacerbate autoimmune
disease in some mouse models3. It is now recognized that many
autoimmune diseases previously attributed to TH1 cells are driven by a
third class of effector CD4+ T cells that produce IL-17 rather than
IFN-g and are therefore called ‘TH-17’ cells3,4. IL-17 and/or its
receptor have also been linked to resistance to infection by extra-
cellular bacteria such as Klebsiella pneumoniae as well as by fungi such
as Candida albicans5,6. However, the mechanisms leading to the
generation of TH-17 cells during infection remain poorly understood.
The differentiation of TH1 or TH-17 cells is determined by exposure
to IFN-g or to transforming growth factor-b (TGF-b) and IL-6,
respectively7–10. These cytokines act on newly primed CD4+ T cells
to induce expression of the transcription factor T-bet, which promotes
TH1 responses
11, or RORgt, a transcription factor required for the
differentiation of TH-17 cells
12. T-bet and RORgt control expression of
the IL-12 and IL-23 receptors, respectively12,13, and render T cells
susceptible to IL-12 or IL-23, cytokines that sustain and amplify the
TH cell differentiation process. The critical importance of these
cytokines is emphasized by the fact that mice lacking IL-12 or IL-23
cytokine subunits are unable to mount TH1 or TH-17 responses,
respectively3. IL-12, IL-23 and other factors that influence T cell
effector fate are produced by dendritic cells (DCs) that have been
activated by signals from pattern-recognition receptors (PRRs), which
recognize components of microbes or viruses14. Members of the Toll-
like receptor (TLR) family have been linked to the induction of IL-12
production by DCs and the initiation of TH1 responses
15. Whether
other pattern-recognition pathways control alternative forms of
TH cell differentiation is not clear.
An alternative pattern-recognition pathway initiated by the engage-
ment of a C-type lectin, dectin-1, by fungal b-glucans has been
described16. Dectin-1 signals through a ‘hemITAM’ motif, an immuno-
receptor tyrosine-based activation motif–like sequence containing a
single ‘YxxL’ motif (where ‘x’ is any amino acid)16, that becomes
phosphorylated by Src family kinases after receptor engagement17. This
allows recruitment of the spleen tyrosine kinase Syk, which
then activates ‘downstream’ signaling components, including the
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transcription factor NF-kB16–18. Activation of NF-kB by dectin-1
requires the CARMA1-related adaptor protein CARD9, which binds
the adaptors MALT1 and Bcl-10 and promotes activation of the IKK
kinase complex18.
Dectin-1–Syk signaling in DCs has thus far been associated only
with the production of IL-10 and IL-2 (ref. 16), a cytokine pattern not
generally associated with the induction of TH cell responses. Therefore,
it remains unclear whether dectin-1 acts in a way similar to TLRs,
allowing the ‘translation’ of innate information into adaptive immu-
nity or, alternatively, whether it acts mainly to modulate signals from
other PRRs. Here we show that dectin-1–Syk–CARD9 signaling
promoted DC maturation and induced the secretion of proinflamma-
tory cytokines, including IL-23, but little IL-12. Notably, DCs activated
by dectin-1 engagement strongly biased TH cell differentiation to a
TH-17 fate, and the use of dectin-1 agonists as adjuvants promoted
TH-17 and TH1 responses in vivo. Furthermore, TH-17 cells developed
naturally during experimental infection with C. albicans in wild-type
but not Card9–/– mice. Thus, Syk-CARD9–coupled innate signaling
pathways may promote DC activation independently of TLRs and may
regulate TH-17 responses to certain infections.
RESULTS
Dectin-1–Syk–CARD9 signaling activates DCs
Zymosan, a b-glucan-containing preparation of yeast cell walls, is
widely used for ‘probing’ dectin-1-mediated innate responses. How-
ever, zymosan-induced production of IL-10 and IL-2 is almost normal
in dectin-1-knockout DCs, indicating receptor redundancy19,20 (data
not shown). We therefore sought to identify a selective dectin-1
agonist. Curdlan, a pure b-glucan that has been shown to stimulate
DCs deficient in the TLR adaptor MyD88 (Myd88–/– DCs)21, elicited
much more production of IL-10 and IL-2 from bone marrow–derived
DCs (BMDCs) than did a selection of TLR agonists ‘titrated’ to induce
similar quantities of IL-6 (Supplementary Fig. 1 online). Notably,
IL-10 and IL-2 production was mostly independent of the TLR
adaptors MyD88 and TRIF but was dependent on dectin-1, Syk and
CARD9, suggesting that curdlan acts as a selective agonist of the
dectin-1 signaling pathway (Fig. 1). We therefore used curdlan to
delineate the consequences of dectin-1–Syk–CARD9 signaling on DC
phenotype and function.
Curdlan stimulation induced rapid Syk-dependent phosphorylation
of the mitogen-activated protein kinases p38, Erk and Jnk and
activation of NF-kB in BMDCs (Fig. 2). Consistent with the fact
that mitogen-activated protein kinases and NF-kB regulate the expres-
sion of genes involved in the innate response, curdlan stimulation also
led to Syk-dependent but MyD88-independent upregulation of the
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CD86, CD40 and CD80 surface proteins, similar to that achieved by
stimulation through the TLR9-MyD88 pathway with CpG oligo-
deoxynucleotides (Fig. 3a,b). In addition, curdlan stimulation led to
the production of large quantities of proinflammatory cytokines,
including IL-6, tumor necrosis factor (TNF) and IL-12p40 (a subunit
of both IL-12 and IL-23; Fig. 3c–e). Notably, most of the DCs that
produced IL-12p40 in response to curdlan simultaneously produced
TNF and IL-6, whereas DCs producing only IL-12p40 predominated
after CpG stimulation (Fig. 3f and data not shown). Induction of
IL-12p40 by curdlan was accompanied by the production of trans-
cripts encoding IL-12p19 (a subunit of IL-23) and secretion of IL-23
protein; however, in contrast to CpG stimulation, curdlan elicited little
production of transcripts encoding IL-12p35 (a subunit of IL-12) or
IL-12p70 protein (Fig. 3g and Supplementary Fig. 2 online). Cyto-
kine induction by curdlan was independent of MyD88 but depended
on dectin-1, Syk and CARD9 (Fig. 3c–e,g and Supplementary Fig. 2).
In contrast, CpG-induced cytokine production was dependent on
MyD88 and independent of Syk, except for the production of
IL-12p35 and IL-12p70, which was dependent on both MyD88 and
Syk (Fig. 3g and Supplementary Fig. 2).
As an alternative approach to examine the effects of dectin-1
signaling, we transduced BMDCs with retroviruses encoding dectin-1
molecules bearing a streptavidin-binding peptide tag17 and stimulated
the cells with streptavidin-sepharose. Streptavidin-sepharose triggered
phenotypic maturation of and cytokine production by BMDCs
expressing full-length dectin-1 but not those expressing a
signaling-deficient dectin-1 mutant (Fig. 4). Those responses were
unaffected by lack of MyD88 and TRIF, which excluded the possibility
of a contribution by contaminating TLR agonists and confirmed that
triggering of dectin-1 alone was sufficient for DC activation.
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We conclude that, like TLR signaling, selective triggering of the dectin-
1–Syk–CARD9 signaling pathway in DCs induces activation but results
in an altered cytokine profile characterized by large amounts of IL-2,
IL-10, IL-6 and TNF and a bias in production of IL-23
rather than IL-12.
Dectin-1-activated DCs prime TH1 and TH-17 cells
To assess whether dectin-1–stimulated DCs can ‘instruct’ CD4+ T cell
proliferation and effector differentiation, we cultured ovalbumin-
specific OT-II CD4+ T cells with antigen and BMDCs in the presence
of curdlan or CpG. Both curdlan and CpG led to more T cell
proliferation than did antigen alone (data not shown). However,
whereas CpG induced differentiation skewed mainly toward the
generation of IFN-g-producing TH1 cells, the presence of curdlan also
led to the accumulation of IL-17-producing T cells (Fig. 5a). Com-
pared with a range of specific TLR agonists, curdlan and, to a lesser
extent, zymosan, induced a much higher ratio of IL-17 production to
IFN-g production (Supplementary Fig. 3 online). Neither stimulus
induced the development of IL-4-producing T cells (data not shown).
The effect of curdlan and CpG was mediated by the antigen-presenting
cells and not the T cells, as the effect was abrogated by the use of
BMDCs lacking Syk or MyD88, respectively (Fig. 5b). In addition, the
cytokine bias induced by curdlan versus CpG was not simply a
reflection of quantitative differences in DC activation, as ‘titration’
of either compound did not allow interconversion of its effect
(Supplementary Fig. 4 online).
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Figure 5 Dectin-1-stimulated DCs promote TH-17 differentiation of CD4
+ T cells. (a) Flow
cytometry of intracellular cytokine production by total CD4+ OT-II T cells cultured with C57BL/6
wild-type BMDCs and ovalbumin protein plus curdlan or CpG. Numbers in quadrants indicate
percent gated CD4+ T cells in each after restimulation. Cells producing IFN-g and IL-17 did not
express the lineage marker Foxp3 (data not shown). (b) ELISA of cytokines in supernatants of
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ovalbumin peptide plus curdlan or CpG, evaluated after restimulation. (c) ELISA of cytokines in
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on day 0 (h). Data are the mean ± s.d. of triplicate (b,c,e–h) or duplicate (d) cultures and are representative of two to four independent experiments.
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Notably, depleting the OT-II CD4+ T cell preparation of CD25+
regulatory T cells (Treg cells) led to the differentiation of TH1 cells even
in the presence of curdlan (Fig. 5c). As reported for TLR-stimulated
DCs8, only when Treg cells were ‘added back’ to the starting
T cell population did the IFN-g-dominated response subside and
IL-17-producing cells emerge (Fig. 5c and Supplementary Fig. 3).
Similarly, we detected transcripts encoding IL-17A, IL-17F and
RORgt only in curdlan-containing cultures when Treg cells were
present (Fig. 5d). The effect of Treg cells was not simply to prevent
TH1 cell differentiation, as it could not be mimicked by the neutraliza-
tion of IFN-g (Supplementary Fig. 5 online). Instead, as reported
before8, Treg cells served at least in part as a source of TGF-b; their
effect could be blocked by antibody to TGF-b (anti-TGF-b) and could
be mimicked, albeit only partially, by exogenous TGF-b (Fig. 5e,f).
The differentiation of TH-17 cells induced by curdlan and Treg cells was
also dependent on IL-23 and TNF, as this differentiation was blocked
by antibodies neutralizing either cytokine (Fig. 5g,h). Finally, the
addition of excess IL-12p70 prevented the differentiation of TH-17
cells induced by curdlan-stimulated DCs, whereas the addition of
IL-23 led to TH-17 skewing in cultures of CpG-stimulated DCs
(Supplementary Fig. 6 online). We conclude that DCs stimulated
with curdlan can bias the differentiation of CD4+ T cells toward a
TH-17 fate through a pathway requiring Treg cells and involving
TGF-b, TNF and IL-23.
Dectin-1 agonists are adjuvants for TH1 and TH-17 priming
To assess whether dectin-1 stimulation also leads to the induction of
TH-17 responses in vivo, we tested curdlan as an adjuvant. Adoptively
transferred OT-II cells proliferated more extensively in response to
antigen mixed with curdlan or CpG than in response to antigen alone
(Fig. 6a). Cells from draining lymph nodes of mice that had received
antigen and CpG produced considerable IFN-g but little IL-17 after
restimulation with antigen in vitro (Fig. 6b). In contrast, substantial
IL-17, as well as IFN-g, was produced by cells from mice immunized
with antigen and curdlan (Fig. 6b,c). Intracellular cytokine staining
showed the presence of TH1 and TH-17 cells, which existed together as
separate populations (data not shown). Notably, the TH-17 and TH1
responses induced by antigen and curdlan in vivo were dependent on
dectin-1, as they were abrogated in chimeric mice containing dectin-1-
knockout hematopoietic cells (Fig. 6c). In contrast, the TH1 response
induced by CpG was unaffected by dectin-1 deficiency (data not
shown). Consistent with the finding that curdlan and CpG induced
TH1 cells, both stimuli triggered the production of ovalbumin-specific
immunoglobulin G2c (IgG2c) antibodies (Fig. 6d). However, curdlan
also promoted the production of high titers of ovalbumin-specific
IgG1 antibodies (Fig. 6d). In addition, mice that received curdlan
developed anti-b-glucan IgM, which could be used to stain C. albicans
yeast (Supplementary Fig. 7 online). We conclude that selective
engagement of dectin-1 in vivo is able to link innate immunity with
the induction of T cell and B cell responses.
CARD9 regulates TH-17 responses to C. albicans
Finally, we sought to determine whether CD4+ TH-17 cell responses
are induced during fungal infection and to what extent this depends
on the dectin-1–Syk–CARD9 signaling pathway. Large amounts of
IFN-g and IL-17 were produced by CD4+ spleen cells from mice
infected with C. albicans after restimulation with heat-killed organisms
(Fig. 7a). Dectin-1 was redundant for this response (data not shown),
consistent with the fact that it is also not essential for DC responses to
zymosan19,20. In contrast, CARD9 was indispensable for the TH-17
response and partially contributed to the TH1 response (Fig. 7b). We
conclude that adaptive immune responses to C. albicans infection
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include the induction of TH-17 cells and that this process is dependent
on innate signaling via CARD9.
DISCUSSION
Pattern recognition is critical for the mobilization of defense mechan-
isms after invasion by potential pathogens14. In addition to stimulat-
ing the microbicidal effector functions of myeloid cells, some classes of
PRRs can signal to regulate the expression of genes involved in the
innate response and to facilitate the induction of adaptive immune
responses by DCs15. However, of the many possible PRRs expressed at
the cell surface, only the TLR family members have been conclusively
proven to generate immunogenic DCs. Here we have added
Syk-coupled C-type lectin PRRs to that list and have shown that
dectin-1 signaling through the Syk-CARD9 pathway induced the
maturation of DCs into effector antigen-presenting cells capable of
eliciting the differentiation of TH-17 and TH1 cells. Furthermore, we
have shown that the same signaling pathway was critical for the
development of TH-17 responses during infection with C. albicans.
Thus, our results identify the Syk-CARD9 axis as a TLR-independent
innate signaling pathway for activating DCs that is nonredundant for
directing potent TH-17 responses to infection.
Dectin-1 signaling in DCs resulted in maturation and the produc-
tion of a distinct combination of cytokines, including considerable
IL-2, IL-10, TNF and IL-23. All DC responses to dectin-1 agonists
were strictly dependent on Syk, distinguishing them from responses to
TLR signals, which are independent of Syk. One apparent exception
was the induction of IL-12p35 and IL-12p70 by CpG, which seemed to
be dependent on Syk. IL-12p35 production is regulated at many levels
and is strongly enhanced by synergistic interaction between different
TLRs, costimulation by IFN-g or CD40 ligand, or type I interferon
receptor signaling22. The Syk dependence of the production of
IL-12p35 and IL-12p70 in response to CpG may therefore indicate
involvement of a Syk-coupled cellular receptor that can act in synergy
with TLR9 for IL-12p35 induction. In addition, dectin-1 signaling for
cytokine production was dependent on CARD9, again distinguishing
it from TLR signaling, which is CARD9 independent18,23. The CARD9
dependence of cytokine induction is consistent with the importance of
this adaptor in coupling dectin-1–Syk signals to NF-kB activation18.
However, CARD9 has also been associated with linking signaling by
the receptor Nod2 to activation of p38 and Jnk23. It is therefore
possible that CARD9 also coordinates activation of the mitogen-
activated protein kinase cascade ‘downstream’ of dectin-1–Syk.
Experiments with curdlan stimulation of CARD9-deficient cells will
help address this issue.
TLR stimulation of DCs can induce TH-17 responses
8, but activa-
tion through the dectin-1–Syk–CARD9 pathway induced greater
TH-17 skewing. However, in both cases the mechanism involved was
similar, being dependent on the presence of Treg cells and requiring
TGF-b8. This is consistent with reports suggesting that TGF-b (in
concert with IL-6) acts in the first step of TH-17 instruction
8–10 and
that IL-23 acts secondarily to support the proliferation and differ-
entiation of TH-17 cells
24,25. DCs stimulated through the dectin-1–
Syk–CARD9 pathway had a propensity to produce IL-23 rather than
IL-12. The lack of IL-12, together with the production of IL-10, may
limit TH1 skewing, thereby diminishing the amount of negative
feedback on TH-17 cell differentiation. Indeed, the addition of
IL-12p70 abrogated the induction of TH-17 cells by curdlan-
stimulated DCs, probably because IL-12 boosts the differentiation of
TH1 cells, which produce IFN-g and inhibit the differentiation of
TH-17 cells
26,27. However, the IL-23–versus–IL-12p70 balance is not
sufficient to explain the effect of curdlan, as, for example, Syk–/– DCs
stimulated with CpG, which also make IL-23 but little IL-12p70,
elicited little TH-17 cell differentiation. In this context, the finding that
DCs produce large quantities of TNF, IL-12p40 and IL-6 after curdlan
stimulation is notable, as IL-23, TNF and IL-6 all have synergistic
effects on the induction of TH-17 cells
8. Consistent with that
idea, blockade of TNF or IL-23 decreased the curdlan-dependent
differentiation of TH-17 cells. Notably, even though zymosan induces
TGF-b production by macrophages28 and DCs can secrete TGF-b8,29,
the amount of TGF-b induced by curdlan alone was insufficient to
promote the differentiation of TH-17 cells in the absence of Treg cells.
Treg cells act by providing TGF-b or signals that potentiate
the ability of DCs to secrete this cytokine8. In addition, curdlan-
stimulated DCs produce considerable IL-2, which might help main-
tain Treg cell function and establish a positive feedback loop
30,31. The
combination of all these factors may explain why DCs stimulated
through the dectin-1–Syk–CARD9 pathway were more efficient than
TLR-stimulated DCs at inducing the differentiation of TH-17 cells.
The importance of adaptive immunity in protection from
C. albicans is emphasized by the notable susceptibility of immuno-
deficient patients to this otherwise nonpathogenic commensal
organism32. Furthermore, protective T cell responses to Aspergillus
fumigatus33–35 are partially MyD88 independent36, consistent with the
possibility that many antifungal responses may be induced through
the Syk-CARD9 pathway. However, the induction of TH-17 responses
to fungal infection has not been reported before to our knowledge,
even though both TGF-b and IL-17 are critical for resistance to
C. albicans infection6,37. How TH-17 cells might contribute to fungal
clearance is unknown, but it is notable that IL-17 is a potent
recruitment factor for neutrophils and that neutropenia is a chief
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Figure 7 Infection with C. albicans induces CARD9-dependent TH-17
antifungal responses. (a) ELISA of IFN-g and IL-17 production by total
splenocytes (Total spleen) or splenocyte samples depleted of CD4+ cells
(CD4+ depl); cells were obtained from wild-type mice infected with
C. albicans and were restimulated with heat-killed organisms. (b) ELISA of
IFN-g and IL-17 production by total splenocytes from Card9–/– or Card9+/–
mice infected with C. albicans before restimulation of cells with heat-killed
organisms. Each symbol represents one mouse (mean of triplicate
restimulations); horizontal bars, median. *, P o 0.05; **, P o 0.01;
***, P o 0.001. Data are from six to fourteen mice per group pooled
from three independent experiments.
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risk factor for invasive candidiasis38. Notably, the induction of
TH-17 cells through the Syk-CARD9 pathway may also explain
why subclinical fungal infections and fungal b-glucans precipitate
disease in mouse models of rheumatoid arthritis21,39 and
other autoimmune diseases40,41. How this conforms with the
observation that zymosan can also promote immunological tolerance
is unclear28.
The finding that dectin-1–Syk–CARD9 signaling in DCs acts as an
autonomous pattern-recognition pathway capable of linking the
innate and adaptive immune system has notable implications. It is
becoming increasingly apparent that dectin-1 is not the only C-type
lectin that can signal by means of Syk42. The possibility that other Syk-
coupled receptors act as PRRs in myeloid cells could help explain the
development of TH-17 responses not only during infection with fungi
but also during infection with extracellular bacteria such as
K. pneumoniae and Citrobacter rodentium5,9. All of these organisms
engage many receptors, in particular those of the TLR family, so it will
be useful to study how signaling by means of C-type lectins is
integrated with signaling from other PRRs42. Nevertheless, the identi-
fication of a PRR family that accomplishes a function analogous to
that of TLRs but more is powerful in ‘instructing’ TH-17 cell devel-
opment reinforces the idea that innate recognition is central to
immune regulation and opens the possibility for therapeutic inter-
vention. Thus, agonists of the Syk-CARD9 pathway might be useful in
vaccine development, whereas antagonists might find a place in the
treatment of immunopathology. Finally, the central function of Syk in
DC activation by means of C-type lectin PRRs raises the issue of
whether other receptors that engage Syk in myeloid cells, such as
TREM proteins43, Fc receptors44 and integrins45, can also couple
innate and adaptive immunity. Syk coupling by myeloid receptors
could therefore extend the function of immunoreceptor
tyrosine-based activation motif signaling, the central pivot of adaptive
immunity, to the earlier step of innate recognition42.
METHODS
Mice. C57BL/6 mice were from Charles River. Mice lacking both MyD88 and
TRIF were generated by intercrossing of MyD88-knockout and TRIF-knockout
mice. OT-II TCR-transgenic mice on a B6.SJL background (congenic CD45.1+)
were generated by intercrossing of OT-II TCR-transgenic mice on C57BL/6
background with B6.SJL mice. All of these mice, as well as MyD88-knockout,
TRIF-knockout and OT-II TCR-transgenic mice on a C57BL/6 background,
were bred at Cancer Research UK in specific pathogen–free conditions.
Dectin-1-knockout mice19 were bred at the University of Cape Town,
South Africa. CARD9-knockout mice18 were bred at the Technische Universita¨t
Mu¨nchen, Germany. Radiation chimeras were generated as described16. All
animal experiments were in accordance with national and institutional guide-
lines for animal care.
Reagents. Culture medium was RPMI 1640 medium supplemented with
glutamine, penicillin, streptomycin, 2-mercaptoethanol (all from Invitrogen)
and 10% (vol/vol) heat-inactivated FCS (Bioclear). Curdlan (Wako) was
suspended in PBS at a concentration of 10 mg/ml. Zymosan, MALP2, FSL
and Pam3CSK4 were from Invivogen. CpG oligonucleotide 1668 was synthe-
sized by Sigma. Streptavidin-sepharose was from GE Healthcare. Ovalbumin
peptide (residues 323–339) was synthesized and purified by high-performance
liquid chromatography at Cancer Research UK. Ovalbumin protein used for
in vitro assays was from Calbiochem, and sterile-filtered egg white for in vivo
use was prepared as described46. The amount of egg white presented here
always represents the ovalbumin equivalent. Granulocyte-macrophage colony-
stimulating factor (GM-CSF) was made by the Cancer Research UK protein
purification service and batches were ‘titrated’ to produce optimal growth
conditions for BMDCs. Antibodies used for flow cytometry were from BD
Pharmingen and included those specific for CD11c (clone HL3), CD86 (GL1),
CD80 (16-10A1), CD40 (3/23), CD4 (RM4-5), CD25 (PC61), CD45.1 (A20),
IFN-g (XMG1.2) and IL-17 (TC11-18H10.1). Neutralizing antibodies were
anti-TGF-b (1D11; R&D Systems), anti-p19 (G23.8; eBioscience), anti-TNF
(MP6-XT3; BD Pharmingen) and anti-IFN-g (XMG1.2; BD Pharmingen).
Purified 2.4G2 (anti-FcgRIII/II used to block nonspecific antibody binding)
was from the Cancer Research UK antibody production service. Antibodies
used for immunoblot analysis were rabbit polyclonal antibodies, except the
p38-specific antibody (L53F8), and were from Cell Signaling.
BMDC culture and stimulation. BMDCs were generated as described47, and
DCs were purified from bulk cultures with anti-CD11c microbeads before use
(Miltenyi Biotec). BMDC purity was checked by flow cytometry and was
routinely over 98% (data not shown). For expression of streptavidin-binding
peptide–tagged dectin-1 (ref. 17) in BMDCs, the streptavidin-binding peptide
tag48 was fused to the carboxyl terminus of wild-type dectin-1 or dectin-1 with
a substitution in its signaling domain (Y15F) and was cloned into the retroviral
vector pFB-IRES-GFP. Retrovirus production and BMDC infection were done
as described49. Of the CD11c+ cells, 80–95% were routinely positive for green
fluorescent protein (data not shown). For analysis of cytokine production and
surface marker expression, 5  104 to 10  104 BMDCs per well were cultured
for 18–24 h in 96-well round-bottomed plates in 200 ml culture medium
containing GM-CSF in the presence of curdlan (100 mg/ml), CpG (500 ng/ml)
and/or lipopolysaccharide (50 ng/ml) or as described in the legends to Figures
1b,d,e and 3d,e,g. Streptavidin-sepharose was used at a concentration of
25 ml/ml. All stimuli were ‘pretitrated’ and were used near their optimal
concentration, as determined by induction of maximum cytokine production
and DC maturation. Cytokines in the supernatants were measured by sandwich
ELISA. For RNA isolation, 4  105 BMDCs per well were cultured for 3 h in
48-well plates in 0.5 ml culture medium containing GM-CSF and various
stimuli as described in the legend to Supplementary Figure 2. For biochemical
assays, 1  106 to 2  106 BMDCs per well were cultured overnight in 24-well
plates in 1 ml culture medium containing GM-CSF before stimulation for
various times with or without curdlan (500 mg/ml) or CpG (10 mg/ml).
Flow cytometry. Cell suspensions were stained in ice-cold PBS supplemented
with 2 mM EDTA, 1% (vol/vol) FCS and 0.02% (wt/vol) sodium azide. For
intracellular cytokine staining, cells were stained with anti-CD4 or anti-CD11c,
were fixed with Fix and Perm Reagent A (Caltag Laboratories) and then were
resuspended in Fix and Perm Reagent B (Caltag Laboratories) containing
labeled antibodies. Data were acquired on a FACSCalibur (BD Biosciences) and
were analyzed with FlowJo software (TreeStar).
RNA isolation and real-time RT-PCR. Total RNA was prepared with TRIzol
reagent (Invitrogen). The cDNA was synthesized from total RNA with random
hexamers and Superscript II reverse transcriptase (Invitrogen). Quantitative
real-time PCR was accomplished with SYBR Green incorporation (for tran-
scripts encoding IL-17A, IL-17F, RORgt, IL-23p19, IL-2, IL-6 and TNF) or
Taqman (for transcripts encoding IL-12p35, IL-12p40 and IL-10). For SYBR
Green reactions, primer sequences were as described12,50,51; for IL-6, primer
sequences were as follows: forward, 5¢-GTTCTCTGGGAAATCGTGGA-3¢;
reverse, 5¢-TGTACTCCAGGTAGCTATGG-3¢. For Taqman reactions, primers
and probes were from Applied Biosystems. Measurements were made in
duplicate wells with the ABI PRISM 7700 sequence detection system (Applied
Biosystems). Results were normalized to those obtained with 18S rRNA
(primers and probe from Applied Biosystems) and results are presented as
relative quantities of mRNA.
Immunoblot analysis and NF-jB assay. Cells were collected by being scraped
into ice-cold PBS supplemented with 5 mM EDTA. After centrifugation, the
cell pellet was lysed for 30 min on ice with buffer (50 mM Tris, pH 7.5, 1%
(vol/vol) Nonidet-P40, 0.5% (wt/vol) deoxycholic acid, 0.1% (wt/vol) SDS,
150 mM NaCl, 10 mM NaF, 1 mM Na3VO4 and 2 mM Na4P2O7, plus a mixture
of protease inhibitors; Roche Molecular Biochemicals). Cell debris were
removed by centrifugation and extracts were quantified by protein assay
(Bio Rad). For immunoblot analysis, a fixed amount of total protein was
mixed with sample buffer (0.125 M Tris, pH 6.8, 4% (wt/vol) SDS, 20%
(vol/vol) glycerol, 5% (vol/vol) 2-mercaptoethanol) and was resolved by
SDS-PAGE (4–20% acrylamide gradient, Tris-glycine; Invitrogen). After
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transfer to a polyvinyldifluoride membrane (Millipore), proteins were analyzed
by immunoblot and were visualized by enhanced chemiluminescence (Pierce).
NF-kB was measured in the extracts by analysis of a fixed amount of total
protein with the NF-kB p65 transcription factor assay kit according to the
manufacturer’s instructions (Pierce).
In vitro T cell differentiation. CD4+ T cells from the lymph nodes of OT-II
mice (C57BL/6 background) were purified by a two-step procedure with MACS
beads (Miltenyi Biotec), which included depletion of antigen-presenting cells
followed by enrichment for CD4+ cells. Alternatively, CD4+CD11c–CD25– and
CD4+CD11c–CD25+ cells were sorted from the spleens of OT-II mice (C57BL/6
background) by flow cytometry with a MoFlo (Dako Cytomation) or a
FACSAria (BD Biosciences). Purified OT-II T cells (5  104) were cultured
together with BMDCs (1  104) and 10–50 mg/ml of ovalbumin protein or
2–10 nM ovalbumin peptide (residues 323–339) in the presence or absence of
curdlan (50 mg/ml) or CpG (0.5 mg/ml) in complete culture medium further
supplemented with sodium pyruvate, nonessential amino acids and HEPES (all
from Invitrogen). In some experiments, neutralizing antibodies (10 mg/ml) or
recombinant cytokines (TGF-b, 1-10 ng/ml (Sigma); IL-12 p70, 5 ng/ml
(Biosource); IL-23, 10 ng/ml (eBioscience)) were added. Cultures were
split at a ratio of 1:2 on day 3 and were restimulated on day 5 for 5 h with
phorbol 12-myristate 13-acetate (10 ng/ml; Sigma), ionomycin (1 mg/ml;
Calbiochem) and GolgiStop (BD Pharmingen), and intracellular cytokines
were analyzed by flow cytometry. Alternatively, the entire content of each well
was restimulated on day 5 on plate-bound anti-CD3e (Cancer Research UK
antibody production service) for 48 h before cytokines in the supernatant were
analyzed by sandwich ELISA.
Immunizations. Naive C57BL/6 mice were immunized intraperitoneally with
5 mg curdlan alone or with 50 mg egg white plus 2 mg curdlan or 5 mg CpG or
were immunized in the footpads with 3 mg egg white plus 50–500 mg curdlan or
0.5–2.5 mg CpG. For T cell differentiation assays, CD4+ OT-II populations
(from OT-II mice on B6.SJL background; 1  106 to 4  106 cells per mouse),
depleted of antigen-presenting cells and labeled with CFSE, were transferred
into host mice by intravenous injection 1 d before immunization. CFSE
dilution of CD4+CD45.1+ spleen cells was analyzed by flow cytometry 3 d
after immunization. Alternatively, 1  106 to 2  106 total popliteal lymph
node cells were restimulated for 48 h with egg white before cytokines in the
supernatant were measured by sandwich ELISA.
Infection. Card9–/– mice and Card9+/– control mice were infected intravenously
with 4  103 to 1.2  104 colony-forming units of C. albicans strain SC5314.
On days 6–8 after infection, mice were killed and total splenocytes or
splenocyte samples depleted of CD4+ cells (2  106 cells per well) were
restimulated in 96-well U-bottomed plates with heat-inactivated C. albicans
(1  106 to 1  108 per ml). After 48 h, IFN-g and IL-17 in the supernatants
were measured by sandwich ELISA.
Antibody measurement. Relative titers of ovalbumin-specific IgG2c and IgG1
in serum samples from experimental mice were measured by capture ELISA
with anti–mouse IgG1 (BD Pharmingen, clone A85-1) or anti–mouse IgG2c
(Jackson Immunoresearch) on plates coated with ovalbumin protein.
The b-glucan-specific immunoglobulins were detected by ELISA with anti–
mouse immunoglobulin (Jackson Immunoresearch) and plates coated
with curdlan made soluble in NaOH. For staining of C. albicans, heat-
inactivated yeast cells were incubated with diluted serum followed by
anti–mouse immunoglobulin. Confocal images were acquired on a Zeiss
LSM510 microscope.
Statistics. Statistical significance was determined by a two-tailed unpaired t-test
with Graphpad Prism (GraphPad Software).
Note: Supplementary information is available on the Nature Immunology website.
ACKNOWLEDGMENTS
We thank M. Weber for the acquisition of confocal images, and F. Batista,
A. O’Garra and members of the Immunobiology Laboratory (Cancer Research
UK) for advice and discussions. MyD88-knockout and TRIF-knockout mice
were from S. Akira (Osaka University), OT-II TCR-transgenic mice on a
C57BL/6 background were from W. Heath (Walter and Eliza Hall Institute),
lipopolysaccharide was from S. Vogel (University of Maryland), and
pFB-IRES-GFP was from R. Germain (National Institute of Allergy and
Infectious Diseases). Supported by Cancer Research UK and EMBO (S.LG-L).
AUTHOR CONTRIBUTIONS
S.LG.-L. and C.R.S. designed the study, analyzed data and wrote the paper;
S.LG.-L. coordinated the study, did experiments and analyzed data; M.J.R., F.O.
and E.C.S. contributed additional experiments and intellectual input; O.G. and
J.R. did the experiments with CARD9-knockout cells and mice; S.V.T. and
G.D.B. provided dectin-1-knockout bone marrow and infected dectin-1-
knockout mice; and E.S. and V.T. provided Syk-knockout fetal livers.
COMPETING INTERESTS STATEMENT
The authors declare no competing financial interests.
Published online at http://www.nature.com/natureimmunology/
Reprints and permissions information is available online at http://npg.nature.com/
reprintsandpermissions
1. Sher, A. & Coffman, R.L. Regulation of immunity to parasites by T cells and T cell-
derived cytokines. Annu. Rev. Immunol. 10, 385–409 (1992).
2. Abbas, A.K., Murphy, K.M. & Sher, A. Functional diversity of helper T lymphocytes.
Nature 383, 787–793 (1996).
3. Harrington, L.E., Mangan, P.R. & Weaver, C.T. Expanding the effector CD4 T-cell
repertoire: the Th17 lineage. Curr. Opin. Immunol. 18, 349–356 (2006).
4. Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M. & Murphy, K.M. Th17: an
effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677–688
(2006).
5. Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine
and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host
defense. J. Exp. Med. 194, 519–527 (2001).
6. Huang, W., Na, L., Fidel, P.L. & Schwarzenberger, P. Requirement of interleukin-17A
for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190, 624–631
(2004).
7. Szabo, S.J., Dighe, A.S., Gubler, U. & Murphy, K.M. Regulation of the interleukin (IL)-
12Rb2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med.
185, 817–824 (1997).
8. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFb in the
context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-
producing T cells. Immunity 24, 179–189 (2006).
9. Mangan, P.R. et al. Transforming growth factor-b induces development of the TH17
lineage. Nature 441, 231–234 (2006).
10. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic
effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
11. Szabo, S.J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment.
Cell 100, 655–669 (2000).
12. Ivanov, I.I. et al. The orphan nuclear receptor RORgt directs the differentiation program
of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).
13. Szabo, S.J., Sullivan, B.M., Peng, S.L. & Glimcher, L.H. Molecular mechanisms
regulating Th1 immune responses. Annu. Rev. Immunol. 21, 713–758
(2003).
14. Janeway, C.A., Jr. Approaching the asymptote? Evolution and revolution in immunology.
Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).
15. Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune
responses. Nat. Immunol. 5, 987–995 (2004).
16. Rogers, N.C. et al. Syk-dependent cytokine induction by dectin-1 reveals
a novel pattern recognition pathway for C type lectins. Immunity 22, 507–517
(2005).
17. Underhill, D.M., Rossnagle, E., Lowell, C.A. & Simmons, R.M. Dectin-1 activates Syk
tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production.
Blood 106, 2543–2550 (2005).
18. Gross, O. et al. CARD9 controls a non-TLR signalling pathway for innate anti-fungal
immunity. Nature 442, 651–656 (2006).
19. Taylor, P.R. et al. A critical role for b-glucan recognition in the control of fungal
infection. Nat. Immunol. 8, 31–38 (2007).
20. Saijo, S. et al. Dectin-1 is required for host defense against Pneumocystis carinii but
not against Candida albicans. Nat. Immunol. 8, 39–46 (2007).
21. Yoshitomi, H. et al. A role for fungal b-glucans and their receptor dectin-1 in the
induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201,
949–960 (2005).
22. Trinchieri, G. & Sher, A. Cooperation of Toll-like receptor signals in innate immune
defence. Nat. Rev. Immunol. 7, 179–190 (2007).
23. Hsu, Y.M. et al. The adaptor protein CARD9 is required for innate immune responses to
intracellular pathogens. Nat. Immunol. 8, 198–205 (2007).
24. Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J. & Gurney, A.L. Interleukin-23
promotes a distinct CD4 T cell activation state characterized by the production of
interleukin-17. J. Biol. Chem. 278, 1910–1914 (2003).
25. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces
autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005).
NATURE IMMUNOLOGY VOLUME 8 NUMBER 6 JUNE 2007 637
A R T I C L E S
©
20
07
 
N
at
ur
e 
Pu
bl
is
hi
ng
 G
ro
u
p 
 h
ttp
://
w
w
w.
n
at
ur
e.
co
m
/n
at
ur
ei
m
m
u
n
o
lo
gy
26. Harrington, L.E. et al. Interleukin 17–producing CD4+ effector T cells develop via a
lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132
(2005).
27. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by
producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
28. Dillon, S. et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory
antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116, 916–928
(2006).
29. Morelli, A.E. et al. Cytokine production by mouse myeloid dendritic cells in relation to
differentiation and terminal maturation induced by lipopolysaccharide or CD40 liga-
tion. Blood 98, 1512–1523 (2001).
30. D’Cruz, L.M. & Klein, L. Development and function of agonist-induced CD25+Foxp3+
regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6,
1152–1159 (2005).
31. Fontenot, J.D., Rasmussen, J.P., Gavin, M.A. & Rudensky, A.Y. A function for inter-
leukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142–1151
(2005).
32. Hohl, T.M., Rivera, A. & Pamer, E.G. Immunity to fungi. Curr. Opin. Immunol. 18,
465–472 (2006).
33. Cenci, E. et al. T cell vaccination in mice with invasive pulmonary aspergillosis.
J. Immunol. 165, 381–388 (2000).
34. Cenci, E. et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect.
Immun. 65, 564–570 (1997).
35. Perruccio, K. et al. Transferring functional immune responses to pathogens
after haploidentical hematopoietic transplantation. Blood 106, 4397–4406
(2005).
36. Rivera, A. et al. Innate immune activation and CD4+ T cell priming during respiratory
fungal infection. Immunity 25, 665–675 (2006).
37. Spaccapelo, R. et al. TGF-b is important in determining the in vivo patterns of
susceptibility or resistance in mice infected with Candida albicans. J. Immunol.
155, 1349–1360 (1995).
38. Huffnagle, G.B. & Deepe, J.G.S. Innate and adaptive determinants of host
susceptibility to medically important fungi. Curr. Opin. Microbiol. 6, 344–350
(2003).
39. Hirota, K. et al. T cell self-reactivity forms a cytokine milieu for spontaneous develop-
ment of IL-17+ Th cells that cause autoimmune arthritis. J. Exp. Med. 204, 41–47
(2007).
40. Hida, S., Nagi-Miura, N., Adachi, Y. & Ohno, N. Beta-glucan derived from zymosan acts
as an adjuvant for collagen-induced arthritis. Microbiol. Immunol. 50, 453–461
(2006).
41. Veldhoen, M., Hocking, R.J., Flavell, R.A. & Stockinger, B. Signals mediated by
transforming growth factor-b initiate autoimmune encephalomyelitis, but chronic
inflammation is needed to sustain disease. Nat. Immunol. 7, 1151–1156 (2006).
42. Robinson, M.J., Sancho, D., Slack, E.C., LeibundGut-Landmann, S. & Reis e Sousa, C.
Myeloid C-type lectins in innate immunity. Nat. Immunol. 7, 1258–1265 (2006).
43. Klesney-Tait, J., Turnbull, I. & Colonna, M. The TREM receptor family and signal
integration. Nat. Immunol. 7, 1266–1273 (2006).
44. Ravetch, J.V. & Bolland, S. IgG Fc receptors. Annu. Rev. Immunol. 19, 275–290
(2001).
45. Mocsai, A. et al. Integrin signaling in neutrophils and macrophages uses adaptors
containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 7,
1326–1333 (2006).
46. Boes, M. et al. T cells induce extended class II MHC compartments in dendritic
cells in a Toll-like receptor-dependent manner. J. Immunol. 171, 4081–4088
(2003).
47. Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow
cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp.
Med. 176, 1693–1702 (1992).
48. Keefe, A.D., Wilson, D.S., Seelig, B. & Szostak, J.W. One-step purification of recombi-
nant proteins using a nanomolar-affinity streptavidin-binding peptide, the SBP-Tag.
Protein Expr. Purif. 23, 440–446 (2001).
49. Mackey, M.F., Wang, Z., Eichelberg, K. & Germain, R.N. Distinct contributions of
different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and
IL-12 secretion. Eur. J. Immunol. 33, 779–789 (2003).
50. Holscher, C. et al. A protective and agonistic function of IL-12p40 in mycobacterial
infection. J. Immunol. 167, 6957–6966 (2001).
51. Overbergh, L. et al. The use of real-time reverse transcriptase PCR for the quantification
of cytokine gene expression. J. Biomol. Tech. 14, 33–43 (2003).
638 VOLUME 8 NUMBER 6 JUNE 2007 NATURE IMMUNOLOGY
A R T I C L E S
©
20
07
 
N
at
ur
e 
Pu
bl
is
hi
ng
 G
ro
u
p 
 h
ttp
://
w
w
w.
n
at
ur
e.
co
m
/n
at
ur
ei
m
m
u
n
o
lo
gy
